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THE HISTOLOGY AND IMMUNOPATHOLOGY OF VITILIGO 
SUMMARY 
Twenty-nine Caucasoid patients with 'common' 
vitiligo were studied. The sera of these patients 
were tested for autoantibodies. Shave biopsies 
from uninvolved, marginal and involved areas were 
studied by DOPA method, direct immunofluorescence 
tests, indirect immunofluorescence complement 
fixation technique, Epon embedded tissue for light 
microscopy and by electron microscopy. 
All the patients had symmetrical vitiligo 
apart from one. About 50% of these patients had 
the onset of their vitiligo before the age of 20 
years. The incidence of autoimmune disorders that 
are commonly associated with vitiligo seemed to be 
increased. These patients frequently had a positive 
family history of vitiligo and other autoimmune 
disorders. The organ specific autoantibodies were 
also increased in the sera of these patients. There 
was no significant deposition of immunoglobulins 
in all areas biopsied apart from the presence of 
cytoid (colloid/amyloid) bodies. However, in many 
patients, there was deposition of fibrin in the 
papillary dermis and at the dermo-epidermal junction 
of the marginal and involved areas. There was no 
complement fixing antibody to the melanocytes in 
the sera of all the patients tested. 
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On light and electron microscopy, inflammatory 
changes were seen in the skin of these patients, 
mostly in the marginal areas. This consisted of 
spongiosis of the epidermis with a mononuclear cell 
infiltrate. Many of the intraepidermal lymphocytes 
were found in direct contact with melanocytes and 
Langerhans cells. The degree of mononuclear cell 
infiltrate of the dermis did not parallel that seen 
in the epidermis. Sometimes, there was a massive 
lymphocytic infiltrate in the epidermis, even forming 
Pautrier-like micro-abscess, but only a few lympho- 
cytes in the upper dermis. It is suggested that 
the primary inflammatory reaction occurs in the 
epidermis where an antigen is present. 
Langerhans cells were found to be increased 
in the epidermis-of uninvolved areas of patients 
with vitiligo compared to that of normal controls. 
These cells were also increased in the involved 
depigmented areas. Some of these cells were seen 
to be in direct contact with lymphocytes. 
The melanocytes were markedly reduced in the 
marginal areas and only a few residual cells were 
found in the involved skin. The melanosomes had 
the tendency to be singly dispersed in the keratino- 
cytes rather than in membrane bounded complexes. 
There was no obvious pathological changes in 
the cutaneous nerves. However, there appeared to 
X 
be some evidence of regeneration of axons. In 
a third of the patients intra-epidermal nerves 
were found in the basal layer. Some of these nerves 
were adrenergic in type and observed occasionally 
in direct contact with a secretory melanocyte. 
Colloid/amyloid bodies were demonstrated in 
the papillary dermis, by a variety of techniques. 
They had the tendency to occur in the skin of 
patients with vitiliqo compared to that of normal 
controls. These colloid/amyloid bodies had many 
features that would suggest these bodies were 
derived from degenerating melanocytes. 
Three patients with occupational vitiligo 
due to paratertiary butyl phenol were studied. 
The findings were similar to that found in idiopathic 
vitiligo. 
The light microscopic ultrastructural and 
immunopathological findings in vitiligo do support 
the hypothesis that this condition is an 'auto- 
immune' disorder. 
xi 
INTRODUCTION 
I. HISTORICAL NOTES 
Vitiligo is a disease which has been known 
from time immemorial. The earliest information 
concerning it comes from Egyptian writing, the time 
of the Pharaos and it is contained in the Ebers 
Papyrus (Ebbell 1937). In this two types of 
diseases are described, one that is probably leprosy 
and the other vitiligo. Also in the Indian Sacred 
book, Antharva Veda, which dates back to 1400 BC, 
there is mentioned a disease, Schwetakustha, which 
was almost certainly vitiligo (Whitney 1905). 
The arabic word bohak as well as baras was used 
for vitiligo. The word baras "white skin" is mentio- 
ned in the Koran in relation to Jesus being able to 
cure patients with the condition (chapter 3, V48 and 
chapter 5, V109). 
The name vitiligo is derived from latin word 
vitelius, which means a calf. It was first used by 
Roman physician Celsus, of second century AD. The 
white patches of the disease resembled those of a 
calf (Fitzpatrick 1964). 
It has been known for many thousands of years 
in the ancient Indian and ancient Egyptian writings 
about certain plants that could be used for the treat- 
ment of vitiligo. The historical aspects of the 
treatment of vitiligo with psoralens has been reviewed 
by Fitzpatrick and Pathak (1959). Psoralea Coryli- 
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folia was the most widely used plant for the treat- 
ment of vitiligo which has subsequently been found 
to contain psoralen. Ibn El Bitar in the thirteenth 
century used a plant in Egypt called Ammi Majus Linn 
which also contains psoralen, for the treatment of 
vitiligo. Psoralens are still the most effective 
treatment for vitiligo. 
II. CLINICAL ASPECTS 
(a) Incidence 
Vitiligo affects all races and seems to affect the ' 
sexes equally. It has been estimated that it occurs 
in about 1% of the world population (Lerner 1959; 
El Mofty 1968). Although there is preponderance of 
females in most large series, this-is because they 
are based on out-patient figures rather than on the 
actual incidence in the population. The incidence is 
similar in both sexes (Howitz et al 1977). Genetic 
factors are undoubtedly involved and between 30-40% 
of patients have a positive family history of the con- 
dition (Lerner 1959; Fitzpatrick 1964; Copeman, Lewis 
and Bleehen 1974). Some pedigrees suggest that inheri- 
tance is determined by an autosomal dominant gene of 
variable penetrance. 
Histocompatibility antigen studies have shown 
that HLA antigens were found with similar frequency 
in ninety patients with vitiligo as in 341 controls 
(Retornaz et al 1976). A second study also did not 
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show significant association among general popu- 
lation but increased frequency of HLA B13 and HLA 
BW35 in certain "ethnic" groups (Metzker et al 1980). 
A third study showed that twenty-two out of thirty- 
three Japanese patients with Vogt-Koyanagi-Harada 
syndrome had the histocompatibility antigen HLA-LD- 
Wa (Yakura 1976). 
(b) Clinical Features 
Vitiligo can start at any age, but in 50% of 
patients it develops before the age of twenty (Lerner 
1959). It is an acquired pigmentary disorder in 
which there are variously sized patches of depigmen- 
tation of the skin that enlarge and coalesce toge- 
ther to form larger areas. These are white in colour, 
the borders of the lesions often being somewhat hyper- 
pigmented. In lightly pigmented individuals these 
white patches are first apparent in the summer months 
where they fail to tan. Sometimes these white areas 
burn as a result of sun exposure, but in most patients 
no symptoms are noted other than the cosmetic disabi- 
lities. 
The sites most commonly affected are the face, 
particularly around the eyes and mouth (fig 1), the 
backs of the hands and fingers, the axillae and groin $, 
umbilicus and genitalia. The parts which are subject 
to friction and trauma, such as the elbows and knees, 
are often affected. Vitiligo also occurs in sites of 
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Fig 1. Face of a patient with vitiligo showing symmetrical 
areas of depigmentation, mainly around the mouth and eyes. 
the skin that have been damaged, this being an 
isomorphic or Koebner phenomenon, (El Mofty 1968; 
Lerner and Nordlund 1978; Sweet 1978; Bleehen and 
Ebling 1979). Vitiligo can develop in linear 
scratch on the skin (fig 2) and the Koebner pheno- 
menon can be of diagnostic value (Fitzpatrick 1964). 
Occasionally, the marginal area in the lesion 
of vitiligo may be erythematous and elevated 
(Habermann 1933; Becker and Obermayer 1937; Garb 
and Wise 1948; Buckly and Lobitz 1953; Shukla 
1959; 
Pinkus 1959, Lerner 1959, Fregert, Möller and Rose- 
man 1959; Allende and Reed 1964; Michaelsson 1968; 
MacMillan and Rook 1971). Similarly few patients 
have noticed that the loss of pigment in an area 
has been preceeded by erythematous and itchy rash 
(Nordlund et al 1980). 
Careful examination of the depigmented areas 
of skin in patients with vitiligo show that there are 
some varying degrees of loss of pigmentation in the 
macules. These range from completely white to light 
brown to a darker brown. This has been described as 
trichrome vitiligo by Fitzpatrick (1964) and El Mofty 
(1968). This variable pigmentation of the skin in the 
areas of vitiligo can be confirmed by examination of 
patients under a Wood's lamp. 
(c) Types of Vitiligo 
Vitiligo may assume various forms. 
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Fig 2. Isomorphic (Koebner) phenomenon at site of scratches. 
Complete Vitiligo 
The depigmentation of the skin can become so 
extensive that little or no pigment remains except 
in the eyes. Even in these patients there are 
usually some areas of residual pigmentation of the 
skin. Not only the pigment of skin is lost, but 
also that of the hair. 
Segmental Vitiligo 
Not infrequently vitiligo has a dermatomal or 
quasidermatomal distribution. This is not infrequently 
seen on the face, particularly in the distribution of 
one of the divisions of the trigeminal nerve. 
Halo Naevi 
In this condition a halo of depigmentation occurs 
around a pigmented naevus. This is most commonly a 
compound naevus. Not infrequently these halo naevi 
are multiple and antedate the onset of vitiligo (Kopf, 
Morrill and Silberberg 1965; Frank and Cohen 1964). 
Many patients with vitiligo have a previous history of 
halo naevi and in one quoted series this was the case 
with 50% of patients (Lerner and Nordlund 1978). Halo 
naevi also occurs, not infrequently, with other auto- 
immune disorders in which one can demonstrate organ 
specific auto-antibodies (Bleehen and Ebling 1979). 
The central naevus in these lesions usually disappears 
almost completely, and after a number of years the 
depigmented halo around it may repigment. 
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Grey Hair 
It is not uncommon in patients with vitiligo 
for them to develop premature greyness of hair. 
Many with vitiligo give a positive family history 
of premature greyness (greyness of hair before the 
age of thirty). This is almost certainly vitiligo 
affecting the melanocytes of'the hair bulbs. Grey- 
ness of the hair is part of the disease of vitiligo 
(Nordlund et al 1978). 
Ocular Vitiligo 
Even in patients with extensive vitiligo the 
colour of the eyes do not change. However, changes 
have been noted in the uveal-and retinal pigment 
epithelium and this can be detected by slit-lamp 
examination. In one series of patients 50% had 
discrete areas of depigmentation in-the choroidal 
and retinal epithelium (Albert, Nordlund and Lerner 
1979; Nordlund and Lerner 1979). It is possible 
that these ocular changes are the result of uveitis 
from other diseases. However, there is a well known 
association of vitiligo with inflammatory disease of 
the eye as in the Vogt Koyanagi-Harada syndrome. 
This disease is characterised by acute uveitis, alo- 
pecia, vitiligo, halo naevi, poliosis and dysacusis 
with an aseptic meningitis (Nordlund et al 1980, 
Nordlund and Lerner 1979). 
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Occupational (Chemical) Vitiligo 
A number of chemical compounds can induce 
cutaneous depigmentation. A number of substituted 
phenolic compounds can produce a picture that is 
indistinguishable from vitiligo. Vitiligo can be 
induced by contact with the mono-benzyl ether of 
hydroquinone (Oliver, Schwartz and Warren 1940). 
In recent years, workers in contact with para 
tertiary butyl phenol (Malten et al 1971; James, 
Mayes and Stevenson 1977) have developed vitiligo. 
The clinical and histological features of 
those patients who have either their vitiligo, due 
to occupational contact with those substituted phenols, 
or as a result of therapy are identical to that 
observed in idiopathic vitiligo (Kahn 1970, Malten 
et al 1971; Dogliotti et al 1974; Calnan 1973, 
Bleehen and Sharquie 1982). 
(d) Clinical Association of Vitiligo 
Vitiligo is not infrequently clinically associa- 
ted with a number of disorders that are considered to 
be autoimmune in aetiology (Lerner 1959; Cunliffe et 
al 1968; Dawber 1968; Bor, Feiwel, Chanarin 1969, 
Howitz and Schwartz 1971; McGregory, Katz and Doe 
1972; Dawber 1970). 
Increased incidence of vitiligo has been repor- 
ted in the following disorders (see Table 1). 
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Diabetes mellitus (Dawber 1968, Macaron et al 1977) 
Hyperthyroidism (Lerner 1959, Cunliffe et al 1968, Ochi and 
DeGroot 1969) 
Hypothyroidism (Lerner 1955; Morgans 1964; Doniach et al 1972; 
McGregor et al 1972) 
Hashimoto's thyroiditis (McGregor et al 1972) 
Pernicious anaemia (Francis 1931; Dawber 1970; Howitz and 
Schwartz 1971) 
Addison's disease (Addison 1855; Dunlop 1963; Lerner 1971; 
McGregor et al 1972) 
Hypoparathyroidism (Fisher and Fitzpatrick 1970; Fields, Fragola 
and Hadley 1971, Hertz et al 1977) 
Alopecia areata (Lerner 1971; Fields et al 1971, Tan 1974, 
Hertz et al 1977) 
Scleroderma (Hertz et al 1977) 
Morphoea(Hertz et al 1977, Lerner and Nordlund 1978) 
Lichen sclerosus et atrophicus (Wallace 1971) 
Myasthenia gravis (Durance 1971; Tan 1974) 
Auto-immune haemolytic anaemia (Durance 1971; Walters, Lerner 
and Nordlund 1978) 
Chronic thrombocytopenia (Walters et al 1978) 
Melanoma (Lerner 1971; Milton, McCarthy and Carlon 1971) 
Table 1. Clinical associations of vitiligo 
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(e) Emotional Factors 
It is sometimes claimed by patients that the 
onset of their vitiligo coincides with emotional 
stress (Lerner 1959). However, what is more common 
is that vitiligo produces emotional distress as a 
result of the cosmetic disabilities that are all 
too often apparent. In some countries, vitiligo 
is thought to be the same as leprosy and this leads 
to considerable social difficulties. 
III. PATHOGENESIS OF VITILIGO 
Three major theories have been proposed to 
explain the pathogenesis of vitiligo. In one, melano- 
cytes are destroyed by an autocytotoxic process. in 
another, an immune mechanism is involved in the 
destruction of the melanocytes and in the third a 
neural factor is also implicated. 
(a) Auto-destructive Theory 
It has been suggested (Lerner 1971) that melano- 
cytes in the lesion of vitiligo are destroyed as a 
result of accumulation of toxic melanin precursors. 
The melanocytes "work themselves to death". In the 
areas that are most likely to be affected with viti- 
ligo the skin is usually hyperpigmented. It is 
possible that these melanocytes have been stimulated 
to produce more melanin and they are more susceptible 
to destruction as a result of an accumulation of toxic 
melanin precursors. There is evidence that some of 
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the intermediate metabolites in the biosynthesis 
of melanin are highly toxic to melanocytes in vitro 
(Hochstein and Cohen 1963; Pawelek 1976; Wick et al 
1977; Graham et al 1978). Many phenolic compounds 
have selective lethal effects to melanocytes, both 
in vitro (Riley 1970; Mansur et al 1978 and Bleehen 
1976) and vivo (Bleehen et al 1967,1968 and Riley 
1969) and contact with these chemical compounds has 
been the cause of occupational and therapeutic 
vitiligo (Oliver et al 1940, Kahn 1970; Malten et 
al 1971; Dogliotti et al 1974; " Calnan 1973 and James 
et al 1977). 
(b) Auto-immune Theory 
It has been suggested that vitiligo is an auto- 
immune disorder and this has been mainly based on the 
clinical association of vitiligo with a number of 
other disorders that are considered to be auto-immune. 
Patients with vitiligo have increased incidence of 
organ specific auto-antibodies compared with the 
general population (Brostoff, Bor and Feiwel 1969; 
Betterle et al 1976). Organ specific auto-antibodies 
to thyroid tissue, "gastric parietal cells and-adrenal 
tissue are frequently found among patients with 
vitiligo (Cunliffe et al 1968; Bor, Feiwel and Chanarin 
1969; Brostoff et al 1969; Howitz and Schwartz 1971; 
Dobmeier and Sams 1971; Betterle et al 1976; Macaron 
et al 1977). However, at the present time the majority 
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of patients with vitiligo do not have specific 
anti-melanocyte antibodies. One report by Langhof 
et al (1965) reported the presence of precipitating 
antimelanin antibodies in the sera of the majority 
of patients with vitiligo that they studied. How- 
ever, this has not been confirmed by other workers 
(Woolfson et al 1975). Immunofluorescent studies, 
both direct and indirect, have also failed to 
demonstrate an antimelanocyte antibodies (Dobmeier 
and Sams 1971, Betterle 1976, Bleehen 1979). In a 
recent study by Hertz et al (1977) demonstrated in 
the sera of two patients with vitiligo, alopecia 
areata, muco-cutaneous candidiasis and other endo- 
crine disorders, the presence of a complement fixing 
serum factor against melanocytes. The factor in the 
serum was bound to melanocytes in normal skin, mela- 
noma and naevus cells. This study was confirmed by 
Betterle et al 1979 who found that one of two patients 
with vitiligo and multiple endocrine disorders had 
circulating antibody against melanin producing cells 
using this indirect immunofluorescent complement 
technique. These recent studies have renewed interest 
that vitiligo could be autoimmune disotders in which 
antibodies are formed that react with melanin produ- 
cing cells leading to their destruction. However, it 
could also be an epiphenomenon and that the antibodies 
are the result of melanocytic damage. 
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A further possibility is that cell mediated 
immune mechanisms are also involved. This is 
supported by the high lymphocyte microcytotoxicity 
against melanoma cells in vitro, in cases of 
regressing halo naevi and Vogt-Koyanagi-Harada 
syndrome (Roenigk et al 1975; Tagawa 1978; Nordlund 
et al 1980). Also the lymphocytic cell infiltrate 
among the naevus cells in cases of actively regressing 
halo naevi (Frank and Cohen 1964; Stegmaier, Becker 
and Medenica 1969; Swanson, Wayte and Helwig 1968; 
Rowden and Lewis 1975) as observed both by light and 
electron microscopy, suggests further the possibility 
of cell-mediated immune mechanisms in vitiligo. 
(c) Neurogenic Theory 
It has been implicated that the cutaneous nerves 
are involved in vitiligo and that neurochemical factors 
are released at peripheral nerve endings that have a 
damaging effect on the melanocytes. This hypothesis 
was suggested by Lerner (1971). Electron microscopic 
studies on vitiliginous skin have shown that there are 
minor degenerative changes in the nerves (Breathnach, 
Bor and Wyllie 1966, Bleehen 1979). 
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CHAPTER ONE 
PATIENTS AND METHODS 
PATIENTS AND METHODS 
A total of twenty-nine Caucasian vitiligo 
patients were studied. Twenty-three were females 
and six males. The mean age of the patients was 
39.2 years, with a mean age of onset of their 
vitiligo being twenty-six years. (Summary of 
patients shown in table II). All the patients 
were examined under a Wood's lamp to determine the 
extent of the disease and all were assessed for any 
associated diseases. The following investigations 
were carried out on all the patients: Full blood 
count and sedimentation rate and full immunological 
screen for the following auto-antibodies was carried 
out; immunofluorescent nuclei (ANF); antibody to 
mitochondria; antibody to smooth muscle; antibody to 
gastric parietal cell; antibody to thyroid microsomes 
and antibody to thyroglobulin. 
Multiple shave biopsies were taken from all 
the patients. 
Skin biopsy: The areas of vitiligo were 
intensified by examining the patients under a Wood's 
lamp light. The skin was. swabbed with alcohol and 
the biopsy sites were anaesthetised with 2% plain 
xylocaine. Shave biopsies were taken from the centre 
of white vitiligo areas, from marginal pigmented skin 
and from the adjacent uninvolved pigmented skin, as 
shown in fig 3. The rectangular shave biopsy from 
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Fig 3. Forearms of a patient with vitiligo showing the sites 
of shave biopsies from uninvolved (U), marginal (M) and involved (I) 
areas. 
each area was immediately divided into three pieces 
with a sharp blade. One piece processed for direct 
immunofluorescence studies, the second for histo- 
chemistry (DOPA) studies and the third portion for 
plastic embedded sections for light and electron 
microscopy. Ten millilitres of blood was taken, 
left at room temperature for twenty minutes to clot 
and then centrifuged at about 2,000 r. p. m. for about 
twenty minutes. The serum collected was kept at 
temperature of -30°C until used for the experiments. 
Three patients with occupational vitiligo, due 
to paratertiary butyl phenol, were also studied. 
I. DIRECT IMMUNOFLUORESCENCE STUDIES 
The skin biopsies were wrapped immediately in 
normal saline impregnated gauze and immersed in cold 
saline for immediate transportation tothe laboratory. 
The biopsies were then snap frozen using a cryospray 
and the tissue mounted on a chuck with O. C. T. compound 
at -30°C. Vertical cryostat sections 6-8µ in thick- 
ness were cut and placed on glass slides. Before 
staining, the sections were washed in diluted veronal 
buffer at pH 7.2 for fifteen minutes. Commercially 
available fluorescein isothiocyanate - conjugated 
rabbit antihuman antisera (Behringwerke) for IgA, 
IgG, IgM, fibrin and complements C3, C4 in a 1: 15 
dilution were pipetted onto the labelled specimens 
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and left in a moist box for thirty minutes. The 
slides were then thoroughly washed with buffer for 
fifteen minutes. The sections were mounted in a 
Sodium barbitone buffered and glycerol mounting 
solution and covered with coverslips. The stained 
sections were examined using a Leitz orthoplan 
fluorescent microscope. For full details of the 
method see appendix I. 
Biopsies from nineteen normal individuals as 
controls were studied by direct immunofluorescence 
using the same techniques and to assess the deposi- 
tion of immunoglobulins, fibrin and complement. 
Also twenty further patients with different patho- 
logical skin conditions were studied by direct immuno- 
fluorescence for the presence of cytoid bodies. 
II. INDIRECT IMMUNOFLUORESCENCE COMPLEMENT FIXA- 
TION TEST 
Sera samples obtained from vitiligo patients 
were stored at temperature -30°"C. These samples were 
tested for the presence of a complement binding 
factor capable of reacting with melanin producing 
cells in the skin. The method for this technique 
has been fully described by Jordan, Sams and Beutner 
(1969), Katz, Hertz and Yaoita (1976) and used in 
relation to vitiligo by Hertz et al (1977). 
Biopsies were taken from normal skin, involved 
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areas of vitiligo and also a pigmented naevus and a 
blue naevus were used as substrates. The tissues 
were snap frozen and mounted as described previously. 
The sections were then washed in phosphate buffered 
saline (PBS) for fifteen minutes and treated with 
patients and control sera at different dilutions 
for forty-five minutes in a moist box at room 
temperature. Then the sections were washed with 
PBS for fifteen minutes and dried with a fan. The 
sections were then treated with complement (human 
serum as a source of complement) for forty-five 
minutes at 370C temperature and washed again in PBS 
for fifteen minutes. The sections were then covered 
with fluorescein labelled antibody for C3 for thirty 
minutes and washed for thirty minutes in PBS. Finally, 
the sections were mounted in the sodium barbitone/ 
glycerol buffer. The sections were then examined 
using the fluorescent microscope. 
As a further control sera from patients with 
bullous pemnhigoid and from normal individuals were 
used. All patients and controls sera were diluted 
with PBS in dilutions of 1: 1,1: 2,1: 4 and 1: 8. The 
human sera as source of complement were diluted with 
either complement diluent or PBS in 1: 5. For full 
details of the method see appendix II. 
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III. HISTOCHEMISTRY STUDY (DOPA METHOD) 
Portions of the biopsy specimens were incu- 
bated in 2N NaBr solution at 370C for one hour 
(Staricco and Pinkus 1957). The epidermis was 
separated off from dermis using dissecting micro- 
scope and fine forceps. The epidermal sheets were 
preliminarly fixed in 5% formaldehyde saline for 
five minutes, washed several times with distilled 
water and then incubated in 1: 1,000 L-Dopa solution 
at 37°C for four to five hours. The epidermal sheets 
were then fixed in 10% formaldehyde saline at 
37°C 
overnight and then dehydrated in graded concentration 
of ethanol. The sheets were cleared in cedar wood 
oil and then xylene and finally the epidermal sheets 
were mounted in depex on microscope slides. The 
stained tissues viewed with a Leitz orthoplan micro- 
scope using a X40 objective and a X8 eyepiece. The 
melanocytes were counted in approximately 7-10 areas 
with an eyepiece graticule in the microscope. The 
final number of melanocytes were expressed in terms 
of melanocytes per one square millimeter. For full 
details of the methods see appendix III. 
IV. EPON EMBEDDED TISSUES FOR*LIGHT MICROSCOPE 
(HUBER STAIN) 
(a) Processing Technique 
The tissues were immediately fixed in phosphate 
buffered glutaraldehyde solution for twenty-four hours. 
- 19 - 
After washing with distilled water and fixed with 
osmium tetroxide for two hours the tissues were 
washed again in distilled water and dehydrated in 
graded concentrations of ethanol. The tissues 
were then embedded in epon (see appendix IV for 
details). 
(b) Staining Technique 
Sections one micron thick were cut with glass 
knives on Reichert OMU3 ultramicrotome. The sections 
were stained with basic fuchsin and methylene 
blue 
(Huber, Parker and Odland 1968; Chu, Smith and 
MacDonald 1980). A small drop of. water was place on 
a clean glass slide and with the wire 
loop four to 
five sections were placed on the surface of water 
and the sections were dried on hot plate at 80°C for 
five minutes. The sections were first stained with 
filtered 3% basic fuchsin on a hot plate at 80°C and 
dried. Then they were stained with 2% alkaline methy- 
lene blue at pH 12, at various intervals of time until 
the desired effect was obtained. Finally, the sections 
were dried at room temperature and mounted in lenzol. 
The edges of the coverslips were sealed with glyceal. 
For details see appendix IV. 
(c) Quantitative Analysis of Cells 
The sections were viewed using a Leitz ortho- 
plan light microscope with a X100 objective oil 
immersion lens and a X8 eyepiece. The clear cells 
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of the epidermis melanocytes and Langerhans cells, 
as well as the mononuclear cell infiltrate of the 
epidermis and the cells in the dermis, were counted 
using an eyepiece graticule. 
The clear cells lying in the basal layer 
and those in the whole epidermis were counted (fig 4). 
The number of cells counted were related to in length 
at the dermo-epidermal junction. The counts, at 
least 7-10, were finally expressed in terms of clear 
cells per one millimeter of the epidermis. 
Dermal cells, including endothelial cells, 
were counted along the size of one graticule in 
vertical lines from the dermo-epidermal junction 
and at least 7-10 counts were performed in different 
sections. The counts were then expressed in terms 
of cells per one square millimeter of the dermis 
(fig 4). 
The mast cells were counted in the same way 
as dermal cells and expressed as per one square 
millimeter of dermis. 
Biopsies from thirteen normal individuals were 
also processed and epon-embedded sections stained 
using the Huber method. 
V. ELECTRON MICROSCOPIC STUDY 
After biopsy, the tissues were immediately 
fixed in 3% phosphate buffer glutaraldehyde for 
- 21 - 
ow . 
ION 
r 
i 
ýß 
.ý .ýt 
\-ý '11* 
ýý 
ý 
,ýýýý 
'ýý. ýý` rl 
, `ý'r 
ý ý1ý' da 
Fig 4. Light micrograph of a normal skin showing the method 
of counting of epidermal clear and dermal cells. lµ thick 
epon-embedded tissue, stained with methylene blue and basic 
fuchsin. A-A represents the epidermal clear cells per one 
millimeter along the dermo-epidermal junction. While the whole 
graticule (A-A, B-B) represents the dermal and mast cells per 
one square millimeter of the dermis. 
twenty-four hours and stored in phosphate buffer 
to be processed. The tissues were then washed with 
distilled water several times and post-fixed with 
2% osmium tetroxide for one and a half to two hours 
in a fridge. The tissues were washed with distilled 
water and stained with uranyl acetate for two hours 
in a dark place at room temperature. The tissues 
were dehydrated in graded concentrations of ethyl 
alcohol. After the tissues were immersed in epoxy 
propane they were then embedded in araldite using 
the appropriate moulds. The moulds were placed in 
600C oven for forty-eight hours and-the tissues 
were then ready for cutting. Ultra-thin sections 
60-70nm in thickness were cut with glass knives on 
Reichert OMU3 ultramicrotome and stained with lead 
citrate. Stained sections were observed in AEI 801 
electron microscope and photographs taken with 
attached camera. For details of the method see 
appendix V. 
The biopsies from nine normal individuals 
were also processed as above and were studied. 
VI. STATISTICAL METHODS 
For comparison of melanocytes, mast cell, 
dermal cell and epidermal clear cell counts in 
different areas of patients with vitiligo, the 
Wilcoxon signed rank test for paired differences 
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was used (Swinscow 1978). The Wilcoxon two sample 
rank test was used to compare all these cells 
between vitiligo patients and normal control skin. 
- 23 - 
CHAPTER TWO 
RESULTS 
I. CLINICAL SUMMARY OF PATIENTS AND AUTOANTIBODY TEST 
(a) Common Vitiligo 
Patients 
A total of twenty-nine patients with common 
idiopathic vitiligo were studied. A summary of 
these patients is shown in table II. There were 
twenty-three females and six males. The age of onset 
of these vitiligo patients ranged from one year to 
sixty-five years, with a mean of twenty-six years. 
In 44.8% of patients, the onset of the disease was 
before the age of twenty years. The clinical picture 
closely resembled to what has been described as to 
the morphology of the lesions, their symmetrical 
distribution and the sites most commonly affected. 
There was one patient with segmental vitiligo, where 
the depigmentation was localised to the left side of 
neck, left shoulder, left upperarm and forearm. A 
few patients had a trichrome appearance to their 
lesions of vitiligo. Many patients developed areas 
of depigmentation at the site of the biopsy from the 
uninvolved area. This represented an isomorphic or 
Koebner phenomenon. 
Associated Diseases 
Many of the patients had one or more of the 
diseases that are commonly clinically associated 
(table III). 51.7% of patients had these disorders; 
thyroid diseases, alopecia areata, lichen sclerosus, 
- 25 - 
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Males Females Total % 
Alopecia areata 1 1 6.8 
Lichen sclerosus 0 2 6.8 
Atopic eczema 1 1 6.8 
Halo naevi 0 3 10.3 
Pernicious anaemia 1 0 3.4 
Addison disease 2 0 6.8 
Thyroid diseases 1 1 6.8 
Lichen planus 0 1 3.4 
Discoid lupus erythematosus 1 0 3.4 
Table III Incidence of "autoimmune" diseases in 29 
patients with vitiligo. 
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atopic eczema and Addison's disease. All these 
conditions occurred in 6.8% of the twenty-nine 
patients studied. Pernicious anaemia, lichen 
planus and discoid lupus erythematosus occurred 
each in one patient in the series representing a 
percentage of 3.4%. Halo naevi were associated 
with vitiligo in 10.3% representing three of the 
twenty-nine patients. 
Family History 
A study of the families of patients showed 
a high incidence. of diseases that are commonly associa- 
ted with vitiligo. 51.7% ( fifteen out of twenty- 
nine) had a positive family history of these auto- 
immune disorders in their close relatives (table IV). 
24.1% of patients had a family history of vitiligo. 
There was an increased incidence of diabetes mellitus 
in families of the patients with vitiligo (20.6%). 
Immunological Screen 
The results of immunological screening for 
auto-antibodies are shown in table V. 26.3% of 
patients had auto-antibodies against gastric parietal 
cells, while 21% had positive auto-antibodies to 
thyroid microsomes and 30% for thyroglobulin anti- 
bodies. The test for antinuclear factor (ANF) was 
positive in 12.5%. Only one patient had positive 
mitochondrial antibodies (4.1%) while non of the 
patients had antibodies to smooth muscle. 
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Number of vitiligo patients 
with positive family history 
% 
Vitiligo 7 24.1 
Diabetes mellitus 6 20.6 
Thyroid diseases 5 17.2 
Pernicious anaemia 3 10.3 
Alopecia areata 1 3.4 
Table IV Incidence of "autoimmune" diseases in the relatives 
of 29 patients with vitiligo. 
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(b) Occupational Vitiligo 
Three male patients with occupational vitiligo 
were studied (table VI). All three patients were 
handling at work paratertiary butyl phenol. Two of 
the patients had noticed that some of their workmates 
had also developed white areas of depigmentation. 
The clinical picture was exactly similar to that seen 
in the common idiopathic vitiligo, both in distri- 
bution and the morphology of the lesion and their 
symmetrical arrangement. Two of the patients had 
involvement of the anogenital areas that is also 
seen in common vitiligo. 
In all the patients the blood picture was 
normal and screening for auto-antibodies was negative 
in two of these patients with occupational vitiligo. 
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II. DIRECT IMMUNOFLUORESCENCE 
(a) Controls 
A total of nineteen normal controls (mean 
age twenty-five years) were studied. All the 
biopsies were taken either from the upperarm or 
forearms. A summary of the findings are shown in 
table VII. 
Most of the controls had a moderately strong 
diffuse reticulate fluorescence of the papillary 
dermis with the IgG conjugate and a faint fluore- 
scence at the dermo-epidermal junction zone. In 
some of the controls there was a weak fluorescence 
of the dermis with the fibrin conjugate. Immuno- 
fluorescence for IgA, IgM and C3 were negative apart 
from cytoid bodies. 
Cytoid (Colloid/Amyloid)Bodies 
Globular bodies varying in size were seen, 
mainly in the papillary dermis at the dermo-epidermal 
junction. Some of these were in the basal layer of 
the epidermis and they were dispersed along the dermo- 
epidermal junction either in regular fashion or in 
clusters. The shape of these bodies was either oval 
or round and sometimes the fluorescence appeared 
more intense around the periphery than the centre. 
These cytoid bodies were stained with IgA, IgG, IgM, 
fibrin and complement. However, they were more 
frequently stained with IgM and IgA (table VIII). 
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No. IgG IgA IgM Fibrin Complement 
(C3) 
1 Neg Neg Neg Blood vessel Neg 
2 Dermis Neg Neg Neg Neg 
3 Dermis Neg Neg Neg Neg 
4 Neg Neg Neg Neg Neg 
5 Dermis Neg Neg Dermis Neg 
6 Dermis Neg Neg Dermis Faint DEJ 
papillae 
7 Dermis Neg Neg Neg Neg 
8 Dermis Neg Neg Neg Neg 
9 Dermis Neg Neg Neg Neg 
10 Faint, DEJ Neg Neg Neg Neg 
11 Dermis Neg Neg Neg Neg 
12 Dermis, Faint Neg Neg Neg Neg 
DEJ 
13 Dermis Neg Neg Neg Neg 
14 DEJ Neg Neg Neg Neg 
15 Dermis Neg Neg Neg Neg 
16 Dermis, Faint Neg Neg Papillary Neg 
DEJ dermis 
17 Dermis Neg Neg Neg Neg 
18 Neg Neg Neg Neg Neg 
19 Dermis Neg Neg Neg Neg 
Table VII. Direct immunofluorescence of normal controls showing 
distribution of immunoglobulin fibrin and complement deposition. 
DEJ Dermo-epidermal junction. 
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No. IgG IgA IgM Fibrin Complement 
(C3) 
1 lieg Neg Neg Neg Neg 
2 Neg Neg Neg Neg Neg 
3 Neg Neg Neg Neg Neg 
4 Neg Neg Pos Neg Neg 
5 Neg Neg Neg Neg Neg 
6 Neg Neg Neg Neg Neg 
7 Neg Neg Neg Neg Neg 
8 Neg Neg Neg Neg Neg 
9 Pos Pos Pos Neg Neg 
10 Pos Pos Neg Neg Pos 
11 Pos Pos Neg Neg Pos'' 
12 Pos Pos Pos Pos Neg 
13 Neg Pos Neg Neg Neg 
14 Neg Pos Pos Neg Neg 
15 Neg Pos Pos Pos Neg 
16 Pos Pos Pos Neg Neg 
17 Pos Neg ND ND Neg 
18 Neg Neg Pos Neg Neg 
19 Neg Pos Pos Neg Neg 
Table VIII Direct immunofluorescence of control skin showing 
distribution of immunoglobulin, fibrin and complement deposition 
in cytoid bodies. ND not done. 
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Biopsies from twenty patients with various 
dermatoses were also examined using immunofluorescent 
techniques. The distribution and number of cytoid 
bodies in these disorders were much the same as in 
the normal controls (table IX). 
(b) Common Vitiligo 
A total of twenty-eight patients were studied. 
The direct immunofluorescence results are shown in 
tables X, XI and XII. Weak fluorescence for IgG was 
found in the dermis in a diffuse reticulate pattern. 
It was, however, more intense in the papillary dermis. 
This pattern was seen in the uninvolved, marginal and 
involved areas of most of the patients. The fluores- 
cence was much stronger in the involved and marginal 
areas when compared with the uninvolved areas. Faint 
fluorescence at the dermo-epidermal junction was also 
noticed using IgG conjugate in many of the patients, 
mainly in the involved skin and also some marginal 
areas (fig 5). With IgA, IgM conjugates no signifi- 
cant immunofluorescence was observed apart from the 
presence of cytoid bodies. Deposits of fibrin were 
found in the dermis in nearly two-thirds of the patients 
either in the involved, marginal or uninvolved areas. 
A moderate fluorescence was observed mainly in the 
papillary dermis. In some specimens a faint fluores- 
cence was present at dermo-epidermal junction, but a 
strong band of fluorescence (fig 6A, B) was seen at 
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No. Diagnosis IgG IgA IgM Fibrin Complement 
(C3) 
1 Lichen planus Neg Neg Neg Neg Neg 
pilaris 
2 Bullous pemphigoid Pos Pos Neg Neg Neg 
3 Pyoderma Neg Neg Neg Neg Neg 
gangrenosum 
4 Bullous pemphigoid Neg Neg Neg Neg Neg 
5 Herpes gestationis Neg Pos Neg Neg Neg 
6 Bullous pemphigoid Neg Neg Pos Neg Neg 
7 Psoriasis Neg Pos Pos Neg Pos 
(post-PUVA) 
8 Psoriasis Neg Neg Neg Neg Neg 
9 Dermatitis Neg Neg Pos Neg Neg 
Herpet if ormis 
10 Nodular prurigo Neg Pos Pos Neg Neg 
11 Pityriasis Neg Neg Neg Neg Neg 
rubra pilaris 
12 Pemphigus vegetans Neg Neg Neg Neg Neg 
13 Bullous pemphigoid Neg Pos Pos Neg Neg 
14 Dermatitis Neg Neg Pos Neg Neg 
Herpetiformis 
15 Dermatitis Neg Neg Neg Neg Neg 
Herpet if ormis 
16 Pityriasis Neg Neg Neg Neg Neg 
lichenoides 
17 Porphyria cutanea Neg Neg Pos Neg Neg 
tarda 
18 Pemphigus Foliaceus Neg Neg Neg Neg Neg 
19 Pemphigus Neg Neg Neg Neg Neg 
20 Discoid Lupus Neg Neg Neg Neg Neg 
Erythematosus 
Table IX Direct immunofluorescence in various dermatoses showing 
distribution of immunoglobulin, fibrin and complement deposition in 
cytoid bodies. 
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No. Pt. 
Name 
IgG IgA IgM Fibrin Complement 
(C3) 
Complement 
(CO 
1 JTR Neg Neg Neg Neg Neg Neg 
2 MO Neg Neg Neg Neg Neg Neg 
3 CH Dermis Neg Neg Dermis Neg Neg 
4 JC Neg Neg Neg 
Faint 
DEJ 
Neg Neg 
5 EM Neg Neg Neg 
Der is, Neg Neg 
6 JW Dermis Neg Neg Dermis Faint DEJ Neg 
7 LG 
Dermis, Neg Neg 
Faint 
Neg Neg 
Faint DEJ DEJ 
8 BR Dermis Neg Neg Dermis Neg Neg 
9 MF Dermis Neg Neg Neg Neg Neg 
10 DH Dermis Neg Neg Dermis 
Granular 
(papillae) Neg 
11 AB Neg Neg Neg Neg Neg Neg 
12 EMA Dermis Neg Neg Neg Neg Neg 
13 PL Dermis Neg Neg Dermis Neg Neg 
14 GG Neg Neg Neg Neg Neg ND 
15 SE Neg Neg Neg Neg Neg ND 
16 CL Dermis Neg Neg Neg Neg ND 
17 TB Dermis Neg Neg Neg Neg ND 
18 CE Neg Neg Neg Neg Neg ND 
19 im Dermis Neg Neg Neg Neg ND 
20 JH Dermis Neg Neg Neg Neg ND 
21 MB Neg Neg Neg Neg Neg ND 
22 MT Dermis Neg Neg Neg Neg ND 
Table X Direct immunofluorescence of uninvolved skin of patients 
with vitiligo showing distribution of immunoglobulin, fibrin and 
complement deposition. DEJ Dermo-epidermal junction, BV Blood vessel, 
ND not done. 
Mýu 
5ý'SAI 
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No. 
Pt. 
name 
IgG IgA IgM Fibrin 
Complement 
(C3) 
Complement 
(C4) 
1 DB Neg Neg Neg Faint DEJ Neg Neg 
2 SD Neg Neg Neg Neg Neg Neg 
3 RY Dermis Neg Neg Neg Neg ND 
4 JTR Neg Neg Neg Neg Neg Neg 
5 CH Dermis Neg Neg Dermis Neg Neg 
Faint DEJ Faint DEJ 
6 JC Neg Neg Neg Neg Neg Neg 
7 JA Dermis Neg Neg Faint DEJ Neg Neg 
& papillae 
8 JT Dermis Neg Neg Dermis Neg Neg 
9 EM Faint DEJ Neg Neg Dermis Neg Neg 
10 JW Dermis Neg Neg Dermis Faint DEJ Neg 
11 LG Dermis Neg Neg Neg Neg Neg 
12 BR Dermis Neg Neg Neg Neg Neg 
13 MF Dermis Neg Neg Neg Faint DEJ Faint DEJ 
14 DH Dermis, Neg Neg Neg Neg Neg 
Faint DEJ 
15 AB Dermis Neg Neg Neg Neg Neg 
16 EMA Dermis Neg Neg Neg Neg Neg 
17 JR Neg Neg Neg Neg Neg Neg 
18 PL Dermis Neg Neg Neg Neg Neg 
19 GG Neg Neg Neg Dermis Neg ND 
20 SE Neg Neg Neg Neg Neg ND 
21 CL Dermis Neg Neg Neg Neg ND 
22 TB Dermis Neg Neg Neg Neg ND 
23 CE Neg Neg Neg Neg Neg ND 
24 JM Dermis Neg Neg Neg Neg ND 
25 JH Dermis Neg Neg Neg Neg ND 
26 MB Neg Neg Neg Neg Neg ND 
27 MT Dermis Neg Neg Neg Neg ND 
Table XI Direct immunofluorescence of marginal skin of patients with 
vitiligo showing distribution of immunoglobulin, fibrin and complement 
deposition. DEJ dermo-epidermal junction, ND not done. 
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No. 
Pt. 
Name 
IgG IgA IgM Fibrin 
Complement 
(C3) 
Complement 
(C4) 
1 DB Faint DEJ Neg Neg Neg Neg Neg 
2 SD Neg Neg Neg Neg Neg Neg 
3 RY Dermis Neg Neg Neg Neg Neg 
4 JTR Faint DEJ Neg Neg Neg Neg Neg 
5 MO Dermis Neg Neg Neg Neg Neg 
6 CH Dermis Neg Neg Dermis Neg Neg 
7 JC Dermis Neg Neg DEJ & Neg Neg 
DEJ papillae 
8 JA Neg Neg Neg Neg Neg Neg 
9 JT Dermis Neg Neg Dermis & Neg Neg 
blood vessel 
10 EM Neg Neg Neg Neg Neg Neg 
11 LG Faint DEJ Neg Neg Neg Neg Neg 
12 BR Faint DEJ Neg Neg Dermis DEJ Neg Neg 
13 MF Dermis Neg Neg Band DEJ Neg Neg 
14 DH +Dermis, Neg Neg Neg Neg Neg 
Faint DEJ 
15 AB Dermis, Neg Neg Neg Neg Neg 
Faint DEJ 
16 EMA Dermis Neg Neg Band DEJ Neg Neg 
17 JR Dermis Neg Neg Bat. d DEJ Neg Neg 
blood vessel 
18 PL Dermis Neg Neg Neg Neg Neg 
19 GG Neg Neg Neg Dermis Neg ND 
20 SE Neg Neg Neg Neg Neg ND 
21 CL Dermis Neg Neg Dermis Neg ND 
22 TB Dermis Neg Neg Neg Neg ND 
23 CE Neg Neg Neg Neg Neg ND 
24 im Neg Neg Neg Neg Neg ND 
25 JH Dermis Neg Neg Neg Neg ND 
26 MB Neg Neg Neg blood vessel Neg ND 
27 MT Faint DEJ Neg Neg Neg Neg ND 
Table XII Direct immunofluorescence of involved skin of vitiligo patients 
showing distribution of immunoglobulin, fibrin and complement deposition. 
ND not done. DEJ dermo-epidermal junction, 
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Fig 6A. Direct immunofluorescence study of an involved area 
from a patient with vitiligo showing intense band of fibrin 
deposition along the dermo-epidermal junction. (X 80) 
Fig 6B. Direct immunofluorescence study of an involved 
area from a patient with vitiligo showing intense fibrin deposi- 
tion along the dermo-epidermal junction, mainly in the region of 
the dermal papillae. (X 80) 
dermo-epidermal junction in three patients only in 
the involved areas. Some deposition of fibrin was 
present around the blood vessels. As regards depo- 
sition of complement, a faint fluorescence was seen 
at the dermo-epidermal junction in the marginal areas 
of a few patients, and in one patient a granular 
fluorescence was present in the papillary dermis of 
the uninvolved skin. 
Cytoid (Colloid/Amyloid) Bodies' 
These globular bodies were located in the 
papillary dermis (fig 7), similar to the controls, in 
the uninvolved, marginal and involved areas (table XIII, 
XIV and XV). They were more numerous in the marginal 
areas as compared to the involved skin. In the 
involved areas, although cytoid bodies were present 
in many of the patients, they were less numerous 
when compared with those found in the uninvolved and 
marginal sites. In general cytoid bodies have a 
tendency to occur in vitiligo skin more than in con- 
trols. These bodies were stained with immunoglobulins, 
complement and fibrin conjugates; more with IgA, IgM 
and IgG, but less with fibrin and complement. 
(c) Occupational Vitiligo 
Two patients were studied by direct immuno- 
fluorescence, the results being similar to those of 
the common vitiligo patients (table XVI). In the 
first patient there was diffuse reticulate fluores- 
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Fig 7. Direct immunofluorescence study of a marginal area 
from a patient with vitiligo showing IgA stained cytoid bodies 
in the papillary dermis. (X 80) 
No. Name IgG IgA IgM Fibrin Complement 
(C3) 
1 JTR Neg Neg Neg Neg Neg 
2 MO Neg Neg Neg Neg Neg 
3 JC Neg Neg Neg Neg Neg 
4 EM Neg Neg Neg Neg Neg 
5 LG Neg pos' pos Neg Neg 
6 BR pos pos Neg Neg Neg 
7 MF Pos Neg Pos Neg Neg 
8 DH pos pos pos Neg Neg 
9 AB Neg Neg Neg Neg Neg 
10 EMA Neg Neg Neg Neg Neg 
11 PL Neg Neg Neg Neg Neg 
12 GG Neg Neg Neg Neg Neg 
13 SG Neg pos pos pos pos 
14 CL Neg pos pos Neg Neg 
15 TB Neg Neg Neg Neg Neg 
16 CE pos pos pos Neg pos 
17 JM Pos Neg Pos Neg Neg 
18 JH pos pos pos pos Neg 
19 MB pos pos pos pos pos 
20 MT pos pos Neg Neg pos 
Table xIII Direct immunofluorescence of uninvolved skin of vitiligo 
patients showing the distribution of immunoglobulin, fibrin and 
complement deposition in cytoid bodies. 
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No. Pt. 
Name 
IgG IgA IgM Fibrin Complement 
(C3) 
1 DB Neg Neg Pos Neg Neg 
2 SD Neg Neg Pos Neg Neg 
3 RY Neg Neg Pos Neg Neg 
4 JTR Neg Neg Neg Neg Neg 
5 CH Neg Neg Neg Neg Neg 
6 JC Neg Neg Neg Neg Neg 
7 JA Pos Pos Neg Neg Neg 
8 JT Neg Neg Neg Neg Neg 
9 EM Neg Neg Neg Neg Neg 
10 JW Neg Neg Neg Neg Neg 
11 LG Pos- Neg Neg Neg Neg 
12 BR Neg Neg Neg Neg Neg 
13 MF Neg Pos Pos Neg Neg 
14 DH Pos Pos, Pos Neg Pos 
15 AB Neg Neg Pos Neg Neg 
16 EMA Neg Neg Pos Neg Neg 
17 JR Pos Neg Neg Neg Neg 
18 PL Neg Neg Neg Neg Neg 
19 GG Neg Neg Neg Neg Neg 
20 SE Pos Pos' Pos Pos Pos 
21 CL Neg Pos Pos Neg Neg 
22 TB Neg Neg Neg Neg Neg 
23 CE Neg Pos Pos Neg Neg 
24 JM Pos Pos Pos Neg Neg 
25 JH Neg Pos Pos Pos Pos 
26 MB Pos Pos Pos Pos Pos 
27 MT Neg Neg Pos Neg Pos 
Table XIV Direct immunofluorescence of marginal skin of vitiligo 
patients showing distribution of immunoglobulin, fibrin and complement 
deposition in cytoid bodies. 
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No. Pt. 
Name 
IgG IgA IgM Fibrin Complement 
(C3) 
1 DB Neg Neg Neg Neg Neg 
2 SD Neg Neg Neg Neg Neg 
3 RY Neg Neg Pos Neg Neg 
4 JTR Neg Neg Neg Neg Neg 
5 MO Neg Neg Pos Neg Neg 
6 CH Neg Neg Neg Neg Neg 
7 JC Neg Neg Neg Neg Neg 
8 JA Neg Neg Neg Neg Neg 
9 JT Neg Neg Neg Neg Neg 
10 EM Neg Neg Neg Neg Neg 
11 JW Neg Neg Neg Neg Neg 
12 LG Pos Pos Pos Neg Pos 
13 BR Pos Neg Pos Neg Neg 
14 MF Neg Pos Pos Neg Neg 
15 DH Neg Pos Pos Neg Neg 
16 AB Neg Neg Neg Neg Neg 
17 EMA Neg Neg Neg Neg Neg 
18 JR Neg Neg Pos Neg Neg 
19 PL Neg Neg Neg Neg Neg 
20 GG Neg Neg Neg Neg Neg 
21 SE Neg Pos Pos Pos Neg 
22 CL Neg Pos Pos Neg Neg 
23 TB Neg Neg Neg Neg Neg 
24 CE Neg Pos Pos Neg Neg 
25 JM Neg Neg Neg Neg Neg 
26 JH Neg Pos' Pos Pos Pos 
27 MB Pos Pos Pos Pos Pos 
28 MT Neg Pos Neg Neg Pos 
Table XV Direct immunofluorescence of involved skin of vitiligo 
patients showing distribution of immunoglobulin, fibrin and 
complement deposition in cytoid bodies. 
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Name IgG IgA IgM Fibrin Complement 
(C3) 
AG - uninvolved Dermis Neg Neg CB Neg 
- marginal Dermis Neg Neg Neg Neg 
- involved Faint CB Neg Neg Neg 
DEJ 
AD - uninvolved CB Neg CB ND Neg 
- marginal CB Neg Neg Neg Neg 
- involved Neg Neg Neg Neg Neg 
Table XVI Direct immunofluorescence of patients with occupational 
vitiligo showing distribution of immunoglobulin, fibrin and complement 
deposition. CB cytoid body, ND not done. 
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cence of uninvolved and marginal area, with a mode- 
rate fluorescence at dermo-epidermal junction of 
the involved area when stained with an IgG conjugate. 
Cytoid bodies were also seen in the papillary dermis 
in both patients. 
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III. INDIRECT IMMUNOFLUORESCENCE COMPLEMENT FIXA- 
TION TEST 
Sera from twenty-three vitiligo patients were 
tested using the indirect immunofluorescence comple- 
ment fixation method and all gave negative results 
on the normal skin and on several melanocytic naevi. 
Sera from three patients with bullous pemphigoid 
were tested using the same method and all gave an 
intense linear band of immunofluorescence along the 
dermo-epidermal junction and on all the skin substrates 
used. 
Sera from two patients with occupational 
vitiligo were tested using the same method and both 
samples gave similar negative results. 
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IV. DOPA METHOD 
(a) Common Vitiligo 
Twenty-nine patients with common 'idiopathic' 
vitiligo were studied (table XVII). The sites of 
the shave biopsies from these patients, the number 
of melanocytes per mm2 in the uninvolved, marginal 
and involved areas of skin are recorded in the 
table XVII. 
Uninvolved Skin 
The melanocytes in this area were generally 
smaller in size when compared with those cells in 
the marginal skin (fig 8). The cells had smaller 
dendrites, but not much in the way of secondary 
branching. They were dopa-positive, but their 
reaction was weaker than those cells found in the 
marginal areas. In many of the biopsies the melano- 
cytes were larger than normal with many primary 
and secondary dendrites. The dendrites were full 
of melanin granules and frequently appeared to be 
beaded. In a number of patients the melanocyte 
size was very variable even in the same small area. 
The number of melanocytes was variable not only 
for the region, but even in different sites of the 
same area biopsied. The mean number of melanocytes 
for the forearms was 1890 + 167 SEM, while the total 
mean for the backs was 1464 + 236 SEM. It was also noti- 
ced in these 'uninvolved areas, there were small foci in 
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No. Name Uninvolved 
+SEM 
Marginal 
+SEM 
Involved 
±SEM 
Site of biopsy 
1 MO 1850+124 1567+70 0 Back 
2 JTR 2093+168 1471+128 ND Back 
3 JT ND 833+55 28+12 Back 
4 LG 423+33 265+26 129{-37 Back 
5 BR 838+84 360+49 79+30 Back 
6 MF 1325+65 899+70 400+116 Back 
7 EMA 1889+131 479+106 87+16 Back 
8 GG 1835+56 774+131 39+17 Back 
9 DB ND ND 359+60 Forearm 
10 SD ND ND 0 Forearm 
11 CH 2145+81 2188+120 175+79 Forearm 
12 JC 2150+154 - 53+12 Forearm 
13 EM 1366+51 507+80 74+30 Forearm 
14 AB 2106+174 1306+195 137+48 Forearm 
15 JR 1476+111 926+143 92+29 Forearm 
16 PL 982+114 675+122 62+21 Forearm 
17 SE 1874+233 1105+200 6+4 Forearm 
18 TB 2201+195 880+179 67+21 Forearm 
19 CE 1467+81 1094+86 65+31 Forearm 
20 JM 2667+124 1103+134 143+25 Forearm 
21 JH 2922+114 1054+160 175+56 Forearm 
22 MB 1325+52 352+79 69+20 Forearm 
23 TM ND ND 138+41 Forearm 
24 DH 1682+151 941+115 111_+35 Upperarm 
25 CL 1326+50 888+59 54+20 Axilla 
26 JA ND 567+75 0 Face 
27 JW 2009+137 1239+149 184+78 Leg 
28 MT 1916+44 1267+105 77+18 Upperarm 
29 RY ND ND 0 Upperarm 
Total 
Mean+SEM 1733+118 948+89 100+18 
Table XVII Showing the population density of melanocytes/mm2 of 
epidermal sheets taken from patients with vitiligo. 
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which there was marked reduction in the density of 
melanocytes (fig 9). Some of the melanocytes in 
these areas had lost their dendrites and were rather 
small in size. 
Marginal Areas 
The sites biopsied were pigmented margins 
between involved and uninvolved areas of skin. In 
these sites there was marked reduction in the number 
of melanocytes, when compared with uninvolved skin 
from these patients (P<0.001). In general, there was 
a gradual reduction in the population density of 
melanocytes from the uninvolved to the involved areas 
(fig 10). Often there was a sudden drop in the 
number of melanocytes in this area of vitiligo (fig 11). 
The mean population density of melanocytes on the sites 
biopsied from the forearms was 1017 + 145 SEM, while 
from the number on the back was 831 + 170 SEM. 
The morphology of the melanocytes in this area 
was variable. Many of the cells were much larger than 
normal and in addition to being strongly dopa-positive 
also contained more melanin granules. These cells had 
large, thick and long primary dendrites with many 
smaller secondary dendrites coming off them. The 
dendrites had a rather beaded appearance resembling a 
rosary. Some melanocytes in several of the biopsies 
from the marginal areas had more spindle-shaped 
appearance without many dendrites. In the marginal 
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areas there were three types of remaining melanocytic 
cells. The first, being strongly dopa-positive, with 
either a large or a small cell body, but with thick 
dendrites, some of which appeared truncated (fig 11). 
The second type of cell, (fig 12) also large, with 
thick large dendrites that was weakly dopa-positive 
and as a consequence the dendrites were hard to 
visualise. These cells also contained only a few 
melanin granules. Some of these cells had lost most 
of their dendrites leaving weakly dopa-positive cell 
bodies. The third type of residual melanocyte was 
small and rounded and was weakly dopa-positive. This 
last type was similar to what was found in the 
involved areas of vitiligo. 
Involved Skin 
Shave biopsies were taken-from the central 
portions of established lesions of vitiligo that when 
examined under a Wood's lamp prior to biopsy appeared 
to be completely depigmented. In these areas there 
was a marked reduction in the number of melanocytes; 
in many sites a complete absence. The melanocytes 
that remained were around hair follicles, but were 
also found in the inter-follicular areas (fig 13). 
These melanocytes were small and had rounded cell 
bodies. Most of them had lost their dendrites and 
in general they were weakly dopa-positive. In a few 
patients though there was a marked reduction in the 
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number of melanocytes, the residual cells were much 
larger than normal and were very dendritic (fig 14). 
(b) Occupational Vitiligo 
Shave biopsies were taken from three patients 
with occupational vitiligo due to contact with para- 
tertiary butyl-phenol. Quantitative studies on the 
population density of melanocytes in these epidermal 
sheets showed a marked reduction in the number of 
melanocytes in the marginal area and a complete 
absence of dopa-positive cells in the involved viti- 
liginous areas (table XVIII). These changes were 
similar to what was found in ordinary 'idiopathid 
vitiligo. 
(c) Study of Hair Follicles 
During separation of epidermis from dermis the 
hair follicles remained usually intact and attached 
to the dermal surface of the epidermis. The external 
hair root sheaths were as buds on the dermal surface 
of epidermis when viewed undera dissecting microscope 
and hair follicles contained shaft of hairs. 
In the uninvolved and marginal areas the dopa- 
positive melanocytes could clearly be seen in the 
external root sheath, mainly in the upper third, but 
particularly around the follicular orifices. They 
were very few in the lower two-thirds of the follicles 
and also occasionally seen in the hair bulbs. In the 
involved areas, few residual melanocytes could be seen 
- 55 - 
in the hair follicles. This later finding was 
always associated with a few residual melanocytes 
in the inter-follicular sites. However, they were 
completely absent in the hair follicles when melano- 
cytes were completely lacking in the epidermis. 
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Number of melanocytes/mm2+SEM 
Name Site Uninvolved Marginal Involved 
AG Forearm 2057+2.57 1047+146.55 0 
AD Forearm 1574+28.9 1097+134.2 0 
KR Hand 2105+70 595+50 0 
Table XVIII Showing the population density of melanocytes in 
areas of patients with occupational vitiligo. 
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Fig 8. Dopa - incubated epidermis of an uninvolved area from a patient with vitiligo showing normal melanocytes. 
(X 128) 
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Fig 9. Dopa - incubated epidermis of an uninvolved area 
from a patient with vitiligo showing an early focus (arrow) 
of loss of melanocytes. (X 32) 
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Fig 10. Dopa - incubated epidermis of a marginal area 
from a patient with vitiligo showing gradual reduction in 
the number of melanocytes. (X 32) 
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Fig 11. Dopa - incubated epidermis of a marginal area from 
a patient with vitiligo showing sudden reduction in the number of 
melanocytes. (X 80) 
Fig 12. Dopa - incubated epidermis of a marginal area 
showing few residual melanocytes. The cells are very large 
but weakly dopa-positive. Some of the cells have lost their 
dendrites leaving a shadow of cell bodies. (g 80) 
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Fig 13. Dopa - incubated epidermis of an involved area from 
a patient with vitiligo showing a few residual melanocytes. 
The cells have lost their dendrites and changed into small 
rounded bodies. (X 128) 
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Fig 14. Dopa - incubated epidermis of an 
involved area from 
a patient with vitiligo showing a few residual functioning 
melanocytes. Some of the cells have truncated dendrites. 
(x 80) 
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V. EPON EMBEDDED TISSUE 
A. NORMAL CONTROLS 
Skin biopsies from thirteen normal individuals 
were studied. The ages of these individuals ranged 
from 25-35 years, with a mean of 30 years. There 
were three females and ten males. The shave biopsies 
were taken in ten patients from the upperarms and in 
three from the flexor surface of the forearms. 
1. Epidermis 
(a) General Appearance 
The epidermis (fig 15) was composed of a 
number of layers termed horny, granular, malpighian 
and basal. The most superficial horny layer con- 
sisted of flattened keratinised cells. The next, 
the granular layer was composed of tightly opposed 
cells containing keratohyalin granules and about two 
to three cells deep. The malpighian layer, which 
constituted the main portion of the epidermis, con- 
sisted of polyhedral cells that were attached to 
each other by intercellular bridges. These cells 
had large prominent nuclei with the heterochromatin 
arranged mainly at the periphery. The nucleus usually 
contained one distinct nucleolus but sometimes two 
were present. The cytoplasm of these keratinocytes 
was packed with tonofilaments, leaving a clear peri- 
nuclear area. The basal layer consisted of cells 
arranged in a perpendicular position to dermo- 
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epidermal junction. The cells in the basal layer 
of the epidermis contained a variable amount of 
melanin granules which were principally located at 
the upper pole of the basal keratinocytes. 
(b) Clear Cells (table XIX) 
In addition to keratinocytes, the epidermis 
contained clear-looking cells that appeared clear 
because of a lack of tonofilaments. These cells 
did not have intercellular bridges. The clear cells 
in the epidermis of the normal control skin were 
melanocytes and Langerhans cells. 
Melanocytes 
These clear-looking cells were located mainly 
in the basal layer of the epidermis (fig 15) and 
surrounded by the basal keratinocytes. The frequency 
of these cells in the basal layer of the epidermis 
was variable and there was usually one melanocyte 
per four to six keratinocytes in the basal layer. 
The melanocytes made. contact at the dermo-epidermal 
junction without an intervening keratinocyte. In 
many samples they were seen to be hanging down into 
the dermis. The bulky cytoplasm of these cells was 
clear and melanosomes could be seen. -Portions of 
dendrites from these cells were to be found among 
keratinocytes and occasionally could be seen budding 
off from the main cell body of the melanocyte. The 
nucleus was large, rounded, or oval in shape and 
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Fig 15. Light micrograph of a normal skin showing the 
epidermis (E), basal melanocytes (M), dermis (D) and blood 
vessel (V). Epon-embedded tissue, stained with basic 
fuschsin and methylene blue. (X 128) 
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sometimes was convoluted. The heterochromatin 
pattern was arranged around the periphery of the 
nucleus. One or sometimes two nucleoli were seen. 
Langerhans Cells 
These clear-looking cells were usually seen 
suprabasal and were high up in the epidermis. They 
had large amounts of cytoplasm and were sometimes 
seen to be dendritic. The nucleus was big and 
convoluted. 
2. Dermis 
(a) General Appearance 
In the biopsies the papillary and upper 
reticular dermis was present. In addition to the 
collagen bundles, blood vessels and nerves were 
also present. Mast cells; fibroblasts and histio- 
cytes could be recognised. 
(b) Blood Vessels 
They consisted of endothelial cells that 
lined the lumen and were surrounded by pericytes. 
Some of the blood vessels contained erythrocytes. 
(c) Histiocytes 
Histiocytes were identified by their large 
lobate nucleus and clear bulky cytoplasm and occa- 
sionally the cells contained melanosomes and were 
melanophages (fig 16). Sometimes it was difficult 
to distinguish these cells from other dermal cells. 
- 61 - 
(d) Mast Cells 
The mast cells were readily identified as 
fusiform, round or oval cells with round or oval 
nuclei (fig 16). The cells had one nucleus but 
portions of mast cell without nuclear material 
could be seen. The cytoplasm sometimes was large, 
but sometimes there was a narrow amount ringing 
around the nucleus. The granules were mostly round 
and regular in shape and size. They stained bright 
red with the basic fuchsin and in poorly stained 
sections blue from the intensity of methylene 
blue. 
They were mainly seen in the papillary dermis 
around blood vessels, although they were also 
present in the deeper dermis. They were readily 
distinguished from melanophages by the characteristic 
granules that also stained differently. The mast 
cell number in the dermis was very variable, but the 
mean in papillary region in the thirteen normal 
individuals was 27.9 + 6.6 SEM/mm2 (table XIX). 
(e) Cutaneous Nerves 
Polyaxonal nerves were seen-mainly in the 
reticular dermis usually associated with blood 
vessels. These nerves were composed of many axons 
that lightly stained with basic fuchsin. These axons 
were collectively enveloped by bluish staining col- 
lagenous endoneurium and perineurium. Some of these 
axons looked medullated. 
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Fig 16. Light micrograph of a dermis showing many macrophage- 
histiocytes (H), containing melanosomes and mast cells (MC). 
Epon-embedded tissue stained with basic fuchsin and methylene 
blue. (X 128) 
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(f) Cytoid (Colloid/Amyloid) Bodies 
These were globular bodies that varied in 
size, but were usually large. When stained with 
basic fuchsin they appeared pinky/red, similar in 
shade to the staining of the basal epidermal cells. 
They were seen only in the papillary dermis and 
usually near to the dermo-epidermal junction. Some- 
times, they appeared in the basal layer of the 
epidermis. They were seen in five of the normal 
controls (table XIX). The frequency of these colloid/ 
amyloid bodies in the normal controls was very low. 
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B. COMMON VITILIGO 
1. Epidermis 
(a) General Appearance 
Changes in the epidermis were noted mainly 
in the marginal and involved areas of skin. There 
was hyperkeratosis seen in the involved skin. This 
was observed in many of the patients when compared 
with the uninvolved areas in the*same patients and 
with normal controls. Some spongiosis of the epi- 
dermis was seen in many of the biopsies, particularly 
those from the marginal areas. This was not observed 
in the controls. The number of melanosomes in the 
keratinocytes was markedly reduced from the unin- 
volved to involved areas. Only a few melanosomes 
were seen in the basal keratinocytes in the involved 
areas. This was apparent in only a few of the patients 
biopsied (fig 17). The total number of clear cells 
seemed to be diminished as one went from uninvolved to 
involved skin (fig 18, table XX). 
(b) Melanocytes 
The number of basal clear cells in the unin- 
volved areas of vitiligo were diminished (forearm 
mean 19.9 + 1.8 SEM) as compared to that of the 
control group (mean 21.8 +2 SEM). However, this 
difference was not of statistical significance 
(P>0.05). The melanocytes were markedly diminished 
in number, as one proceeded from the uninvolved to 
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Fig 17. Light micrograph of an involved area from a patient 
with vitiligo showing basal keratinocytes containing melano- 
somes and some basal clear cells. The dermis contains a few 
mononuclear cells. Epon-embedded tissue stained with basic 
fuchsin and methylene blue. (X 320) 
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Fig 18 Comparison of epidermal total clear cells in normal 
controls (c) and uninvolved (u), marginal (m) and involved (i) 
areas of patients with vitiligo. 
umi L 
Uninvolved n=21 Marginal Involved 
n=29 n=29 
No. Name BCC TCC LC BCC TCC BCC TCC 
(LC) 
1 DB ND ND ND 5.1 6.2 3 4 
2 RY ND ND ND 25.7 28 3.2 12 
3 SD ND ND ND 10.5 11.5 3.6 7.2 
4 MO 14.2 15.3 1.1 12.7 18.4 6.2 8.2 
5 JTR 12.6 14.4 0.8 12.1 15.6 0 4.5 
6 CH 23.7 25.6 1.1 17.5 17.5 12.7 12.7 
7 JC 21.7 25 3.1 8.9 13.2 2.6 8.3 
8 JA ND ND ND 15.1 21.1 10.8 28.2 
9 JT ND ND ND 11.2 14.8 19.9 22.7 
10 TM ND ND ND 22.7 27.3 10 12.8 
11 EM 17 22.1 5.1 11.5 16.6 4.4 10.2 
12 JW 14.1 18.5 4.4 11.5 13.2 7.8 10.6 
13 LG 11.5 15.3 3.8 8.5 10 14.2 18.3 
14 BR 15.3 18.8 3.5 16.2 16.2 4.4 6.6 
15 MF 11.5 13.8 2.3 18.1 22 12.7 17.3 
16 DH 30.7 36.2 5.5 26 27.7 16.2 18.6 
17 AB 18.4 25.3 6.9 22.5 22.5 1.9 1.9 
18 EMA 20.1 21.1 0 5 50 0 
19 JR ND ND ND 8.1 8.1 6 6 
20 PL 11.1 13.9 2.8 9.7 13.2 9.4 10 
21 GG 23.9 23.9 0 14 15 13.2 15.7 
22 SE 32.9 34 1.1 18.9 20.3 3 4 
23 CL 16.6 17.9 1.3 16.1 19.7 2.3 4 
24 TB 18.8 20.2 1.4 16.8 18.7 3 3 
25 CE 16.9 16.9 0 36.8 63.5 4.6 4.6 
26 JM 23 26.2 3.2 17 17.3 4.4 5.2 
27 JH ND ND ND 13.1 16 3.4 5.1 
28 MB 11.1 15.3 4.2 7 11.5 11.5 14.1 
29 MT 20.1 25 4.9 16.4 16.4 6.4 6.4 
Mean+SEM 18.3+1.3 21.1 2.72 14.9 18.6 6.9 9.7 
+1.3 +0.4 +1.2 +1.9 +. 94 +1.2 
Table XX Showing the population density of epidermal clear cells/mm 
in areas of patients with vitiligo. BCC basal clear cells, TCC total 
clear cells, LC Langerhans cells which represent the s-uprabasal clear 
cells in the uninvolved areas and total clear cells in the involved 
areas. ND not done. 
involved areas. In the involved areas only a few 
residual functioning melanocytes were seen. 
(c) Langerhans Cells 
In the uninvolved skin the Langerhans cells 
were represented by the clear looking cells that 
were lying suprabaselly and high up in the epidermis. 
In the involved areas of skin, the Langerhans cells 
were represented by the total clear cells in the 
epidermis, as confirmed by electron microscopy. 
The number of suprabasal clear cells 
in the uninvolved 
epidermis in the biopsies taken from patients with 
vitiligo was significantly increased when compared 
with those found in the biopsies taken 
from the 
normal controls (P<O. 05). 
In the biopsies taken from involved areas, the 
Langerhans cells were to be found both in the basal 
layer and also high up in the epidermis (fig 19). 
In many of the specimens examined the Langerhans cells 
were only in the basal layer and inonly a few of the 
samples were the Langerhans cells to be found 
in the upper portion of the epidermis. Langerhans 
cells were absent in the involved skin from one of 
the patients. 
The number of clear cells (Langerhans cells) 
in the involved areas of skin was significantly 
raised when compared with that of those suprabasal 
clear cells (Langerhans cells) of the uninvolved 
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Fig 19. Light micrograph of an involved area from a patient 
with vitiligo showing a few basal and suprabasal clear cells 
(arrows). Dermis showing mononuclear cells around blood 
vessels. Epon-embedded tissue, stained with basic fuchsin 
and methylene blue. (X 80) 
skin in the patients with vitiligo (P<O. 01), (fig 
20, table XX). 
It was not uncommon to see in the specimens 
from patients with vitiligo, two adjacent clear 
cells that were apparently in contact with each 
other in the basal layer of the epidermis. This 
finding was most unusual in the biopsies taken from 
the normal controls. 
(d) Mononuclear Cell Infiltrate of Epidermis 
A mononuclear cell infiltrate in the epidermis 
was present in many of the biopsy specimens. It 
was mainly observed in the portions from the marginal 
areas (fig 21,22) and less frequently and less marked 
in those samples from the involved areas of skin 
(fig 23). The infiltrate was usually in small foci, 
the cells being grouped together and lying mainly in 
the basal part of the epidermis. Sometimes, the 
cells had a tendency to form Pautrier-like micro- 
abscesses (fig 24,25). 
The main type of cell in this infiltrate was 
a large lymphocyte (fig 26). This cell had a hyper- 
chromatic nucleus with many deep invaginations and 
was easily distinguishable from adjacent histiocytes 
or Langerhans cells. Some of these lymphocytes had 
an elongated nuclei. The lymphocytes within the 
epidermis were similar to those in the dermis and 
some were seen to be traversing the dermo-epidermal 
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Fig 20 Comparison of epidermal Langerhans cells in normal 
controls (c, suprabasal clear cells) and uninvolved (u, suprabasal 
clear cells) and involved (i, total clear cells) areas of patients 
with vitiligo. 
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Fig 21. A. Light micrograph of a marginal area from a 
patient with vitiligo showing a focus of lymphocytes in the 
epidermis (E) and similar cells in the dermis (D). Blood 
vessel (V). Epon-embedded tissue, stained with basic 
fuchsin and methylene blue. (X 128) 
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Fig 21. B. Higher magnification showing a group of 
lymphocytes (arrows) surrounding a clear cell, probably a 
melanocyte. H Histiocytes, E Epidermis, D Dermis. 
(X 320) 
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Fig 22. Light micrograph of a marginal area 
from a patient 
with vitiligo showing invasion of the epidermis by lymphocytes, 
similar cells being seen in the dermis. Epon-embedded tissue 
stained with basic fuchsin and methylene blue. (X 320) 
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Fig 23. Light micrograph of an involved area from a patient 
with vitiligo showing a few lymphocytes in the epidermis. 
Similar cells are seen in the dermis. One of the lymphocytes 
with an elongated nucleus (arrow) is passing into the basal 
layer. Epon-embedded tissue, stained with basic fuchsin and 
methylene blue. (X 320) 
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Fig 24. Light micrograph of a marginal area from a patient 
with vitiligo showing a focus of intra-epidermal lymphocytes 
(arrows) with a tendency to form Pautrier like micro-abscess. 
E Epidermis, D Dermis, H Histiocyte. Epon-embedded tissue 
stained with basic fuchsin and methylene blue. (X 320) 
F 
Fig 25. Light micrograph of a marginal area from a patient 
with vitiligo showing intra-epidermal focus of lymphocytes 
(arrows) forming a Pautrier-like micro-abscess. C Clear 
cells, which are either Langerhans cells or histiocytes. Epon- 
embedded tissue, stained with basic fuchsin and methylene blue. 
(X 320) 
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Fig 26. Light micrograph of a marginal area from a patient 
with vitiligo showing invasion of epidermis with lymphocytes 
(arrows). Similar cells are seen in the dermis. C clear 
cells which are either Langerhans cells or histiocytes. Epon- 
embedded tissue stained with basic fuchsin and methylene blue. 
(X 320) 
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junction zone and entering the epidermis. 
The degree of the lymphocytic infiltration 
of the epidermis in many of the biopsies was not 
parallel with that seen in the dermis. In some 
specimens there were many lymphocytes in the epi- 
dermis, yet the papillary dermis contained only a 
few cells. 
The total number of clear cells in the epi- 
dermis of the marginal areas that was expected to 
be reduced when compared with that from the unin- 
volved skin due to a reduced number of melanocytes, 
was in some specimens actually increased. This 
was attributed to the presence of a mononuclear 
cell infiltrate in the epidermis in these marginal 
areas (table XX, fig 18). 
2. Dermis 
(a) General Appearance 
There was an increased cellularity of the 
dermis in many of the patients biopsies, particularly 
from the marginal and involved areas, and when com- 
pared with those from uninvolved skin and from the 
normal controls (table XXI). In many of the unin- 
volved areas in the patients with vitiligo, there 
was also an increased cellularity of the dermis. 
The differences between the mean of the total number 
of dermal cells for an area in the upper dermis in 
- 70 - 
No. Name Uninvolved 
n=22 
Marginal 
n=29 
Involved 
n=28 
Cytoid bodies 
1 DB ND 1071.8 2410.7 Pos 
2 RY ND 1180.6 1437.4 Neg 
3 SD ND 768 1281 Neg 
4 MO 1667 1804 1834 Neg 
5 JTR 459 1084 924 Neg 
6 CH 1413 1841 1343 Neg 
7 JC 1271 1798 1504 Pos, U+I 
8 JA ND 1413 606 Neg 
9 JT ND 1782 1612 Pos, M 
10 TM ND 1182 940 Pos, M+I 
11 EM 1733 985 524 Pos, M 
12 JW 584 1146 401 Pos, U+I 
13 LG 1456 2017 1537 Pos, U+I 
14 BR 1016 1376 992 Neg 
15 MF 1426 579 1478 Neg 
16 DH 1104 754 874 Pos, M+I 
17 AB 870 1219 780 Neg 
18 EMA 1227 361 690 Neg 
19 JR ND 1101 634 Neg 
20 PL 1380 584 ND Neg 
21 GG 863 2544 1104 Neg 
22 SE 726 1178 1191 Neg 
23 CL 1555 1870 1215 Neg 
24 TB 790 1216 921 Pos, I 
25 CE 1326 1723 906 Neg 
26 JM 1251 571 626 Neg 
27 JH 458 1225 1841 Neg 
28 MB 1387 1706 547 Pos, U+M 
29 MT 2003 1368 1873 Neg 
Mean+SEM 1180+88.9 1291+93.7 1143+93.4 
Table XXI Showing the population density of dermal cell/rant in 
areas of patients with vitiligo, also indicating the presence of cytoid 
bodies in the dermis of these patients. 
M Marginal, I Involved, U Uninvolved 
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various sites was not of statistical significance 
(00.05). 
There were no obvious changes of the blood 
vessels in the skin though in some specimens from 
the marginal and from the involved areas there was 
some thickening of their wall (fig 27). 
On microscopic examination of the plastic- 
embedded semi-thin sections stained with Huber 
method, it was difficult to be certain about the 
nerves and to comment on any differences. 
(b) Histiocytes 
These large phagocytic cells were distinguished 
by the presence of engulfed melanin granules. They 
were melanophages and were present in the uninvolved 
and marginal areas. In most of the biopsies from 
involved areas the histiocytes were devoid of 
melanosomes. 
(c) Lymphocytes 
Lymphocytes were frequently found in the dermis, 
particularly around blood vessels (fig 28). The cells 
had a big hyperchromatic nucleus with many deep 
invaginations, sometimes having a cerebriform 
(Sezary cell). In many, the cells had an elongated 
indented nucleus. Lymphocytes were seen wandering 
up into the epidermis, but as mentioned before, the 
degree of lymphocytic infiltration of the dermis 
did not parallel that of the epidermis. 
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Fig 27. Light micrograph of a marginal area from a patient 
with vitiligo showing a dermal vessel (V) with thickened wall 
and mononuclear cells. N Nerve. Epon-embedded tissue, 
stained with basic fuchsin and methylene blue. (X 320) 
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Fig 28. Light micrograph of a marginal area from a patient 
with vitiligo showing increased dermal lymphocytes (arrows). 
H histiocytes, N nerve, V blood vessel. Epon-embedded tissue 
stained with basic fuchsin and methylene blue. 
(d) Mast Cells 
Mast cells were found to be increased in the 
marginal and involved areas when compared to unin- 
volved skin and that of normal controls (table XXII, 
fig 29). In a few patients mast cells constituted 
the major number of the cells in the dermis. They 
were found mainly around the blood vessels and in 
the upper dermis. However, when the total mean 
number of mast cells in the different groups were 
compared with each other there was no statistical 
significance (P>0.05). 
(e) Cytoid (Colloid/Amyloid) Bodies 
These had been observed in the uninvolved, 
marginal and involved areas (fig 30, table XXI). 
They were seen mostly in the papillary dermis, some 
of them were seen in the basal layer of the epidermis. 
In some patients they were most frequent, particularly 
in the marginal and uninvolved skin, while in the 
involved areas they were very few. Although it was 
difficult to quantitate these bodies, they were much 
numerous in the vitiligo skin than in the normal 
controls. 
73 
No. Name Uninvolved 
n=22 
Marginal 
n=28 
Involved 
n=29 
1 DB ND 59.1 86 
2 RY ND 9.8 8.4 
3 SD ND ND 33.8 
4 MO 31.8 14.7 44.3 
5 JTR 0 0 0 
6 CH 51.8 73.9 0 
7 JC 17.7 0 29.5 
8 JA ND 52.5 73.9 
9 JT ND 114.6 59.1 
10 TM ND 46.4 0 
11 EM 39.4 26.2 9.8 
12 JW 14.7 25.3 17.7 
13 LG 44.3 0 16.9 
14 BR 36.9 0 22.1 
15 MF 0 0 14.7 
16 DH 22.1 43 100.5 
17 AB 29.5 19.7 0 
18 EMA 3.5 0 0 
19 JR NDI 23.6 12.6 
20 PL 85.4 169 9.8 
21 GG 7.3 0 8.4 
22 SE 7.8 29.5 122.8 
23 CL 14.7 36.9 110.9 
24 TB 5.9 133.1 29.5 
25 CE 0 0 65.7 
26 im 24.6 0 36.1 
27 JH 0 23 22 
28 MB 31.8 86.1 0 
29 MT 29.5 44.3 29.5 
Mean±SEM 22.64±4.4 36.81+8.2 33.24±6.6 
Table XXII Showing the population density of dermal mast cells/mm2 
in areas of patients with vitiligo. ND not done. 
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Fig 29 Comparison of dermal mast cells in normal controls (c) 
and uninvolved (u), marginal (m) and involved (i) areas of patients 
with vitiligo. 
Fig 30. Light micrograph of an involved area from a patient 
with vitiligo showing a cytoid (colloid/amyloid) body (CB) in 
the papillary dermis. Many mononuclear cells (arrow ) in 
the basal layer of the epidermis are also seen. Epon-embedded 
tissue stained with basic fuchsin and methylene blue. (X 320) 
C. OCCUPATIONAL VITILIGO 
The histopathological features in the biopsies 
of skin from the two patients with occupational 
vitiligo are shown (table XXIII, XXIV). The changes 
were similar to that found in common vitiligo. 
There was some hyperkeratosis of the epidermis 
in the involved skin in both patients. This was 
very marked in one of them when compared with the 
epidermis from the uninvolved area. No melanosomes 
were seen in the keratinocytes from the involved 
areas of skin. The melanocytes were diminished in 
number in the marginal areas and appeared to be 
absent in the involved skin. 
In one patient there was a marked increase 
in the cellularity of the dermis, mainly lymphocytes. 
Melanophages were also seen in the dermis in the 
marginal and uninvolved skin, but not in the involved 
amelanotic area. 
Mast cells were also seen to be increased in 
number in one of the patients, both in the marginal 
and involved areas. Cytoid (colloid/amyloid) bodies 
were seen in one patient. 
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Uninvolved Dermis Marginal Dermis Involved Dermis 
Name Dermal Mast cells Dermal Mast cells Dermal Mast cells 
cells cells cells 
AG 1420 39.4 1400 32.8 ND ND 
AD 1319 23.6 2873 85.4 1408 72.3 
Table XXIII Showing the population density of total dermal cells 
and dermal mast cells/mm2 in areas of patients with occupational vitiligo. 
ND not done. 
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Uninvolved Marginal Involved 
Name BCC TCC LC BCC TCC BCC TCC(LC) 
AG 
AD 
27.6 
24.4 
36.1 
26.5 
8.5 
2.1 
18.8 
7.6 
27.3 
12.8 
4.7 
10 
5.3 
11.5 
Table XXIV Showing the population density of epidermal clear 
cells/mm of epidermis in areas of patients with occupational 
vitiligo. BCC Basal clear cells, TCC total clear cells, 
LC Langerhans cells. 
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VI. ELECTRON MICROSCOPY 
A. NORMAL CONTROLS 
Biopsies were taken from nine controls. The 
mean age of these patients was twenty-nine, the 
age range nineteen to thirty-five. The majority 
of these biopsies were taken from the upperarm. 
1. Epidermis 
(a) General Appearance 
The epidermis was recognised to be divided 
into four strata or layers. 
Basal Layer 
This was composed mainly of keratinocytes 
(fig 31) and whose principal function is that of 
division. It can be regarded as the stratum ger- 
minativum. Keratinocytes in this-layer had an 
elongated shape, their nuclei were oval and were 
perpendicular to the plane of the basal surface of 
the epidermis. The nucleus contained one or more 
prominent nucleoli. In addition to the normal cyto- 
plasmic organelles the cell also contained bundles 
of tonofilaments that were arranged mainly at the 
periphery of cytoplasm, leaving a clear perinuclear 
zone. The keratinocytes were attached to each other 
by complete desmosomes and to the basal lamina by 
hemi-desmosomes. In addition to the keratinocytes, 
melanocytes, Langerhans cells and occasionally Merkel 
cells were found in the basal layer. Melanosomes 
were to be frequently found in the basal keratino- 
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cytes and were most likely to be present at the 
upper pole of the nucleus forming what had been 
described as a supranuclear cap (fig 31) The 
melanosomes of Caucasoids are small and aggregated 
in groups of two or more within membrane-bound 
packages, while in negroes the melanosomes are 
larger and remain unaggregated in the cytoplasm. 
Stratum Spinosum 
This consisted of many layers of keratinocytes. 
They were polyhedral in shape in the deeper part, 
but become more flattened and elongated near to 
the granular layer. Desmosomes occurred at intervals 
along the cell membrane which was very folded with 
many villous like projections. Tonofilaments were 
more numerous than in the cells of the basal layer 
and were grouped together, particularly in relation 
to the desmosomes. They frequently enveloped the 
nucleus leaving a clear perinuclear zone. Membrane 
bounded melanosomes were present in the cytoplasm 
of these cells. Dendritic Langerhans cells were 
also found, but they mainly occurred in the upper 
portion of this layer. 
Stratum Granulosum 
This was composed of about two layers of cells. 
The cells were now more flattened than in the stra- 
tum spinosum cells and their nuclei were elongated 
with their long axis horizontal to the surface. 
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Fig 31 . Electron micrograph of a normal skin showing a relatively inactive melanocyte (M) and suprabasal Langerhans cell (LC). The keratinocytes (K) have a lot of melanosomes. D Dermis, E Epidermis, Inset showing a higher magnification of Langerhans granules. (X 25000) 
The cytoplasm contained few organelles. Two charac- 
teristic granules were present; keratohyalin granules 
appearing as amorphous and highly electron dense 
bodies. They were irregular in shape and vary in 
size and seem to intermingle with tonofilaments. 
Not infrequently the tonofilaments seemed to be 
condensing together to form keratohyalin granules 
that measure 100-200nm. Lamellar or Odland bodies 
were much smaller granules that were ovoid or 
round in shape and were seen in close proximity to 
infolding of the cell membrane. On higher magnifi- 
cation the lamellar structure of these granules 
was apparent. The parallel dense lamellae were 
separated from each other by more translucent zones. 
The keratinocytes in this layer were still 
attached to each other by desmosomes. In Caucasians 
only a few melanosomes were seen in the keratinocytes, 
but in more pigmented races well preserved melano- 
somes were frequently found high up in the epidermis. 
Stratum Corneum 
This comprised of variable number of flattened 
keratinised cells that were piled on top of each 
other. The number of layers of cells varied accord- 
ing to different sites. There was a sudden change 
from granular cells to fully keratinised cells. The 
electron density of the cells varied. The inter- 
cellular space contained granular or reticular 
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material. There were intercelluar dense areas 
which represented the remains of desmosomes. The 
cytoplasm of these cells was usually free of any 
organelles apart from dense aggregates of filaments 
and occasionally a few melanosomes. 
Desmosomes 
These were specialised connections between the 
keratinocytes. Desmosomes were primarily composed 
of the plasma membranes of two adjacent cells. They 
are made up of a series of dense and lucent zones. 
On the external surface of the plasma membrane there 
was a row of electron dense granules. In the middle 
of the space between the two plasma membranes there 
was also a row of electron dense granules. There was 
also an electron dense thickening on the inner sur- 
face of each plasma membrane, -forming the attachment 
plaque of the desmosomes. This attachment plaque 
was separated from plasma membrane by lucent areas. 
The size of desmosomes varied, and they were 
either short or very long depending on the plane 
that they were cut. The distribution also varied. 
It was not infrequent to see collections of desmos- 
omes between the keratinocytes and, in particular, 
near the Langerhans cells. Bundles of tonofilaments 
frequently appeared to stream onto and terminate upon 
the attachment plaque of desmosomes. 
(b) Clear Cells 
The clear cells to be found in the normal 
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epidermis were melanocytes, Langerhans cells and 
the occasional Merkel cell. 
Melanocytes 
These pigment-producing cells were usually 
confined to the basal layer (fig 31), where the 
incidence of melanocytes in relation to keratino- 
cytes was variable. Melanocytes were usually basal 
in their position, but occasionally were just 
suprabasal as a result of the sectioning. Effete 
melanocytes were not seen higher up in the epidermis. 
The majority of the melanocytes had a direct relation- 
ship with the dermo-epidermal junction and to the 
basal lamina. Frequently, melanocytes had a pendu- 
lous appearance dipping into the papillary dermis 
but separated from it by the basal lamina. The 
dendritic nature of melanocytes was rarely fully 
apparent due to sectioning, but dendritic processes 
were present interspersed among the neighbouring 
keratinocytes. 
The melanocytes were readily distinguishable 
from surrounding keratinocytes by a more trans- 
lucent cytoplasm and there were no tonofilaments. 
Fine cytofilaments could be seen within the cyto- 
plasm of most melanocytes. The cytofilaments had 
a diameter that ranged from 80-1208, but the majority 
were about 100. These were very well developed 
in the more inactive cells and formed bundles and 
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whorls. Desmosomes were not seen between melano- 
cytes and the neighbouring cells. Hemi-desmosomes 
were not found, though in some cells thickening of 
their plasma membrane forming attachment like 
structures may be seen along the dermo-epidermal 
junction. 
The most characteristic feature of the 
melanocytes was the presence of specific cytoplasmic 
granules, the melanosomes. These pigmented granules 
were present in the cytoplasm and four formative 
stages are recognised. Stage I were vesicles, with 
no apparent internal structure, that were located 
usually near the Golgi system. Stage II contained 
coiled filaments in a smooth-walled vesicle, but 
with no significant deposition of melanin. Stage 
III melanosomes were recognised by deposition 
of melanin which partially obscured their internal 
structure. The melanofilaments exhibited a periodi- 
city of particles along their length of 60-80ä. Stage 
IV melanosomes, the internal structure was completely 
obscured by the deposition of melanin. This fully 
melanised melanosome had an ellipsoidal shape with 
a mean transverse diameter of 0.14m. In the 
relatively inactive melanocytes, these melanosomes 
were mainly seen in portions of the dendrites with 
very few in the cytoplasm of the main cell body. 
However, in the active cells melanosomes were mainly 
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seen around the nucleus and in relation to the Golgi 
system. Collections of melanosomes without an outer 
limiting membrane were seen in the cytoplasm of 
several melanocytes in few of the biopsies (fig 37). 
The distribution of melanosomes in the cytoplasm 
of keratinocytes was mainly in complexes, where two 
or more melanosomes were grouped together within a 
limiting membrane. In few biopsies the melanosomes 
were distributed both singly and in complexes. In 
general, the larger the melanosome the more the tendency 
towards single dispersion. 
Langerhans Cells 
These dendritic cells were present mainly in 
the suprabasal layer of the epidermis (fig 31), but 
were also found in the basal layer. They could be 
distinguished from the keratinocytes by their clear 
appearance and the lack of desmosomes and tonofila- 
ments. Specific organelles (Birbeck granules) were 
present within the cytoplasm of the cell. The nucleus 
of the cell was usually lobate and indented, some- 
times it was highly convoluted. The heterochromatin 
was condensed at the periphery of the nucleus. In 
addition the cytoplasm contained many lysosomes. 
Langerhans cells found high up in the epidermis 
might contain only a few rod or racquet-shaped 
Langerhans cell granules. Microfilaments were not 
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so well developed in these cells although sometimes 
they could be as numerous as found in the melano- 
cytes. 
The Langerhans cell granule was considered 
to be the specific marker for this cell. These 
organelles were frequently arranged near the Golgi 
but also could be found in relation to nuclear and 
cell membranes. Sometimes there were aggregates 
of rod-shaped granules that were arranged in stacks 
parallel to each other. The characteristic mor- 
phology of the Langerhans cell granule was that of 
tennis racquet with an expanded vacuolated end and 
a lower rod-like handle of variable length. In 
the central part of this handle, -there was a linear 
electron-density with periodicity of particles 
along its length of about 90R. Sometimes a para- 
crystaline net or lattice again with periodicity 
of 90R was also seen. Three dimensional reconstruc- 
tions of these granules indicated that they were 
basically discoid bodies with vesicular expansion 
at the margin of the disc. These granules could 
sometimes be found budding off from-the nuclear 
membrane and they occasionally were on the outer 
limiting cell membrane. 
Lysosomal structures were frequently found 
within these cells, many of them being spherical 
membrane bounded bodies with amorphous or granular 
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contents. Lamellated lysosomal bodies were also 
found as well as vacuoles. Rarely membrane bounded 
melanosomal complexes could be found within these 
cells. 
Indeterminate Cells 
These were dendritic non-keratinocytic cells 
that closely resemble the Langerhans cell and the 
melanocyte. The cytoplasm of these cells appeared 
clear and they lack desmosomes and tonofilaments. 
Their morphology resembled that of melanocytes and 
Langerhans cells, but they lacked the characteristic 
organelles for these cells. Occasionally, in serial 
sections, Langerhans cell granules were to be found 
and these cells were then identified as Langerhans 
cells. Most of these cells were to be found either 
in the basal layer or just above this zone in the 
epidermis. Not infrequently, these cells had the 
same 1008 microfilaments as was seen in the melano- 
cytes. However, even on serial sections melanosomes 
could not be identified within the cells. 
Indeterminate cells appeared to be rather 
infrequent in the epidermis of the skin from normal 
controls. 
Merkel Cells 
These were also non-keratinocyte cells and were 
present in the basal layer of the epidermis (fig 32). 
Their cytoplasm was clear and they contaired characteris- 
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Fig 32 Electron micrograph of an involved area from a 
patient with vitiligo showing a basal Merkel cell with its two characteristic features; the electron dense granules (G) 
and the desmosomes (DS). Inset showing desmosome between 
the keratinocyte and Merkel cell. E epidermis, K keratinocytes, D dermis, BL basal lamina. (X 19971 ) 
tic round electron-dense granules measuring 
60-110nm in transverse diameter. These granules 
were membrane bounded and were most frequently to 
be found on the opposite side of the nucleus to 
the Golgi. A further feature of these cells was 
the presence of desmosomes on their outer limiting 
membrane. The cytoplasm also contained micro- 
filaments. One of these cells was found in the 
involved skin of a vitiligo patient. However, they 
were not found in the biopsies taken from normal 
controls. 
2. Dermis 
This was divided into papillary and reticular 
portions and consisted of bundles of collagen fibres 
and ground substance. In addition to the collagen 
fibres there were elastic and reticulin fibres. ' Cells 
to be found in the dermis were fibroblasts, histio- 
cytes, occasional lymphocytes, mast cells as well as 
those of the nerves and blood vessels. 
(a) Dermo-epidermal Junction 
This was the boundary between the epidermis 
and dermis and was composed of; the basal cell 
plasma membrane with hemi-desmosomes; the lamina 
lucida; the lamina densa (basal lamina); the sub- 
basal lamina and its fibrous elements. Anchoring 
fibrils, with an irregular banded pattern, were 
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present in the papillary dermis and extended to 
the lamina densa. There were also special fine 
filaments that transversed the lamina lucida per- 
pendicullarly to the outer surface of the plasma 
membrane of the basal cells into the lamina densa. 
These fine filaments were mainly seen in the region 
of the hemidesmosomes. 
(b) The Collagen and Elastic Fibres 
Collagen fibres were to be found throughout 
the dermis and they were mainly arranged in the 
form of bundles, particularly in the deeper part 
of the dermis. On higher magnification collagen 
fibres showed a striation with a repeated banded 
pattern along the length of the fibre measuring 
550-6408. 
Elastic fibres were also seen between the 
collagen bundles, recognised by being more electron 
dense. They consist of an amorphous very electron 
dense part that was admixed with microfibrils. 
(c) Dermal Cells 
Fibroblasts 
These were elongated or spindle-shaped cells 
that had an oval nucleus. The cytoplasm of these 
cells was bulky and they had well developed rough 
endoplasmic reticulum. These cells were found 
throughout the dermis and were more active in the 
papillary dermis. 
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Histiocytes (Macrophages) 
These were again large cells that had a 
rather indented nucleus and sometimes this might 
be very lobate. In addition to normal organelles, 
the cytoplasm contained membrane bounded electron 
dense bodies that were lysosomes. In the inflam- 
matory disorders the macrophages lying in the 
papillary dermis frequently contained melanosomal 
complexes. These melanophages were particularly 
to be seen in those with racially pigmented skins. 
Mast Cells 
They were to be found in the dermis and the 
population density of these cells varied considerably. 
Most of these cells were normally to be found in 
relation to blood vessels. The size of these cells 
was very variable and they were easily recognised 
by the characteristic granules and by the villous 
like processes of the outer cell membrane. The mast 
cell granules were usually spherical in shape and 
often had very electron dense portion with less 
dense granular peripheral zone. Some of the granules 
showed lamellated internal structure, some of these 
in the form of scrolls. Some of mast cells were 
packed with granules, others might contain very few. 
Nuclei of these cells were usually central in loca- 
tion and occasionally binucleate cells could be seen. 
Mast cells were more common in the papillary dermis 
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but could be found in the deeper portion of the 
dermis and also in the subcutaneous tissue. 
Lymphocytes and Plasma Cells 
Also to be found, particularly around blood 
vessels, were lymphocytes and occasionally plasma 
cells. Plasma cells were recognised by highly 
developed rough endoplasmic reticulum and also very 
prominent Golgi. 
(d) Cutaneous Nerves 
The nerves most commonly found in the papillary 
and reticular dermis were unmyelinated, but one also 
finds myelinated ones occasionally. The nerves were 
composed of a number of axons that were enveloped 
by process of the Schwann cell. *The Schwann cell 
and processes were surrounded by a well defined basal 
lamina. The axons seen in the reticular dermis were 
embedded in the endoneurium collagen. The endo- 
neurium was enclosed by perineurium that consisted 
of concentric layers of flattened cells, similar to 
fibroblasts, but surrounded by basal lamina. The 
axons seen in the superficial dermis and in particular 
in the papillary part were lacking in. endoneurium 
and perineurium. These nerves in the papillary dermis 
usually run parallel with dermo-epidermal junction and 
were only very rarely vertical in their arrangement. 
The nucleus of the Schwann cell was usually 
indented and the cytoplasm of the cell, in addition 
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to having the normal organelles, had as well many 
microfilaments, lysosomes and occasionally melano- 
somes were to be found. The cells could be dist- 
inguished from other dermal cells by the presence 
of axons and surrounding basal lamina. The axons 
associated with the cell and its processes were 
usually completely infolded, although occasionally 
might be partly exposed. Each axon was composed 
of axoplasm that was surrounded by its plasma mem- 
brane. It contained mitochondria and well developed 
neurotubules 23nm in diameter. The neurotubules 
were usually running along the long axis of the 
axon and only a few obliquely. The axons also con- 
tained few neurofilaments. At the nerve terminals 
near the dermo-epidermal junction zone the axon was 
occasionally seen swollen like a button that was full 
of mitochondria and a few electron, dense cored 
granules. Unmyelinated nerves were seen containing 
either large (105nm in diameter) and small (60nm in 
diameter) dense core vesicles of adrenergic type or 
small agranular vesicles of cholinergic nature. Also 
larger electron dense bodies could be seen in the 
axons, some of them resembling dense mitochondria. 
A number of myelinated axons that occasionally were 
present in the dermis, each being surrounded by a 
myelin sheath that consisted of concentric lamellae. 
It was a regular sequence of electron dense and less 
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dense lines in these lamallae. 
(e) Blood Vessels 
Most of the vessels seen in the papillary 
dermis were small capillaries. These were cut in 
various cross-sections and consisted of a small 
lumen with large endothelial cells that formed the 
lining of the vessel. Surrounding the capillaries 
were peri-endothelial cells. The endothelial cells 
had large prominent nuclei and in addition to having 
well developed cytofilaments also had electron 
dense bodies (Weibel - Palade bodies). A type of 
junction was present, points of contact between 
the adjacent outer limiting plasma membranes of the 
endothelial cells. The peri-endothelial cells 
(pericytes) were closely related to the capillaries 
and were surrounded by the basal lamina that enveloped 
the capillary. Replication of the basal lamina 
surrounding the blood vessels in the superficial 
dermis was not infrequently seen, particularly in 
the sun exposed area of the skin. 
(f) Filamentous Colloid/Amyloid Bodies 
Sometimes these were seen in the normal skin 
and were to be found in the papillary dermis near 
the dermo-epidermal junction zones. These globular 
bodies consisted of whorls and rays of unbranched 
filaments of varying cross-sectional diameter. 
They were only found in one of the normal controls. 
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B. COMMON VITILIGO 
1. Epidermis 
a) General Appearance 
Spongiosis of the epidermis was noted in 
almost 50% of biopsies from marginal and involved 
areas of skin and was usually more common and 
apparent in the marginal sites (fig 33). This 
spongiosis was mainly in the lower part of the 
epidermis with oedema between keratinocytes and 
adjacent clear cells. There was widening of the 
intercellular spaces with preservation of cellular 
attachments. Villous-like processes were found 
between the keratinocytes and some of the nuclei 
of the cells appeared pyknotic with a prominent 
heterochromatin pattern. The tonofilaments were 
not infrequently aggregated together forming clumps. 
Occasionally, there was complete disruption of the 
basal part of the epidermis with degeneration of 
keratinocytes leaving debris between the cells 
(fig 55). The spongiosis was not infrequently asso- 
ciated with a mononuclear cell infiltrate of epidermis. 
(b) Melanocytes 
Tininvnl -earl a , -Aaý" These were present usually 
in the basal layer of the epidermis, but also 
occasionally just suprabasally. The nucleus was 
usually round or oval in shape (fig 34), but not 
infrequently lobate with a convoluted nucleus and 
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dense chromatin around its margin. Ellipsoidal 
melanosomes, mostly stage III and IV, were found with 
few premelanosomes, stages I and II. Inactive 
melanocytes were present containing very few melano- 
somes, but with prominent cytofilaments lOOR in 
diameter. In many instances the melanocytes were 
pendulous, dipping into the dermis, but always 
lying above and in relation to the basal lamina. 
Occasionally melanocytes were found apparently in 
the dermis but still enclosed within a sheath of 
basal lamina. In some areas melanocytes were found 
that showed degenerative changes. The nuclei of 
these cells were pyknotic with a prominent hetero- 
chromatin pattern (fig 36). The cytoplasm was 
vacuolated and contained auto-phagosomes. This was 
particularly observed in a spongiotic epidermis. In 
some sections there was marked reduction or even 
complete absence of melanocytes and melanosomes, but on 
further sectioning of the same block of tissue, 
melanocytes were found. This could represent minor 
foci of vitiligo in the 'uninvolved'-skin. In one 
of these areas an intra-epidermal adrenergic poly- 
axonal nerve was seen in direct contact with a 
secretory melanocyte (fig 72). 
Marginal: There was a reduction in the popu- 
lation density of melanocytes. The melanocytes were 
larger than those found in the uninvolved skin, often 
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with many dendrites that were full of melanosomes 
and were to be seen between the keratinocytes. 
Inactive melanocytes (fig 35) were also seen 
containing only a few melanosomes and with promi- 
nent arrays of cytofilaments. In many areas there 
was an apparent complete loss of melanocytes. 
However, portions of dendrites that could be seen 
contained melanised melanosomes. It was in these 
areas that the keratinocytes still contained melano- 
somes. Large collections of melanosomes, without 
a definite limiting membrane, had been seen in the 
cytoplasm of melanocytes in some biopsies (fig 37). 
In areas where there were spongiosis of the 
epidermis the melanocytes were 'involved and appeared 
to be separated from the adjacent keratinocytes by 
the intercellular oedema. Even in the absence of 
spongiosisthe melanocytes showed evidence of degenera- 
tion with pyknotic-like changes of the nucleus with a 
prominent heterochromatin pattern and vacuolation of 
the cytoplasm (fig 36). In the epidermis of these 
marginal areas, lymphocytes were seen to be in contact 
with secretory melanocytes (fig 38,39,40). 
Involved areas: A complete absence of melano- 
cytes was almost universally found in the biopsies 
from these areas. Only a few residual melanocytes 
were found though some of these cells were highly 
active and contained many melanised melanosomes. 
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Fig 33. Electron micrograph of a marginal area showing spongiosis of the epidermis (E) with oedema of the dermis (D). N nerve affected by the oedema (see Fig. 71 ), M Melanocyte, L Lymphocyte, LC Langerhans cell, with its granule (LG) shown in the inset, K Keratino- 
cyte. (X 6250) 
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Fig 34 . 
Electron micrograph of a normal functioning basal melanocyte 
(M). D Dermis, E Epidermis, K Keratinocyte. 
(X 14175) 
Fig 35. Electron micrograph from a marginal area showing inactive 
pendulous melanocyte (M). D Dermis, E Epidermis. 
(X 15120) 
D 
Fig 36 . Electron micrograph of degenerating melanocyte showing 
pyknotic nucleus (N) and vacuolated cytoplasm (V). m melanosomes, 
D Dermis, E Epidermis. (X 38400) 
Fig 37. Electron micrograph of melanocyte (M) showing melanosomes 
collection (arrow) inside the cytoplasm without a limiting membrane. 
m melanosome in different stages of development, K Keratinocytes 
with melanosome, D Dermis, BL Basal lamina. (X 10000) 
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Fig 38. Electron micrograph of 
like lymphocyte (S) passing thron 
and coming in direct contact with 
interdigitations with it. Arrow, 
epidermal junction. D Dermis, E 
(X 17325) 
a marginal area showing $ezary 
gh the dermo-epidermal junction 
a melanocyte (M) and even making 
showing a break in the dermo- 
Epidermis, m melanosomes. 
Although there was almost complete absence of 
melanocytes in these areas, melanosomes were often 
found in the keratinocytes and this occured in 
more than a third of the patients biopsied. It is 
presumed that the presence of a few residual func- 
tioning melanocytes in these involved areas were 
responsible for the production and transfer of 
melanosomes to these keratinocytes. 
Melanosomes: Most of the patients in this 
study were Caucasians and it was observed that in 
the sections from uninvolved and marginal areas of 
the skin the melanosomes, instead of being arranged 
in membrane bound complexes of three or more, tended 
to be arranged singly. The size of the melanosome 
was variable, but the mean transverse diameter of 
uninvolved areas was O. 13µ. 
(c) Langerhans Cells 
Uninvolved areas: These dendritic cells were 
usually seen high up in the epidermis. They had an 
indented nucleus and only a few Langerhans cell 
granules were to be found in the cytoplasm of the 
cell. ofthe Langerhans cells found in the basal 
layer, their nucleus was more convoluted and granules 
were more frequent. In some of the uninvolved areas 
the Langerhans cells were only found in the basal 
layer. Langerhans cells were not found in those 
areas where there were many mononuclear cells in 
- 97 - 
the epidermis. Some of the Langerhans cells had 
vacuolated cytoplasm with a shrunken nucleus. Also 
occasionally melanosomal complexes were seen in 
these cells. In one section Langerhans cell granules 
were found in a membrane bounded body that was a 
lysosome (fig 41). In general the number of Langer- 
hans cells appeared to be increased when compared 
with those biopsies from normal controls. This 
was only an impression, but could not be proven 
statistically. 
Marginal areas: The Langerhans cells were 
mainly basal in location (fig 42) with a few being 
suprabasal. In many patients the cells were few or 
were absent, in particular, when there was a mono- 
nuclear cell infiltrate in the epidermis. The 
Langerhans cells sometimes appeared more 'active' 
than those in the uninvolved areas and had more con- 
voluted nucleus with many characteristic granules and 
more lysosomal structures, and a well developed Golgi. 
Some of the Langerhans cells had vacuolated cytoplasm 
with a shrunken nucleus (fig 47A). Frequently, the 
Langerhans cells were seen in direct relation to lympho- 
cytes, particularly in the basal layer of the epidermis. 
Melanosomal complexes were also found in the cytoplasm 
of these cells. A desmosome-like structure was noticed 
in the cytoplasm of one of these cells which was 
similar to the Langerhans granule. 
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Fig 41 . Electron micrograph of an uninvolved area showing a basal Langerhans cell (LC) with intralysosomal Langerhans granules (arrow), as shown in the inset. LG Langerhans granules, D Dermis, BL Basal lamina, K Keratinocytes. (X 22050) 
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Fig 42 . Electron micrograph of a marginal area showing a 
basal 
melanocyte (M) with different formative stages of melanosomes (m). 
Also a basal Langerhans cell (LC) with its granules (LG) shown in 
the inset. D Dermis, BL Basal lamina, E Epidermis. (X 7000) 
Fig 43 . Electron micrograph of an involved area showing Sezary like lymphocyte (S) in contact with Langerhans cell (LC). Inset showing a higher magnification of Langerhans granules (LG). LD Langerhans dendrite, 
D Dermis, BL Basal lamina, E Epidermis. (X 14490) 
--b =_ LieL: Lron micrograph of an involved area showing lymphocyte (L) in contact with Langerhans cell (LC). LG Langerhans granules, LY Lysosome, K Keratinocyte. (X 17325) 
Involved areas: In the involved areas of the 
skin the Langerhans cells were mainly basal, but 
were also found above this layer. In some patients 
only suprabasal Langerhans cells were identified. 
In a number of patients in serial sections of the 
biopsies from involved skin, no Langerhans cells 
could be positively recognised. However, the 
morphology of the clear cells in the basal layer of 
the epidermis were very suggestive of Langerhans 
cells (see indeterminate cells). Langerhans cells 
were also found to be in close contact with lympho- 
cytes, particularly in the basal layer of the epider- 
mis (fig 43,44). 
The number of Langerhans cells in the basal 
and suprabasal layer appeared to be increased as 
compared with the numbers found in the epidermis 
of uninvolved in patients with vitiligo and in the 
normal skin from controls. 
(d) Langerhans Cell Granules and Desmosomes 
It was not infrequent to see a group of des- 
mosomes aggregated near a Langerhans cell and often 
they were partially enclosed by the Langerhans cell 
cytoplasm (fig 45). In one section a desmosome was 
seen inside the cytoplasm of a Langerhans cell and 
this was similar to the characteristic granule, but 
it had an attachment plaque (fig 46). Also on many 
occasions desmosomes were seen that are similar to 
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Langerhans cell granules even, possessed vesicular 
portions. These were seen between the keratino- 
cytes and near the Langerhans cells (fig 47). 
(e) Indeterminate Cells 
These cells were found in all areas, but 
appeared to be more frequent in the marginal 
(fig 49) and involved (fig 48) areas of skin in 
patients with vitiligo. Morphology of these cells 
was identical to that of Langerhans cells, but no 
Langerhans cell granules could be recognised even 
in serial sections. In the marginal areas of the 
skin the cells appeared to be more frequent and 
were related with mononuclear cells. One Langerhans 
cell/indeterminate cell was found in the marginal 
area lying in the upper dermis. In the normal and 
uninvolved skin, in vitiligo, these indeterminate 
cells were only occasionally seen and were much less 
frequent than melanocytes and Langerhans cells. 
(f) Mononuclear Cell Infiltrate of the Epidermis 
A mononuclear cell infiltrate was found within 
the epidermis in about a third of the patients 
biopsied. Most invariably, this was in the marginal 
areas of skin (fig 50,51,52), but in a few of the 
biopsies taken from uninvolved (fig 53) and involved 
areas of skin showed the presence of mononuclear 
cells within the epidermis. Associated with this 
mononuclear cell infiltrate within the epidermis 
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there was also frequently some degree of spongiosis. 
In some biopsies there was considerable disruption 
of the epidermis with degeneration of keratinocytes 
and cell debris (fig 54,55). A number of breaks 
were present at the dermo-epidermal junction zone 
involving also the basal lamina. Mononuclear cells 
were to be found passing through these breaks into 
the epidermis (fig 38,56,57). Most frequently, the 
mononuclear cell infiltrates were arranged in foci, 
particularly in the basal layer of the epidermis. 
These cells were to be found aggregated and in 
loose contact with each other. In some specimens, 
particularly from the marginal areas there were many 
of these mononuclear cells, sometimes aggregated to 
form Pautrier micro-abscesses. However, in the 
majority of the biopsy specimens these cells were 
arranged singly and were to be found in the epidermis, 
but particularly in the basal layer. Sometimes there 
were foci of these mononuclear cells in a particular 
area, but further sections through the same block 
showed relatively normal epidermis with only occa- 
sional mononuclear cells. 
Mononuclear cells seen were usually atypical 
(stimulated) lymphocytes (fig 51,52) but also histio- 
cytes were clearly recognised. The lymphocytes 
usually had large convoluted nuclei with a prominent 
heterochromatin pattern that was particularly con- 
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Fig 45 . Electron micrograph showing 
Langerhans cell (LC) partially 
phagocytosing a collection of desmosomes 
(DS). LG Langerhans granules, 
MI Mitochondria, LY lysosome, K Keratinocyte. (X 48000) 
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Fig 46 . Electron micrograph showing Langerhans cell (LC) with 
phagocytosed desmosomes. Inset is higher magnification of desmosomes. 
K Keratinocyte, T Tonofilaments, LG Langerhans granules. (X 18199) 
rt yY 
F( 
1 1.41\ 
JLG 
r 3, 
CLI 
1- 
IMP 
,a 
all 
1 
"V94, 
Fig 47 A- Electron micrograph of a marginal area showing Langerhans 
cell (LC) with marked degenerative changes. On the top of this cell 
some of the intercellular desmosomes (DS) had changed into Langerhans 
granule like structures (X 16380). Inset in the left lower corner 
showing a higher magnification of these structures. LG Langerhans 
granules, K Keratinocytes. 
B- showing intercellular desmosomes (DS) changed into Langerhans 
granule like structures. (X 40000) 
Fig 48. Electron micrograph of an involved area showing a basal 
indeterminate cell (ID). D Dermis, E Epidermis. (X 2400) 
Fig 49 Electron micrograph of a marginal area showing a basal indeterminate cell (ID). D Dermis, E Epidermis. (X 2400) 
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Fig 50 . Electron micrograph of a marginal area showing marked 
inflammatory changes, mainly spongiosis with lymphocytic cell infiltrate 
(L) of the epidermis (E). One of the lymphocytes is just passing into 
the epidermis through a break in the dermo-epidermal junction (arrows). 
D Dermis, BL Basal lamina, K Keratinocyte. (X 7500) 
Fig 51 . Electron micrograph of a marginal area showing atypical 
lymphocytes (L) infiltrating the epidermis (E). LC Langerhans cell 
with its Langerhans granule shown in the inset. H Histiocyte, 
D Dermis, K Keratinocytes. Arrows showing a break in the dermo- 
epidermal junction . (X 13275) 
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Fig 53 . A, B - Electron micrographs of an uninvolved area showing marked inflammatory changes of the epidermis, mainly lymphocytes (L) and spongiosis. S Sezary like cell, D Dermis, E Epidermis, H Histiocytes. (A, X 6250, B, X 4000) 
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Fig 54 Electron micrograph of an uninvolved area showing the marked 
inflammatory changes in the epidermis (E) like spongiosis, atypical 
lymphocytes (L). S Sezary like cell ,D Dermis. (X 9200) 
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Fig 55 Electron micrograph of a marginal area showing a marked spongiosis with cell debris (CD). D Dermis, E Epidermis. (X 9200) 
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Fig 56 . Electron micrograph of a marginal area showing two 
lymphocytes (L) just entering into the epidermis (E) through a break 
(arrows) in the dermo-epidermal junction. D Dermis, BL basal lamina. 
(X 16434) 
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Fig 57. Electron micrograph of a marginal area showing marked 
inflammatory changes, mainly spongiosis with lymphocytic cell (L) 
infiltrate of the epidermis (E), together with histiocyte (H). 
The lymphocyte seen is just passing into the epidermis through a 
break (arrow) in the dermo-epidermal junction. D Dermis, 
K Keratinocyte. (X 10000) 
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densed around the periphery. Some of these cells 
resembled those found in the Sezary cell syndrome 
and in mycosis fungoides. The cells identified 
within the epidermis were similar to those lympho- 
cytes and histiocytes seen in the papillary dermis. 
In many biopsies taken from the patients with viti- 
ligo these lymphocytes were in close contact with 
melanocytes (fig 38,39,40) and Langerhans cells 
(fig 43,44), and sometimes formed inter-digitations 
between them. 
The population density of the epidermal mono- 
nuclear cells showed no direct relationship with the 
number found in the upper dermis. In some biopsy 
specimens there were many cells to be found within 
the epidermis, where as the underlying dermis con- 
tained very few lymphocytes and histiocytes. 
(g) Mast cells 
Mast cells with typical cytoplasmic granules 
and villous processes from the cell membrane were to 
be found in the basal layer of the epidermis in three 
of the patients biopsied (fig 58). In two of the 
biopsies the occasional cell was found in the in- 
volved skin and in one from the marginal area. Por- 
tions of these mast cells were to be found between 
the keratinocytes in the basal-layer. None of these 
cells were to be seen in the higher layer of the 
epidermis. In one of the specimens the mast cells 
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Fig 58 A- Electron micrograph of an involved area showing 
intra- 
epidermal mast cell (MC). D Dermis, BL 
basal 1 Dina, V Villous 
processes. (X 15120) 
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Fig 58 .B- Electron micrograph of an involved area showing intra- 
epidermal mast cell (MC) in contact with Langerhans cell (LC), its 
granules are not shown here. D Dermis, E Epidermis, K Keratinocyte. 
(X 16380) 
were partially degranulated. 
2. Dermis 
(a) General Appearance 
Very few alterations were noticed in the 
dermis and these were mainly confined to biopsies 
taken from the marginal areas. In a number of the 
patient's biopsies, there was significant oedema of 
the upper dermis and the collagen bundles appeared 
to be more widely separated. Deposition of fibrin 
was to be found only in the papillary dermis and 
mainly at the dermo-epidermal junction zone (fig 59). 
The dermal cellularity consisted mainly of 
mononuclear cells, but also there appeared to be 
some increase in the number of mast cells, fibro- 
blasts, neural elements and blood vessels. Many of 
the biopsies taken from the involved areas, in the 
blocks that were examined, very few were to be 
found in the dermis. In a number of the specimens 
there was significant replication of the basal 
lamina at the dermo-epidermal junction. 
(b) Mononuclear Cells 
Lympho-histiocytic infiltrate, particularly 
in the upper dermis, was noticed and appeared to be 
most significant in the biopsies taken from the 
marginal areas (fig 60). There was also increased 
cellularity in both the uninvolved and involved areas 
- l03 - 
(fig 61) in the biopsies taken from these patients 
with vitiligo. Histiocytes (melanophages) containing 
melanosomal complexes were seen in the marginal, 
uninvolved, but also occasionally in the involved 
areas of skin. These dermal histiocytes mostly 
resembled the epidermal Langerhans cells, but only 
one Langerhans cell was to be found in the upper 
dermis; this was seen in the marginal area. Lympho- 
cytes were particularly to be found round the blood 
vessels in the marginal area. The cells had 
deeply convoluted nuclei with prominent hetero- 
chromatin pattern (fig 62). Some resembled the 
Sezary cell. These cells were very similar to those 
that were found in the epidermis. 
(c) Mast Cells 
Typical mast cells (fig 63) were found around 
the blood vessels in all the areas that were biopsied. 
It was difficult to quantitate these cells, but 
they appeared to be increased in number, particularly 
in the marginal and involved areas of skin in many 
of the patients that were biopsied. Some of the 
mast cell granules were to be seen lying free in 
the dermis and a number of the mast cells also showed 
early changes indicative of degranulation (fig 64). 
The damage to the mast cells was particularly more 
apparent in the marginal areas. As mentioned pre- 
viously the mast cells were also to be found in a 
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Fig 6 0. Electron micrograph of a marginal area showing inflammatory 
changes mainly oedema of the dermis with atypical lymphocytes (L). 
Many of these cells have convoluted nuclei and looked $ezary like 
cells. (X4000) 
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Fig 61 . Electron micrograph of an involved area showing inflammatory 
changes in the dermis (D), mainly oedema and atypical lymphocytes (L). (X 6000) 
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Fig62 . Electron micrograph showing the lymphocytes that can be seen in the dermis of vitiligo patients. D Dermis, E Epidermis. (A X 3840, BX 15120, CX 12000) 
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Fig 63 . Electron micrograph showing a normal 
mast cell (MC). Inset 
showing ultrastructure of its granules. V Villous processes, 
D Dermis, 
E Epidermis. (X 9600) 
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Fig 64 . Electron micrograph of a marginal area showing degranulating 
mast cell. g granules, C Collagen. (X 48000) 
number of biopsy specimens in the most lower layer 
of the epidermis. 
(d) Blood Vessels 
Some pathological changes were noted in the 
blood vessels, particularly those in the papillary 
dermis. Capillaries and small venules showed some 
thickening of their wall (fig 65,66), due to repli- 
cation of the basal lamina and amorphous granular 
material between thse lamellae. These changes were 
observed in all the areas biopsied, but were more 
noticeable in the marginal and involved areas of 
skin. Changes are those that are not frequently 
seen in the sun-exposed areas of skin. 
The other changes noted were somewhat swollen 
endothelial cells with rather shrunken nuclei and 
the 'tight' endothelial junctions that are normally 
seen, appeared to be more widely separated than 
usual (fig 66,67). 
(e) Cutaneous Nerves 
Dermal nerves: The unmyelinated nerves were 
seen containing either small (6Onm in diameter) and 
large (105 nm in diameter) dense core vesicles of 
adrenergic nature or small agranular vesicles of 
cholinergic type. Replication of basal lamina 
surrounding the axons and Schwann cells was seen 
and this occured in many of the patients biopsies 
and from all areas. The Schwann cells surrounding 
- 105 - 
axons in the involved areas of the skin and occasio- 
nally in other sites, not completely enveloped the 
axons and there appeared to be some regeneration 
(fig 68,69). Infrequently axons were seen that 
were involved in the inflammatory response around 
them and showed oedema (fig 70,71), but otherwise 
changes seen, including vacuolation of the cytoplasm 
of the axons, did not differ from those changes as 
observed in the normal controls. 
Intra-epidermal nerves: In a third of the 
patients intra-epidermal nerves were found. They 
were present on five occasions in the uninvolved 
areas, on three occasions in the marginal skin and 
on four specimens from involved sites. The majority 
of these nerves consisted of Schwann cell processes 
with axons. They were either mono-axonal or poly- 
axonal and were never found in any other site than 
in the basal layer. On two occasions intra-epidermal 
adrenergic nerves were observed in association with a 
secretory melanocyte (fig 72). These nerves had 
typical small and large dense core vesicles. Usually 
there appeared to be no connection between the dermal 
and intra-epidermal nerves. However, in a few cases 
serial sections indicated that the dermal nerves 
crossed the dermo-epidermal junction zone and into 
the epidermis (fig 73). The intra-epidermal nerves 
found were normal and did not differ from those found 
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Fig 65 . Electron micrograph of a marginal 
area showing a blood 
vessel with a thickened wall, mainly due to replication of 
its basal 
lamina (BL). E Endothelial cell, LU Lumen containing red blood cell. 
(X 9600) 
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Fig 66 Electron micrograph of a marginal area showing a blood vessel 
with inflammatory changes, mainly degeneration of endothelial cells (E) 
and interendothelial gaps (arrow). BL basal lamina. (X 15120) 
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Fing 7. Electron micrograph of a marginal area showing dermal blood 
vessel with inflammatory changes like interendothelial gap (arrows). 
Inset showing higher magnification of interendothelial gap. 
E Endothelial cell, LU Lumen. (X 12333) 
mex. . 
ý40 
,tK 
RM 
ýs 
I. 
Fig 69 . Electron micrograph of an involved area showing a polyaxonal 
nerve with one of its axon denuded (A). (X 26000) 
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Fig 68" Electron micrograph of an involved area showing a 
regenerating nerve with many of 
its axons (A) denuded. 
E Endoneurium, P Perineural cell. (X 15400) 
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Fig 70. Electron micrograph of an involved area showing 
degeneration 
of Schwann cell process leaving denuded axons 
(A) and few mitochondria 
(MI). BL Basal lamina, D Dermis, E Epidermis. (X 48000) 
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Fig 71 . Electron micrograph of a marginal area showing papillary 
nerve (N) sharing the inflammatory reaction in the epidermis (E) 
and dermis (D). (X 24000) 
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Fig 72 . Electron micrograph of an uninvolved area showing 
intra 
epidermal adrenergic nerve (N) in contact with functioning melanocyte 
(M). One of the axon contains small and large dense core vesicles 
(arrows) which are shown in the inset. D Dermis, BL Basal lamina, 
E Epidermis. (X 15120) 
Fig 73 . Electron micrograph of a marginal area showing a dermal 
polyaxonal nerve (N) passing into the epidermis (E). D Dermis, 
BL Basal lamina, M Melanocyte dendrite. (X 24000) 
in the dermis. Intra-epidermal nerves were only 
found in the biopsies taken from the patients with 
vitiligo and were not present in those biopsies 
taken from normal controls. 
(f) Filamentous Colloid/Amyloid Bodies 
These were found in nearly 50% of the patients 
and were present in all areas (Table XXV). They 
were more frequent in the marginal and uninvolved 
skin than in the involved vitiliginoüs areas. When 
compared with normal controls they were more frequent. 
Most of these bodies were rather globular in shape 
and varied in size from 7-20N. They were always 
found in the papillary dermis close to the dermo- 
epidermal junction zone (fig 75). In many of the biopsy 
specimens they were also seen in the basal layer of 
the epidermis (fig 74). 
The colloid/amyloid bodies consisted of fila- 
ments that formed whorls (fig 75), but were also with 
straight unbranched filaments as seen in amyloid 
(fig 76,77). However, they had not infrequently a 
mixed appearance of colloid and amyloid filaments 
(fig 74). Most of these filaments resembled more 
those as seen in colloid bodies and had whorled 
appearance. These filaments resembled those cyto- 
filaments seen in the melanocytes (fig 78). The 
diameter of these filaments ranged from 70-l3OR with 
a mean of 100ä. Macrophages (histiocytes) were not 
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Vitiligo 
Normal 
No. Controls 
Uninvolved Marginal Involved 
Neg Neg Neg 
2 - Neg Neg Neg 
3 - Neg Neg Pos 
4 Neg Neg Neg Neg 
5 - Neg Neg Neg 
6 Neg Neg Neg Neg 
7 Neg Neg Neg Neg 
8 - Pos Neg Neg 
9 - Neg Pos Neg 
10 - Pos Neg - 
11 Neg Neg Neg - 
12 Pos Neg Neg - 
13 Neg Pos Pos - 
14 Pos Pos Pos - 
15 Pos Pos Neg - 
16 Pos Pos Pos - 
17 Pos Pos Pos - 
18 Pos Neg Pos - 
19 - Neg Neg - 
20 Neg Neg Neg - 
21 Neg Neg Neg - 
22 Neg Pos Pos - 
23 Neg Pos Pos - 
24 Pos Pos Neg - 
25 Neg Neg Pos - 
26 Neg Pos Pos - 
27 Pos Pos Neg - 
28 Pos Pos Pos - 
29 Pos Pos Neg - 
Table XXV. Indicating the presence or absence of filamentous 
colloid/amyloid bodies on electron microscopic study in patients 
with vitiligo and in normal controls. 
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infrequently seen in relation to those colloid/amyloid 
bodies in the dermis. 
Not infrequently those filamentous bodies con- 
tained electron dense granules that were undoubtedly 
melanosomes. Also remnants of other cellular organel- 
les were to be found. A filamentous body was also 
seen in the papillary dermis of the involved skin and 
this was enveloped by a dendrite of a basal indeter- 
minate'cell that appeared to be dipping into the 
dermis through a break into the basal lamina (fig 79). 
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Fig 74 Electron micrograph of a marginal area showing many filamentous 
bodies (FB). The intra-epidermal filamentous body is showing features of 
both colloid (upper inset) and amyloid (lower inset) filaments. D Dermis, 
E Epidermis, BL basal lamina. (X 15120) 
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Fig 75 . Electron micrograph of a marginal area showing dermal filamentous 
body (FB) which is still surrounded by the basal lamina of dermo-epidermal junction. The filaments in this body mainly of colloid nature. Inset 
showing higher magnification of a filamentous body. D Dermis, BL basal 
lamina, E Epidermis. (X 24000) 
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Fig 77 . Electron micrograph of an involved area showing a filamentous 
body (FB) of amyloid nature. (X 36800) 
Fig ry8 Electron micrograph of an involved area showing a filamentous 
body (FB) of amyloid nature. (X 46000) 
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Fig 78 . A, B, C, D - Electron micrographs showing the ultrastructure 
of melanocytes (M) and their dendrites which are similar to that of 
filamentous bodies. D Dermis, BL basal lamina, E Epidermis, 
m melanosomes. (A, X 10588, B, X 10144, C, X 11650, D, X 3750) 
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Fig 79. Electron micrograph of an involved area showing a basal indeterminate cell (ID). Its dendrite is dropping down into the dermis (D). Filamentous body (FB) has probably originated from the dendrite (asterix) of the indeterminate cell. Inset showing higher 
magnification of the filamentous body. E Epidermis, arrows showing a break in the dermoepidermal junction. (X 22050) 
C. OCCUPATIONAL VITILIGO (LEUCODERMA) 
Biopsies were taken from two patients with 
occupational vitiligo who had been in contact with 
paratertiary butyl phenol. The results of the 
histological studies noted on the biopsies taken 
from these two patients are shown. 
(a) Epidermis 
Melanocytes were frequently seen in the basal 
layer of the epidermis of the uninvolved skin. They 
were markedly reduced in the marginal and completely 
absent in the involved areas. Melanosomes were found and 
tended to be singly distributed within the keratino- 
cytes in the marginal and uninvolved areas. No mela- 
nosomes were found in the keratinocytes in the involved 
areas. 
Langerhans cells were found mainly suprabasally, 
but also within the basal layer of the epidermis. They 
seemed to be increased in the involved areas when com- 
pared with the biopsies taken from other sites. Indeter- 
minate cells were rarely seen. 
The epidermis showed inflammatory changes (fig 80) 
in both patients with spongiosis, particularly in the 
marginal and involved areas in one and marginal in the 
other. There was some disruption of the epidermis and 
a number of degenerated keratinocytes were present. 
Mononuclear cell infiltrate was found within the 
epidermis and this occured in various foci and was 
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present in both patients, particularly in the mar- 
ginal and involved areas. It was also seen in the 
uninvolved skin of one of the patients. Cells 
consisted of lymphocytes and histiocytes and of 
the same appearance as those found in the under- 
lying dermis. Several of these dermal cells were 
to be seen entering the epidermis through breaks 
in the dermo-epidermal junction (fig 80). Many of 
these lymphocytes had convoluted nuclei and were to 
be found in association with histiocytes, melano- 
cytes and Langerhans cells (fig 81). 
(b) Dermis 
Inflammatory changes were to be found in the 
dermis which had a marked increase in its cellularity 
of marginal and uninvolved areas. Cells were mainly 
mononuclear (fig 82,83), particularly lymphocytes 
that had convoluted nuclei and resembled T lympho- 
cytes. 
Blood vessels in areas that had the most marked 
inflammatory changes had swelling of their endothelial 
cells, and some damage (fig 84). Occasionally, in 
addition to red blood cells in the lumen, white blood 
cells were also found. 
Filamentous bodies were also found in the 
biopsies taken from both patients. They resembled 
colloid/amyloid bodies (fig 85) seen in patients 
with idiopathic vitiligo. 
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The histological changes were identical to 
that found in the common (idiopathic) vitiligo. 
The nerves appeared to be normal although a number 
of regenerating axons were found. In the biopsies 
taken from both of these patients no intra-epidermal 
nerves were found. 
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Fig go . A, B. Electron micrograph of a marginal area from a patient 
with occupational vitiligo showing lympho-histiocytic infiltrate of 
the epidermis. Some of these cells just going into the epidermis 
through a break (arrows) in the dermo epidermal junction. D Dermis, 
E Epidermis, H Histiocytes, L Lymphocyte, K Keratinocyte. 
(A, X 3754, B, X 3792) 
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Fig 81 . Electron micrograph of a marginal area 
from a patient with 
occupational vitiligo showing Langerhans cell (LC) in contact with 
lymphocyte (L) in the epidermis. Inset showing a higher magnification 
of Langerhans granules (LG). K Keratinocyte. (X 3840) 
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Fig 82 Electron micrograph of a marginal area from a patient with 
occupational vitiligo showing blood vessels (BV) with 
lymphocytic 
cells (L) in an oedematous dermis (D). (X 2500) 
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Fig 83 " Electron micrograph of an uninvolved area 
from a patient 
with occupational vitiligo showing oedematous dermis (D) with 
inflammatory cell infiltrate mainly lymphocytes(L). H Histiocyte, 
MC Mast cell, BV Blood vessel. (X 3848) 
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Fig 84 A, B. Electron micrograph of a marginal area from a patient 
with occupational vitiligo showing inflammatory changes in the dermis 
mainly lymphocytic cell infiltrate and damage to the blood vessel in a 
form of replication of the basal lamina (BL), swelling and degeneration 
of endothelial cells (E). LU Lumen of a blood vessel, P Pericyte. 
(A, X 6000, B, X 96000) 
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Fig 85 . Electron micrographs of 
filamentous bodies from patients 
with occupational vitiligo showing: - 
A- Amyloid body (A) in the involved area 
(X 42142) 
B- Melanocyte dendrite changed into colloid body 
(C) in the 
uninvolved area (X 49157) 
'Y 
rA 
D Dermis, E Epidermis, BL Basal Lamina, H Histiocyte 
D. A REPIGMENTING VITILIGO 
Biopsy was taken from a freshly repigmented 
area of vitiligo and this showed many melanocytes 
in the basal layer and these contained melanised 
melanosomes. Morphology of these melanocytes 
appeared to be normal and they contained melano- 
somes in various stages of development. No 
inflammatory changes were observed in this biopsy. 
The superficial dermis contained only a few cells 
in the specimens examined. Only a few filamentous 
bodies containing melanised melanosomes'were found. 
CHAPTER THREE 
DISCUSSION 
I. CLINICAL ASPECTS AND ASSOCIATED DISORDERS 
(a) Clinical Aspects 
Vitiligo is a common disease that affects 
about 0.38-1% (Lerner 1959; El Mofty 1968; Mehta 
et al 1973; Howitz et al 1977) of the population. 
It can start at any age and in this study, the age 
of onset ranged from 1-65 years with nearly half 
the patients developing the disease before the age 
of 20. This is comparable to the studies by Lerner 
(1959) who found that 50% developed vitiligo before 
the age of 20. In this study the incidence of the 
disease appeared to be increased in females (79.3%) 
and this is similar to other studies that are based 
on out-patient attendances rather than on studies 
of the general population. The incidence is probably 
the same in both sexes (Howitz et al 1977). A high 
preponderance among females is almost certainly due 
to the fact that these are more aware of a cosmetic 
disability and, therefore, seek medical treatment. 
Vitiligo frequently occurs in families who 
are aware that it is inherited. About 30-40% of 
patients have a positive family history (Lerner 1959; 
Fitzpatrick 1964; Copeman et al 1973). This has 
been shown in the present study, where 24% had a 
positive family history. In this study the families 
of these patients also had an increased incidence of 
auto-immune disorders, e. g. pernicious anaemia, 
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diabetes mellitus etc. Not infrequently one of 
these auto-immune disorders would occur in one 
member of the family and another would have vitiligo. 
All the patients presented with symmetrical 
areas of depigmentation. One only had segmental 
vitiligo. Many of the patients developed depig- 
mentation at the sites of the biopsies, this being 
an isomorphic or Koebner phenomenon; a well known 
feature of, vitiligo and sometimes of diagnostic 
value (Fitzpatrick 1964). 
(b) Associated Disorders 
Vitiligo is not infrequently associated with 
a number of disorders considered to be of auto- 
immune aetiology (Lerner 1959; Cunliffe et al 1968; 
Dawber 1968,1970; Bor et al 1969; Howitz 1971; 
McGregor et al 1972). In this study the incidence 
of auto-immune disorders seemed to be increased. 
1. Pernicious Anaemia 
There is a strong association between this 
disease and other auto-immune disorders. It is 
associated with increased auto-antibodies, particularly 
against intrinsic factor and antibodies are present 
in the sera of these patients to gastric parietal 
cells. Cell mediated immunity is also involved in 
the pathogenesis of pernicious anaemia (Wright 1979). 
Pernicious anaemia is well recognised to occur 
in association with vitiligo and there are many 
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case reports. Francis (1931) found that achlorhydria 
was present in a significant number of vitiligo 
patients and Ishida (1954) showed that many patients 
with vitiligo secreted less gastric acid than 
normal. 
Vitiligo not infrequently occur in those 
patients with pernicious anaemia (Allison and Curtis 
1955). Cunliffe et al (1968) found that three patients 
among fifty-six with vitiligo (5.3%) had pernicous 
anaemia. This was statistically significant. Dawber 
(1970) found that 9% of patients with pernicious 
anaemia had vitiligo. In this study 3.4% of the 
patients had pernicious anaemia. 
2. Addison's Disease 
In the original description of this disorder 
Addison (1855) described a patient with hyperpig- 
mentation of the skin, but also with vitiligo. This 
association of vitiligo in patients with Addison's 
disease was later confirmed (Dunlop 1963). Vitiligo 
is present in 15% of patients with Addison's disease 
(Forsham 1968). Vitiligo has also been reported in 
association with Addison's disease in patients with 
multiple glandular insufficiencies (McGregor et al 
1972; Hertz et al 1977; Betterle et al 1979). In 
this study 6.8% of the vitiligo patients had Addison's 
disease. 
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3. Thyroid Disease 
Several reports have suggested an association 
between vitiligo and thyrotoxicosis (Habermann 1933; 
Lerner 1959; Goudie, Spence and MacKie 1979). The 
clinical association between these two disorders has 
been confirmed (Cunliffe et al 1968; Ochi et al 1969). 
Vitiligo has been demonstrated in patients with hypo- 
thyroidism (Lerner 1955; Morgans 1964; Doniach et 
al 1972). Hashimoto's thyroiditis (auto-immune 
thyroiditis) has been shown to significantly occur 
in patients with vitiligo (Cunliffe et al 1968). An 
association between these two diseases has been 
reported (McGregor et al 1972). Two patients were 
described in this study, one with hypothyroidism 
and the other with thyrotoxicosis. 
Although antithyroid antibodies are usually 
demonstrated. in the sera of patients with thyroid 
diseases, evidence for cell mediated immune reactions 
to thyroid antigens have also been shown to occur 
in patients with Grave's disease, Hashimoto's thyroid- 
itis and spontaneous primary hypothyroidism (Volpe 
et al 1974; Amino and DeGroot 1975; Calder and Irvine 
1975; Tötterman et al 1977 a, b; Gordin et al 1979). 
The close association of vitiligo with auto-immune 
thyroid disease support the possibility that vitiligo 
is also an 'auto-immune' disease. 
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4. Diabetes Mellitus 
Evidence that diabetes is an autoimmune 
disorder is accumulating and it occurs more frequently 
in patients with other autoimmune disorders (Cunliffe 
et al 1968; Bor et al 1969). Autoantibodies to 
gastric parietal cells, adrenal and thyroid tissue 
are found in patients with diabetes (Goldstein et 
al 1970; Irvine et al 1970). Islet cell antibodies 
are found in insulin dependent-diabetes (Lerndrum, 
Walker and Gamble 1975; MacCuish et al 1974; Bottazzo 
et al 1974). A lymphocytic infiltrate of the islets 
of Langerhans in the pancreas - insulitis is an 
autopsy finding in insulin dependent diabetes 
(Gepts 1965; Warren et al 1966). Cell mediated immunity 
has been shown to play a role in the pathogenesis 
of insulin dependent diabetes (MacCuish et al 1974; 
Nerup et al 1971; Sensi and Pozzilli 1979; West, 
Boozer and Haberman 1978; Pozzilli et al 1979). 
As regards the association of diabetes with 
vitiligo, cases have been described with both con- 
ditions (Lerner 1959; Dawber 1968; Villa Verde 1969; 
McGregor et al 1972; Heyman and Lustman 1971; 
Bleehen 1972). The association of juvenile diabetes 
mellitus with vitiligo was also found by Cunliffe 
et al (1968), where 7.1% of the vitiligo patients 
had diabetes. Macaron et al (1977) also reported 
five juvenile diabetics had vitiligo. 
a 
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In this study no patients with diabetes 
mellitus were included. However, a family history 
of diabetes was not uncommon and 20.6% of the 
patients had close relatives with the condition. 
This increased incidence of diabetes in the relatives 
of patients with vitiligo has also been reported 
(Bor et al 1969; Macaron et al 1977). 
5. Alopecia Areata 
About 2% of all new dermatological out-patient 
attendances in the United Kingdom are those with 
alopecia areata. In 70-80% of the cases the first 
attack occurs before the age of 40, but it can 
occur at any time. Both sexes are equally affected 
and family history occur in 10-24% of the cases 
(Ebling and Rook 1979; Friedmann 1981). Alopecia 
areata has many similarities to vitiligo. 
Light microscopy of the hair bulbs has shown 
a lymphocytic infiltrate (Walker and Rothman 1950; 
Thies 1966; Muller, Rook and Kubba 1980; Klaber and 
Munro 1978). Electron microscopy (Sato 1976) con- 
firmed the presence of lymphocytes in the hair 
bulbs. 
No antibodies to epidermal cells and to the 
hair follicles were found either in the patient's 
serum or bound 'in-vivo' in the scalp (Klaber and 
Munro 1978; Muller et al 1980). There are conflic- 
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ting observations concerning the occurrence of auto- 
antibodies, particularly against thyroid constituents 
and gastric parietal cells, in sera of patients with 
alopecia areata. Thus, several authors reported 
positive associations between alopecia areata and auto- 
antibodies (Kern et al 1973; du Vivier and Munro 1975; 
Main et al 1975; Friedmann 1981), while others repor- 
ted a lack of such association (Cunliffe et al 1969; 
Klaber and Munro 1978; Muller et al 1980). In a 
recent study Messenger (unpublished data 1981) has 
been unable to find complement fixing antibody 
against hair bulb cells in sera of patients with 
alopecia areata using an indirect immunofluorescence 
complement fixation test. 
The association of alopecia areata with 
vitiligo has been recognised. Vitiligo is associated 
with alopecia areata in about 4% of cases as com- 
pared with 1% control subjects (Anderson 1950; 
Muller and Winkelmann 1963). Cunliffe et al (1968), 
has shown that 160- of vitiligo patients had alopecia 
areata, while only 1.7% of patients with psoriasis 
had the condition. Bleehen (1972) also reported 
that 9.3% of vitiligo patients had alopecia areata. 
Alopecia areata and vitiligo occur together as part 
of multi-autoimmune disorders (Fields et al 1971; 
Doniach et al 1972; Tan 1974; Hertz et al 1977; Frein- 
kel and Asrman 1977; Betterle, Peserico and Bersani 
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1979). Both disorders occur as part of the Vogt- 
Koyanagi-Harada syndrome. In this disorder a cell 
mediated immune reaction against melanocytes is 
involved, not only in the skin and hair, but also 
in the eye (Hammer 1974; Tagawa 1978). Alopecia 
areata sometimes also affects pigmented hair and 
not grey hair. All the hair in a regrown patch 
may remain white indefinitely (Ebling and Rook 
1979). It is possible that melanocytes in the hair 
bulb are involved in the pathogenesis of alopecia 
areata. 
In this study 6.8% of vitiligo patients had 
alopecia areata. The clinical association between 
these two diseases may have some significance as 
to the aetiology and favour a cell mediated immune 
pathogenesis. 
6. Lichen Sclerosus et Atrophicus 
This uncommon condition occurs mostly in females. 
The major histological change-is a band of hyalini- 
sation of the collagen of the papillary dermis. In 
addition there is lymphocytic infiltrate below this 
altered collagen. In this disorder there is increased 
autoantibodies formation to thyroid tissue and gastric 
parietal cells, when compared with control subjects 
(Goolamali et al 1974). The presence of these anti- 
bodies was not related to the severity or duration 
of the disease. 
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The association of vitiligo with lichen 
sclerosus is well established. Wallace (1971) 
found that 2.6% of patients with lichen sclerosus 
have vitiligo as well. This is probably sig- 
nificant. Goolamali et al (1979) has reported 
that 7.6% of patients with lichen sclerosus have 
vitiligo. This percentage is much higher than in 
a normal population. In this study this associa- 
tion between the two disorders has been confirmed. 
6.8% of vitiligo patients had lichen sclerosus. 
7. Halo Naevi 
This condition is commonly associated with 
vitiligo and not infrequently antedates its onset. 
It has been reported (Lerner and Nordlund 1978) 
that 50% of vitiligo patients have halo naevi. 
Histopathological studies have shown a lympho- 
histiocytic infiltrate of the naevus tissue and 
overlying epidermis (Frank and Cohen 1964; Kopf, 
Morrill and Silberberg 1965; Stegmaier, Becker and 
Medenica 1969; Swanson, Wayte and Helwig 1968; 
Rowden and Lewis 1975). Ultrastructural studies 
of the depigmented halo have shown an absence of 
melanocytes in the basal layer that are replaced by 
Langerhans cells (Hashimoto 1974,1975: Swanson et 
al 1968). 
Circulating autoantibodies in the sera of 
patients with halo naevi have been demonstrated 
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against the cytoplasmic antigen of melanoma cells 
(Lewis and Copeman 1972; Copeman et al 1973; 
Roenigk et al 1975; Rowden and Lewis 1975). Cell 
mediated immunity is involved and lymphocytes from 
these patients with halo naevi are cytotoxic to 
malignant melanoma cells (Roenigk et al 1975: 
Nordlund et al 1980; Mitchell, Nordfund, and Lerner 
1980). 
In this study 10.3% of the vitiligo patients 
had halo naevi. 
8. Psoriasis 
El Mofty (1968) reported that 0.7% of vitiligo 
patients have psoriasis. This incidence is even 
lower than psoriasis in the general population. It 
is likely that psoriasis is coincidental and not 
clinically associated. In a study of 62 patients 
with vitiligo 4.8% had psoriasis (Bor et al 1969). 
In the present study 6.8% of vitiligo patients had 
psoriasis. Both studies appear to confirm that 
there is an association between the two disorders, 
but it could equally be coincidental. 
9. Lichen Planus 
In lichen planus there is a degeneration of 
the epidermal cells in the basal layer and a lympho- 
histiocytic infiltrate in the papillary dermis. 
Electron microscopic studies (Ragaz and Ackerman 
- 124 - 
1980) have shown an increased number of Langerhans 
cells in the epidermis. These cells have been 
seen to be in contact with lymphocytes in the epi- 
dermis and dermis. It has been suggested by the 
authors that lichen planus may represent a mani- 
festation of a delayed hypersensitivity reaction to 
unrecognised antigens. 
The association of lichen planus with vitiligo 
has been recognised (Bor et al 1969; Tan 1974). In 
one study (Bor et al 1969) 4.8% of vitiligo patients 
had lichen planus. In the present study 3.4% of 
patients with vitiligo had lichen planus. 
10. Discoid Lupus Erythematosus 
There is no previous report showing the associa- 
tion of these two disorders. In this study 3.4% of 
patients have discoid lupus erythematosus. 
11. Atopic Eczema 
The association between atopic eczema and 
vitiligo has been reported in two patients where the 
atopic eczema spared the vitiligo lesions (MacMillan 
and Rook 1971). Bleehen (1972) described one case 
of atopic eczema among 32 vitiligo patients. In 
the present study 6.8% of patients have atopic 
eczema. This association could be coincidental as 
both diseases are common in general population. 
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II. AUTOANTIBODIES 
In vitiligo there is an increased incidence 
of organ-specific autoantibodies such as is seen 
in other so called autoimmune disorders. This was 
confirmed in the present study. Autoantibodies to 
gastric parietal cells, thyroid microsomes and 
thyroglobulins were significantly raised in the 
sera of these patients as in other previous studies 
(Cunliffe et al 1968; Bor et al 1969; Brostoff et 
al 1969; Howitz and Schwartz 1971; Dobmeier and 
Sams 1971; Betterle et al 1976; Macaron et al 1977). 
Antibodies to smooth muscle were negative as found 
in other studies (Brostoff et al 1969; Betterle 
1976; Woolfson et al 1975). Antinuclear antibodies 
were found in 12.5% of the vitiligo patients in 
titre greater than 1/20. This finding was signifi- 
cant (Brostoff et al 1969). In previous studies 
antimitochondrial antibodies were reported to be 
negative (Woolfson et al 1975; Betterle et al 1976). 
In this study antimitochondrial antibodies were 
found in the serun of one patient. 
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III. IMMUNOFLUORESCENCE STUDIES 
In 1965 Langhof et al reported the presence 
of precipitating antimelanin antibodies in the sera 
of the majority of 26 patients with vitiligo. In 
a subsequent study of 42 cases of vitiligo (Woolfson 
et al 1975) precipitating antibodies were not found. 
Dobmeier and Sams (1971) were unable to demonstrate 
antimelanocyte antibodies in ten patients using 
direct and indirect immunofluorescent techniques, 
even in vitiligo patients with other associated 
autoimmune disorders; e. g. pernicious anaemia etc. 
Similarly, in another study on 96 patients (Betterle 
et al 1976) these workers were unable to find anti- 
melanocyte antibodies to either malignant or normal 
melanocytes using an indirect immunofluorescent 
method. Bleehen (1979) studied ten vitiligo patients 
using direct immunofiuorescent techniques on both 
the involved and also the uninvolved skin and found 
no significant deposition of immunoglobulins or 
complement. 
Antibodies have been found in the serum of 
patients with halo naevi, some of them also with 
associated vitiligo (Copeman et al 1973). These 
antibodies reacted against the cytoplasm of malig- 
nant melanoma cells. However, these antibodies 
were not found in the sera of patients with vitiligo 
without resolving halo naevi (Copeman et al 1973). 
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Humoral antibodies were found in the patients with 
halo naevi (Roenigk et al 1975) using immunofluorescent 
techniques. These workers also demonstrated lympho- 
cyte cytotoxicity against malignant melanoma cells 
and considered that cell mediated immunity may be 
more important than the humoral antibodies in the 
pathogenesis of halo naevi. Antibodies to melanin 
producing cells were found to be present in the 
sera from two patients with vitiligo who, in addition 
to having multiple endocrine insufficencies, also 
had alopecia areata and muco-cutaneous candidiasis 
(Hertz et al 1977). Both the direct and indirect 
immunofluorescent tests were negative and showed no 
deposition of immunoglobulins and complement. How- 
ever, the in-vitro complement fixation test demons- 
trated a complement fixing serum factor in both 
patients. This factor was bound intracellularly 
to normal melanocytes, naevus cells and malignant 
melanoma cells. This serum factor was also found 
in one of two patients with vitiligo who also had 
multiple endocrine deficiencies (Betterle et al 1979). 
This complement serum factor was also present in the 
sera of patients with muco-cutaneous candidiasis 
without vitiligo (Nordlund et al 1981). 
In the present study there, was no significant 
deposition of immunoglobulins in the involved, 
marginal and uninvolved areas of skin. In many 
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patients there was deposition of fibrin mainly in 
the papillary dermis of the marginal and involved 
areas, and occasionally in the adjacent uninvolved 
skin. In a few of the patients there was a dense 
band of fibrin deposition of the dermo-epidermal 
junction in the involved areas of skin. 
The absence of immunoglobulins and complement, 
but the deposition of fibrin in the dermis is 
commonly found in cell mediated immune reactions 
(Colvin et al 1973). 
A complement fixing antibody to melanocytes 
was not found in the sera of all the_vitiligo patients 
studied using an indirect immunofluorescent technique 
(Jordon et al 1969; Katz et al 1976; Hertz et al 
1977). Even in patients with associated autoimmune 
disorders, such as pernicious anaemia and Addison's 
disease, no serum complement fixing antibody was 
found. However, it was not possible to study the 
serum of patients with multiple endocrinopathies 
and with several autoimmune disorders in which such 
a factor is sometimes present. 
The difficulty in demonstrating humoral anti- 
bodies to melanocytes may be due. to the fact that 
the depigmentation in vitiligo is a slow and gradual 
process. The marked and relatively sudden changes 
as seen in halo naevi, and in a few patients with 
malignant melanoma, are not present in the lesions 
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of vitiligo. 
Antibodies were present in the serum of 
patients only when there was actively regressing 
halo naevi or when the patient had multiple endo- 
crine disorders. It is likely that the anti- 
melanocyte antibodies are probably secondary 
rather than being primary and are directed against 
the cytoplasm rather than against the cell mem- 
brane. 
In autoimmune diseases that are associated 
with vitiligo there is evidence that, in addition 
to organ specific autoantibodies, a cell mediated 
immune reaction is involved in these disorders 
(Wright 1979; Volpe et al 1974; Amino and DeGroot 
1975; Calder and Irvine 1975; Gordin et al 1979; 
MacCuish et al 1974; Nerup et al 1971, Sensi and 
Pozzilli 1979; Pozzilli et al 1979; West, Boozer 
and Haberman 1978). A cell mediated immune reaction 
has been demonstrated in vitiligo patients with 
Vogt-Koyanagi-Harada syndrome (Tagawa 1978; 
Nordlund et al 1980). 
The inflammatory changes, the deposition of 
fibrin and the presence ofa lymphocytic infiltrate 
in the epidermis would favour that a cell mediated 
immune reaction directed against the melanocytes is 
involved rather than a humoral mechanism with a 
melanocytotoxic antibody. However, it is possible 
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that both humoral and cell mediated immune reactions 
are involved. 
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IV. INFLAMMATORY CHANGES 
It is quite rare to observe inflammatory 
changes in lesions of vitiligo. However, there are 
a number of reports in the literature of lesions 
of vitiligo with an inflammatory, raised and palpable 
erythematous border (Habermann 1933; Becker and 
Obermayer 1937; Garb and Wise 1948; Buckely and 
Lobitz 1953; Shukla 1959; Pinkus 1959; Lerner 1959; 
Fregert et al 1959; Allende and Reed 1964; Michaelsson 
1968; MacMillan and Rook 1971; Bleehen and Sharquie 
1981 unpublished). Sometimes these lesions are 
itchy. There are several reports of histopathological 
changes indicative of inflammation. These were 
mainly observed in the inflammatory raised border, 
where severe spongiosis and a mononuclear cell 
infiltrate constituted mainly lymphocytes, were 
found in the epidermis (Gopinathan 1965; Michaelsson 
1968; MacMillan and Rook 1971). Recently an increase 
in the cellularity of dermis including lymphocytes 
and histiocytes has been seen in vitiligo lesions 
(Breathnach 1975; Nordlund et al 1978; Bleehen 1979). 
In this study no obvious inflammatory raised 
borders were seen in any of the lesions in the 
patients. However, the histopathological studies 
revealed inflammatory changes in the vitiligo skin, 
especially in the epidermis of marginal areas. 
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Spongiosis of the epidermis was commonly found in 
these marginal areas, together with a mononuclear 
cell infiltrate consisting mainly of stimulated 
(atypical) lymphocytes and histiocytes that were 
in contact with each other. Intra-epidermal lympho- 
cytes were also seen, some of them were in direct 
contact with Langerhans cells and melanocytes. 
Lymphocytes were seen entering the epidermis through 
breaks in the dermo-epidermal junction. Also mild 
inflammatory changes were observed in the blood 
vessels together with deposition of fibrin in the 
papillary dermis. These changes resembled those 
seen in delayed hypersensitivity reactions (Dvorak, 
Mihm and Dvorak 1976; Dvorak et al 1976; Colvin et 
al 1973). The degree of mononuclear cell infil- 
tration of the dermis did not parallel that seen 
in the epidermis; sometimes a massive cellular 
infiltrate in the epidermis was seen even forming 
Pautrier-like micro abscesses, but with only a few 
mononuclear cells in the dermis. This would suggest 
that the primary inflammatory reaction occurs in 
the epidermis, where an antigen is present. This 
primary epidermal reaction has been described in 
mycosis fungoides (Ryan et al 1973; Tan et al 1974), 
and in Behcet's syndrome (Honma, Saito and Fujioka 
1981). 
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The skin represents a special micro environ- 
ment for T lymphocytes. There seems to be proclivity 
for T lymphocytes to localise preferentially within 
the skin (Streilein 1978). This homing of cells 
to a special tissue is termed ecotaxis (De Sousa 
1971; Goudie, MacFarlane and Lindsay 1974; Goos, 
Kaiserling and Lennert 1976), This may explain the 
pathogenesis and symmetry of vitiligo. In a 
genetically predisposed individual a clone of lympho- 
cytes that are reactive against a melanocyte antigen 
may develop. The abnormal lymphocytes then home in 
on the skin in a focal and symmetrical fashion. 
They destroy the melanocytes as a result of lympho- 
kine production. This primary immunologic damage 
of melanocytes will initiate an early focus of 
vitiligo. The melanocytes surrounding this focus 
will become hypertrophied and hyperactive in order 
to compensate for the loss of the adjacent pigment 
cells. The marginal melanocytes then commit suicide 
by "working themselves to death", 'probably as a 
result of the production of toxic melanin precursors 
(Lerner 1971). Thus the initiating factor is an 
immunological one and the progression is partly 
secondary. 
Quantitative studies of T and B lymphocytes 
in patients with vitiligo did not reveal any signifi- 
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cant changes (Ortonne and Alario 1978). Using the 
microcytotoxicity tests, Tagawa (1978) and Nordlund 
et al (1980) reported that lymphocytes from patients 
with early stages of Vogt-Koyanagi-Harada syndrome, 
showed high cytotoxic activity against melanoma cell 
surface antigen. They suggested that cell mediated 
immunity plays a role in pathogenesis of this disease. 
Lymphocytes cytotoxicity has also been observed in 
patients with actively regressing halo naevi (Roenigk 
et al 1975; Nordlund et al 1980; Mitchell et al 
1980). The microcytotoxicity test was negative in 
patients with vitiligo (Mitchell et al 1980) using 
allogenic melanoma cells. However, in vitiligo the 
process of depigmentation is very slow and this test 
was not very sensitive and may not detect a cell 
mediated immune reaction in patients with vitiligo. 
In addition the immune reaction may be directed 
against a melanocyte antigen that is not found in 
melanoma cells. 
Psoralens and ultraviolet light have been 
used in treatment of vitiligo for several thousand 
years (El Mofty 1948,1968). The mode of action 
of these compounds in promoting the repigmentation 
of the skin is uncertain. It is possible that 
these psoralens that induce photosensitivity may 
also promote mitosis of residual melanocytes and 
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induce tyrosinase activity of residual melanocytes 
(Bleehen 1975). Photochemotherapy using oral 
psoralens and exposure to long wave ultraviolet 
light (PUVA treatment) have been used for the treat- 
ment of many disorders including vitiligo (Bleehen 
1972,1975; Ortonne et al 1979). Recent studies 
indicated that PUVA can alter the immune responses 
and depress lymphocyte function both in vitro and 
in vivo (Roenigk 1976; Hodge et al 1977; Bleehen, 
Briffa and Warin 1978; Morison, Parrish and Epstein 
1979; Morhenn et al 1980; Morison et al 1981; 
Kraemer et al 1981). Repigmentation of vitiligo 
can also be induced by the application of topical 
corticosteroids (Kandil 1970,1974; Koopmans-Van, 
Dorp et al 1973; Bleehen 1976) and nitrogen mustard 
(Van Scott and Yu 1975). Similarly ACTH injections 
have been successful in promoting repigmentation in 
vitiligo (Gokhale and Gokhale 1976). Nitrogen 
mustard and corticosteroids (Webel and Ritts 1977; 
Wang and Zweiman 1981) are both immunosuppressive 
drugs and it is therefore possible these agents are 
effective in vitiligo by suppressing a cell mediated 
immune reaction. 
The inflammatory changes in the epidermis in 
vitiligo are commonly present, but can be easily 
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missed. This is due to the process of depigmentation 
being rarely acute and usually gradual. If 
inflammatory changes are present, they are confined 
to a narrow marginal area that may not be biopsied 
or sectioned for histopathological examination. In 
order to observe the inflammatory changes, the 
advancing margin of lesion of vitiligo should be 
chosen for biopsy and histopathological studies. 
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V. LANGERHANS CELLS 
The Langerhans cells were first described by 
Paul Langerhans in 1868 and since then there has 
been considerable speculation as to their origin 
and function. Paul Langerhans thought that 
the 
cells were nerve receptors. Later there were two 
ideas about these cells. The first, was that they 
had a neural function (Ferreira-Marques 1951; 
Niebauer 1956; Richter 1956; Wiedmann 1952). The 
second, that followed the concept as put 
forward by 
Masson (1951), was that the Langerhans cells were 
the terminal stage in the life cycle of previously 
active melanocytes (Billingham and Medawar 1953; 
Fan and Hunter 1958; Fan, Schoenfeld and Hunter 1959). 
Breathnach (1963) originally regarded Langerhans 
cells as inactive melanocytes. However, as a result 
of later studies both these theories were discarded, 
particularly as it was apparent that the Langerhans 
cell was of different embyronic derivation than the 
melanocyte, the latter being derived from neural 
crest (Breathnach 1968). Other workers similarly 
considered that the Langerhans cell and the melano- 
cyte did have a common lineage (Hashimoto and 
Tarnowski 1968; Kiistala and Mustakallio 1968; 
Prunieras 1969). 
Recently it has been shown that the Langerhans 
cell in humans, guinea pigs and mice have receptors 
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for both Fc portion of IgG and for C3 and also 
express Ia immune associated antigens encoded for 
the major histocompatability complex (Stingl et 
al 1977,1978; Rowden et al 1977,1978; Klareskog 
et al 1977; Berman and Gigli 1979; Tamaki et al 
1979; Rowden 1980). Thus Langerhans cells have 
the characteristic surface markers similar to cells 
of the monocyte-macrophage series and confirming 
a mesenchymal origin for these cells. Recently 
it has been shown that Langerhans cells are derived 
from and continually replenished by a mobile pool 
of precursors cells that originate from the bone 
marrow (Katz, Tamaki and Sachs-1979; Frelinger et al 
1979; Tamaki, Stingl and Katz 1980). 
Up to recently there has been no real idea 
as to the function of Langerhans cells and this has 
been a subject of considerable speculations and 
many hypotheses. There are currently two major 
theories. One postulates that the Langerhans cells 
regulate epidermal cell proliferation and differen- 
tiation (Potten and Allen 1976; Schweizer 1981). 
The other proposes that Langerhans cells are related 
to cells from macrophage-monocyte-histiocyte series 
and play a role in the primary immune response in the 
skin (Silberberg 1971,1973; Silberberg et al 1976). 
Langerhans cells were found in close apposition to 
mononuclear cells in the epidermis and dermis in 
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allergic contact dermatitis, but were not present 
in skin affected by primary irritant dermatitis 
(Silberberg 1971). These cells were also found 
in lymphatic vessels of the dermis in guinea pigs 
passively sensitised to dinitrochlorobenzene(DNCB). 
Also they were found in actively sensitised patients 
and guinea pigs. Some of these cells were apposed 
to mononuclear cells and showed some damage (Sil- 
berberg et al 1976; Silberberg, Thorbecke and Baer 
et al 1976). Shelley and Juhlin (1977) demonstrated 
the selective uptake of ten different contact 
allergens (Formaldehyde, Glutaraldehyde, Paraphenylene- 
diamine, Ethylenediamine, Toluenediamine, Nickel, 
Cobalt, Chromium, Mercury and Gold) by the Langerhans 
cells and postulated that these cells form part of 
the reticulo-endothelial system and binding these 
haptens to form complete antigens and thus, they play 
an important part in the development of allergic 
contact dermatitis. Langerhans cells like macrophages, 
also have been shown to have the ability to present 
antigen to sensitised T lymphocytes and the ability 
to act as stimulator cells for mixed lymphocyte 
reactions (Stingl et al 1978,1980; Green et al 1980; 
Braathen and Thorsby 1980). The cells may also be 
a target for inflammatory cells that as a consequence 
lymphokines, hydrolytic enzymes and prostaglandins 
are released (Thorbecke et al 1980; Silberberg-Sinakin 
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and Thorbecke 1980). 
Though there have been several studies on 
the population density of Langerhans cells in 
vitiligo, there has been a controversy as to 
whether they are increased in the amelanotic 
areas. Using an Osmium iodide technique, Mishima 
and Miller-Milinska (1961) observed an increased 
number of Langerhans cells in the involved skin 
in vitiligo. Though the staining of Langerhans 
cells is excellent with Osmium, unfortunately it 
also stains melanocytes and its use is limited. 
Birbeck, Breathnach and Everall (1961) used 
a gold stain also likewise thought that there was 
an increase in the number of Langerhans cells in 
the involved skin. With the histochemical technique 
that showed Langerhans cells in the skin using the 
adenosine triphosphatase (ATPase) stain, Brown, 
Winkelmann and Wolff (1967) concluded that the counts 
of Langerhans cells were similar in both the involved 
and uninvolved skin. 
Electron microscopy revealed that Langerhans 
cells replaced the basal melanocytes in the involved 
skin and in this quantitative study (Zelickson and 
Mottaz 1968) Langerhans cells were increased in the 
involved areas when compared with the number in the 
uninvolved vitiligo skin. Similarly, in another 
electron microscopic study (Mishima, Kawasaki and 
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Pinkus 1972) the Langerhans cells were to be 
increased in the basal layer, but their total 
number remained constant in the involved skin. 
Langerhans cells were also reported to be encoun- 
tered with much greater frequency in the involved 
skin than normal epidermis in patients with vitiligo 
(Breathnach 1975). Recently Bleehen (1979) studied 
vitiligo by electron microscopy and has found that 
melanocytes appeared to be replaced by Langerhans 
cells, but he did not comment whether these cells 
were increased in number. 
It is difficult to make any definite conclusion 
from these somewhat conflicting studies. The small 
number of skin biopsied, the variability of the 
techniques used and especially the capricious 
staining methods employed, make one most uncertain 
about the validity of the findings. Most of these 
studies did not comment on the alterations in the 
fine structure of the Langerhans cells and on their 
function. 
In this study the Langerhans cells were counted 
in lµ Epon-embedded vertical sections of skin. All 
the suprabasal clear cells in the uninvolved skin and 
all the clear cells in the involved areas were 
considered to be Langerhans cells. This was largely 
confirmed by subsequent electron microscopy. The 
number of these cells in the uninvolved skin of 
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vitiligo was compared with that found in the normal 
control skin and was significantly increased. Also 
when the number of Langerhans in involved skin was 
compared with that of the uninvolved areas, it was 
found to be significantly increased. However, in 
a few patients the Langerhans cells were either not 
seen at all or were found in only few of the sections 
in the involved areas. 
On electron microscopy the Langerhans calls 
were seen mainly suprabasal in the uninvolved areas 
in most of the patients. In some of the uninvolved 
areas the Langerhans cells were only found in the 
basal layer. In the marginal areas the Langerhans 
cells were mainly basal in location with a few being 
suprabasal. In many patients the cells were few or 
absent, in particular when there was a mononuclear 
cell infiltrate in the epidermis. In the involved 
areas, Langerhans c ells appeared to replace 
melanocytes and it seemed that they were increased 
in number compared to that found in the uninvolved 
areas. Their position was mainly basal, but in some 
patients they were only suprabasal. In a number of 
patients the Langerhans cells were not seen at all. 
The increased number of Langerhans cells in 
the uninvolved areas and the absence of these cells 
from the involved skin as seen in few patients will 
account for the varying results as seen by different 
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workers. 
Very little attention has been paid to the 
structural and functional changes in the Langerhans 
cells in patients with vitiligo. In this study the 
Langerhans cells showed a variety of ultrastructural 
changes suggesting activity and cytotoxic damage. 
These included the development of bizarre nuclear 
shapes. In many of the patients these cells had 
very convoluted nuclei with prominent Golgi system 
and lysosomes. Some of the Langerhans cells had 
vacuolated cytoplasm with a shrunken nucleus. Cells 
in direct contact with lymphocytes in the marginal 
areas also were seen, particularly in the basal layer 
of the epidermis. These changes were similar to 
those immunological reactions where delayed hyper- 
sensitivity are involved, such as allergic contact 
dermatitis (Silberberg 1973; Silberberg et al 1974, 
1976). The apposition of mononuclear cells with 
Langerhans cells was also reported in mycosis fungoides 
(Rowden and Lewis 1976) and in lichen planus (Ragaz 
and Ackerman 1980). The apposition of lymphocytes 
with Langerhans is not seen in primary irritant 
dermatitis (Silberberg 1971). The presence of this 
phenomenon in vitiligo indicates that an inflammatory 
reaction is a primary immunological event rather than 
a secondary one. All these findings do suggest that 
vitiligo is a manifestation of a delayed hyper- 
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sensitivity reaction to melanocyte antigens. 
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VI. LANGERHANS CELL GRANULES AND DESMOSOMES 
Langerhans cells contain granules within their 
cytoplasm that are considered specific for these 
cells. Recently it has been shown that these cells 
are part of macrophage-monocyte system and they are 
part of mobile pool of monocytes that originate from 
the bone marrow (Katz, Tamaki and Sachs 1979; Frelinger 
et al 1979; Tamaki et al 1980). It is possible that 
Langerhans cells get their specific granules only 
after these have gained access to the epidermis. In 
active or recent onset lesions of vitiligo intra- 
epidermal histiocytes can be found exactly similar 
to Langerhans cells except the former lack of Birbeck 
granules. If these granules are endocytotic (Breath- 
nach 1964; Zelickson 1965) or secretory (Birbeck; 
Breathnach and Everall 1961; Breathnach 1964; Wolff 
1967; Zelickson 1965,1966) in origin, they should be 
present all the time and not only when these cells are 
in the epidermis. 
Langerhans cells are usually confined to 
epithelia that are composed of stratified squamous 
cells (Wolff 1972). It has even been suggested 
(Wolff and Winkelmann 1967) that these epithelial 
cells, together with the Langerhans cell form an 
Epidermal - Langerhans Cell Unit. 
Langerhans cell granules are similar in 
structure to desmosomes apart from these having an 
- 146 - 
attachment plaque. Desmosomes could also have a 
vesicular portion as in the Langerhans cell granules 
due to an enfolding of the plasma membrane. It is 
not infrequent to see a collection of desmosomes, 
particularly near Langerhans cells and often these 
cells appear to be partly phagocytosing these 
desmosomes. On one occasion an intra-Langerhans cell 
desmosome was seen changing into Langerhans cell-like 
granule. In addition on many occasions desmosomes 
were found to be changing into Langerhans cell-like 
granules in the intercellular areas. These findings 
would suggest that Langerhans cells can phagocytose 
desmosomes and alter them into Langerhans cell 
granules, possibly dissolving the attachment plaque 
as a result of their lysosomal activities. These 
changes may occur within the cytoplasm or within 
lysosomes or even outside the cell membrane. 
It is perhaps speculative that the Langerhans 
cell granules are derived from desmosomes. 
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VII. MAST CELLS 
Recent studies (Eady et al 1979; Cowen, Trigg 
and Eady 1979) have shown that mast cell population 
density varies considerably in the dermis, even in 
different sections from the same biopsy sample. The 
mast cells are mainly found in the superficial 
dermis 
particularly around blood vessels. In this study 
mast cell counts were performed on the upper 
(papillary) 
dermis. The counts on normal controls were variable, 
but comparable to other studies (Eady et al 1979; 
Cowen et al 1979). The figures in this present study 
were lower than in these other studies. 
Mast cells have been identified in the lesion 
of vitiligo for a long time (Marc 1894). Sometimes 
the lesions of vitiligo may be associated with itching 
(Asboe-Hansen 1954). Marc (1894) found that in the 
corium of involved areas mast cell count was increased. 
Gentele (1949) described a case of drug induced urticaria 
occuring only in the depigmented areas of patients 
with vitiligo and has found a high histamine content 
in these areas when compared with the pigmented skin. 
Similarly, it was reported (Quiroga et al 1949) that 
there was an increase in the histamine content of the 
involved areas of skin in vitiligo. Breathnach 
(1975) noted that mast cells were prominent in the 
dermis of the depigmented areas. More recently 
(Nordlund et al 1978) has reported that mast cells 
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are increased in number in the dermis of vitiligo 
patients and in one study (Bleehen 1979) the 
mast cells were significantly increased in the 
marginal skin. Mast cells were also increased in 
the dermis of depigmented area of patients with 
halo naevi (Hashimoto 1974). The problem with 
these studies was that the observations were of a 
limited nature and rarely quantitative. 
In this study, a quantitative method was used 
on the biopsies to assess the number of mast cells 
and in many biopsies samples. In many of the patients 
there was an increase in the mast cell counts, as 
found both in the marginal and involved areas of 
skin. This number was greater than that of unin- 
volved areas of patients with vitiligo and normal 
controls. However, the total mast cell counts of 
all the patients compared to each other and with 
controls did not attain statistical significance. 
This can be attributed to; mast cell number being 
variable, even in the same site; pathological 
changes have been observed in the uninvolved areas; 
the number of mast cells decrease in number and may 
temporarily disappear during acute inflammatory 
conditions (Michels 1938; Riley 1959); the mast 
cell number may vary with the duration of the lesion. 
Intra-epidermal mast cells have been reported 
in vitiligo skin (Breathnach 1966; Bleehen 1979). 
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These cells were observed in the basal layer. 
In this study basal mast cells were seen in a few 
patients and some of them showed degranulation 
within the spongiotic epidermis. 
Mast cells have been shown to play a role in 
cell mediated immune reaction in addition to 
immediate humoral type (Dvorak et al 1976; Dvorak 
et al 1976; Dvorak et al 1974). In this study 
degranulating mast cells were seen in many patients 
as a part of the general inflammatory reaction. 
- 150 - 
VIII. MELANOCYTES 
Previous histochemical studies, (Hu et al 
1959; Bleehen 1979) have shown that in the involved 
areas of vitiligo there was almost a complete 
absence of dopa-positive melanocytes. Electron 
microscopic studies (Birbeck, Breathnach and Everall 
1961; Zelickson and Mottaz 1968; Breathnach, Bor 
and Wyllie 1966; Breathnach 1975; Nordlund et al 
1978; Bleehen 1979) have confirmed that in the 
vitiliginous areas of skin there was a complete lack 
of secretory melanocytes that appeared to be re- 
placed by Langerhans cells. Jarret and Szabo (1956) 
found in their histochemical studies of biopsies 
taken from involved areas of vitiligo, that there 
were a number of residual dopa-positive melanocytes 
and described these cases as 'relative' vitiligo. 
Some of the residual melanocytes were large 
as well as being dopa-positive. Clinically, some of 
these areas of 'relative' vitiligo were pigmented 
and appeared somewhat brown in colour rather than 
the ivory-white appearance of the amelanotic areas 
of vitiligo. 
The involved areas in all the patients in 
this study were ivory-white in colour when examined 
with a Wood's lamp. All the biopsies were taken 
from these ivory-white areas. However, residual 
dopa-posivite melanocytes were found in most of the 
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biopsy specimens from these areas. The residual 
cells were usually small and weakly dopa-positive. 
The presence of these residual melanocytes was 
confirmed on microscopy of the Huber-stained, 
plastic embedded 14 thick sections and also on 
electron microscopy of the ultrathin stained sec- 
tions. Not only were melanocytes found, but also 
melanosomes were not infrequently seen in the 
keratinocytes of the epidermis in the involved 
areas of skin. The number of melanosomes were few 
when compared with that in the adjacent uninvolved 
skin. 
Thus, the main histological findings in the 
epidermis, as a result of the histochemical, light 
and electron microscopic studies, were an almost 
complete lack of melanocytes in the involved areas 
of skin and an almost complete absence of melano- 
somes in the epidermal cells. These findings and 
the marked reduction in number of melanocytes in 
the marginal areas, confirmed those'findings in 
previous studies (Jarret and Szabo 1956; Birbeck, 
Breathnach and Everall 1961; Bleehen 1979). 
Histochemical studies of dopa-incubated 
epidermal sheets showed that in the marginal areas, 
there was frequently a sudden drop in the population 
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density of melanocytes at the margin of the areas 
of vitiligo. 
The melanocytes in this marginal region 
showed a variable morphology. The first type 
probably represented degenerating melanocytes 
and were weakly dopa-positive small and rounded 
cells. These cells had a few dendrites. The 
second type, the melanocytes, were large and 
strongly dopa-positive, but they too had lost some 
of their dendrites. The third type of residual 
melanocyte in this marginal area was large and poly- 
dendritic, but was weakly dopa-positive. Electron 
microscopy indicated that the melanocytes in the 
marginal areas were few in number and those that 
were found were large and some showed degenerative 
changes. 
The uninvolved areas in these patients with 
vitiligo have always been considered to be normal. 
However, in this study although all the biopsies 
were taken from apparently normal skin, it was 
observed that pathological changes occured. Examina- 
tion of dopa-incubated epidermal sheets showed the 
presence of microfoci of vitiligo. This finding was 
confirmed by electron microscopy of the uninvolved 
skin. 
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Many theories have been proposed to explain 
the pathogenesis of vitiligo and the lack of melano- 
cytes and melanosomes in the affected areas of skin. 
The findings in this study would support that a cell 
mediated immune mechanism is involved in the destruc- 
tion of the melanocytes. Intra-epidermal lymphocytes 
were seen, many of them in contact with melanocytes 
and Langerhans. Melanocytes are damaged by lympho- 
kines and lysosomes from the lymphocytes and Langer- 
hans cells and this was suggested as a mechanism in 
the pathogenesis of vitiligo (Nordlund et al 1978). 
The lymphocytes may only require temporary contact 
with the melanocytes (Don et al 1977) and only a few 
of them may be involved in producing the damage. 
The damaged melanocytes may drop down into the dermis 
and become mammified and form colloid/amyloid bodies. 
These colloid/amyloid bodies may be later removed by 
macrophages. This dropping of melanocytes into the 
dermis may be the normal fate of effete cells. The 
degeneration of melanocytes that occur normally may 
be exage rated in vitiligo as a result of an immunolo- 
gical mechanism. 
The progression of the areas of vitiligo could 
be explained on the basis of an autocytotoxic theory. 
Marginal melanocytes become more active and hyper- 
trophic and as a consequence of an accumulation of 
toxic melanin precursors result in the death of 
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these cells (Lerner 1971). It is also likely that 
in the patients with vitiligo they lack a protec- 
tive mechanism that results in this accumulation 
of melanocytotoxic precursors. 
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IX. MELANOSOMES 
The difference in colouration of the skin in 
various races is believed to be due to variations 
in the number, size, degree of melanization and also the 
distribution of melanosomes in the keratinocytes of 
the skin. Melanosomes in Caucasoids, Mongoloids 
and American Indians are small and aggregated in 
groups of two or more as membrane-bound packages 
within the epidermal keratinocytes (Szabo et al 
1969). In Negroes (Szabo et al 1969) and in 
Australian Aborigines (Mitchell 1968) and to a 
lesser extent in racially pigmented individuals 
with less heavily pigmented skin (Oslon, Gaylor 
and Everett 1973; Toda et al 1973) the melanosomes 
are larger in size and remain unaggregated. This 
distribution pattern seems to be a sized dependent 
phenomenon. Larger melanosomes tend to be disposed 
individually and are not aggregated, whereas small 
ones occur in complexes (Toda et al 1972; Konrad 
and Wolff 1973; Wolff 1973; Zaynoun et al 1977). 
Melanosomal size is under genetic control, 
but can be affected by external factors (Quevedo 
1973). It has been shown (Toda et al 1972) that 
exposure of Caucasoid skin to longwave ultraviolet 
(UVA) radiation following application of psoralen 
caused an increase in the number and size of melano- 
somes and a switch from the aggregated to the non- 
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aggregated distribution pattern. After application 
of topical nitrogen mustard (Flaxman, Sosis and Van 
Scott 1973) to the skin and oral therapy with 
bleomycin (Perrot and Ortonne 1978) the pattern 
change of melanosomes from complexes to single 
dispersion was noted. These changes were not 
necessarily related to the size of melanosomes. 
In this study, although all the patients were 
Caucasoids, most of their melanosomes were singly 
dispersed within the keratinocytes. In a few 
patients there was a mixed pattern. The change 
in the melanosomal arrangement may be due to the 
reduced number of melanocytes and as a consequence 
of the sparse number of melanosomes, particularly 
in the marginal area. A sort of compensatory 
mechanism is operating. However, this pattern was 
also seen in the uninvolved areas where if there 
was a reduction in the number of melanocytes, it was 
not very marked. Melanosome complexes were also 
seen in the involved area where there was an almost 
complete absence of melanocytes and melanosomes. 
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X. INDETERMINATE CELLS 
Attention was first drawn to the presence 
of these indeterminate cells in the epidermis by 
Breathnach et al (1963). Since then the nature 
of these cells has been debated. They are dendritic 
non-keratinocyte cells that lack desmosomes and 
tonofilaments. They have cytoplasmic features that 
are similar to those of Langerhans cells and melano- 
cytes, but they lack Langerhans cell granules and 
do not contain melanosomes. 
Over the years the origin of these indeterminate 
cells has been a matter of speculation. It has been 
considered that these cells are premelanocytes. 
Also that they could be precursors of the Langerhans 
cells. It has been also suggested that they are 
'effete' melanocytes or they are completely unrelated 
to the melanocytes and Langerhans cells (Breathnach 
1964; Snell 1965; Brown, Winkelmann and Wolff 1967; 
Tsuji, Sugai and Saito 1969). 
Using an electron microscopic quantitative 
method (Zelickson and Mottaz 1970), it was reported 
that there was an increase in melanocytes and a 
decrease in the number of indeterminate cells 
following ultraviolet irradiation to the skin. 
They suggested that some of the indeterminate cells 
are dormant melanocytes. In another study (Miyazaki 
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et al 1974) it was found that following application 
of Dinitrochlorobenzene (DNCB) that there was marked 
increase in the number of Langerhans cells and a 
decrease in the number of indeterminate cells. It 
could be that the indeterminate cells following the 
application of DNCB develop granules and become 
mature Langerhans cells. Indeterminate cells are 
also found in the skin experimentally deprived of 
neural crest (Breathnach et al 1968). 
Very recently, it has been shown (Rowden, 
Philips and Lewis 1979; Rowden 1980) that a high 
proportion of indeterminate cells in the epidermis 
express Ia antigen. This is similar to that of the 
Langerhans cells. Therefore, it seems unlikely that 
these indeterminate cells are related to melanocytes 
which are from the neural crest. ' It is more likely 
that they are related to the Langerhans cells. 
In this study, indeterminate cells were only 
occasionally seen, particularly in the uninvolved 
areas of patients with vitiligo. Their morphology 
was more related to that of Langerhans cells and 
histiocytes. There were a few that could have been 
melanocytes, but without recognisable melanosomes. 
The number of these cells was not increased in the 
recently depigmented marginal areas. However, 
other workers (Mishima et al 1972) found an increase 
in the indeterminate cells in the newly depigmented 
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areas in vitiligo. Also in the older lesion of 
vitiligo the number of indeterminate cells dropped 
to zero and in these areas there was a complete 
absence of melanocytes. This increase of indeter- 
minate cells in the recently depigmented areas may 
be explained by the presence of mononuclear cell 
infiltrate in the epidermis. Some of these cells 
are histiocytes that do not possess the distinctive 
Langerhans cell granules as has been shown in the 
present study. 
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XI. CUTANEOUS NERVES 
There is evidence that a neurogenic factor may 
play an important role in the pigmentation of some 
animals. In fish and many other cold-blooded 
vertebrates, it has been demonstrated conclusively 
that skin pigment cells are under direct control of 
the nervous system (Pouchet 1876; Frisch 1911; Gray 
1956). Unmyelinated nerve fibres were found in 
direct apposition to pigment cells in Fundulus 
(Bikle, Tilney and Porter 1966). Also catecholamine 
containing fibers found in anatomic proximity to conjuctival 
and dermal melanocytes of a Teleost fish. In the 
frog, Rana pipiens, the pigment cells are not 
innervated directly (Snell and Kulovich 1967). Yet 
these cells, like those in the lizard (Goldman and 
Hadley 1969; Hadley and Goldman 1969) respond to 
pharmacologically active adrenergic and cholinergic 
chemicals as well as to their blocking agents (Lerner 
1971). Also it has been shown clearly that the 
melanocytes of fish, frogs, toads and lizards have 
alpha and/or beta adrenergic receptors (Goldman and 
Hadley 1969; Hadley and Goldman 1969; Scott 1965,1967; 
Scott and Wong 1966; Gupta and Bhide 1967; McGuire 
1970). 
It is apparent that human melanocytes are 
predominantly under endocrine control (Lerner et al 
1966). To what extent those cells are also under 
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neurochemical regulation is as yet unknown. The 
only evidence in mammals that catecholamines affect 
melanocytes is that injection of adrenaline into 
rat skin produced grey hair (Munan 1953; Shelley 
and Ohman 1969). 
In vitiligo a number of clinical observations 
suggest a relationship between the activity of 
human epidermal melanocytes and the nervous system. 
A patient having transverse myelitis with paralysis 
from waist down developed vitiligo on the face and 
upper part of the body, but no depigmentation occured 
below the level of the cord damage (Lerner et al 
1966). Repigmentation in one patient with extensive 
vitiligo and diabetes occured concomitantly with 
development of severe diabetic neuropathy (Lerner 
et al 1966). In two human subjects with cervical 
sympathectomies, the development of grey hair with 
age was retarded on the denervated sides (Lerner et 
al 1966). In vitiligo hypopigmented areas frequently 
are confined to skin regions supplied by a nerve 
segment in a dermatomal distribution (Lerner 1959; 
Koga 1977). 
Morphological changes of the nerves in vitiligo 
skin have been looked for in order to explain the 
pathogenesis of this disorder and to implicate a 
neurogenic factor. Breathnach et al (1966) investi- 
gated five vitiligo patients by electron microscopy 
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and found a minor degenerative change in the few 
nerve terminals, mainly of the marginal area. 
However, those changes are not convincing, especially 
when compared with the changes found in this study 
in normal controls. Bleehen (1979) has also found 
minor degenerative changes in the nerves of the 
upper dermis, but did not comment on the nature of 
these degenerative changes. 
In a number of conditions in which cutaneous 
depigmentation occurs, compensatory proliferation of 
nerves may be present rather than degenerative changes. 
These nerves may enter into the epidermis. Although 
intra-epidermal nerves in a normal skin are seldom 
observed (Breathnach et al 1966; Breathnach 1971; 
Orfanos and Mahrle 1973), increased dermal nerves 
with intra-epidermal axons have been observed in halo 
naevus (Hashimoto 1974), Vogt-Koyanagi syndrome, 
vitiligo and incontinentia pigmenti achromians 
(Morohashi et al 1977). Ultraviolet light with or 
without psoralen can induce dermal and intra-epidermal 
nerve proliferation (Kumakiri and Hashimoto 1978; 
Kumakiri, Hashimoto and Willis 1978). Many of these 
dermal nerves were partly denuded and not completely 
enveloped by the Schwann cell process. 
The association of melanocytEs with nerves 
seem to be very rare in the normal skin. However, 
such an association has been reported. However, 
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the close proximity of nerves with melanocytes in 
vitiligo skin and incontinentia pigmenti achromians 
has been noted (Morohashi 1977). Also direct 
contact of nerve with melanocyte in the basal layer 
of the epidermis in a patient with Voq Koyanagi- 
Harada syndrome (Morohashi 1977). Similarly, this 
association and direct contact between melanocytes 
and axons has been reported in PUVA-treated skin 
(Kumakiri et al 1978; Kumakiri and Hashimoto 1978). 
The following obervations were noted in this 
study with regards to the nerves in the skin. There 
were a number of partially denuded and regenerating 
axons, particularly in the dermis of the involved 
areas. There were an increased number of intra- 
epidermal nerves, particularly in the adjacent pig- 
mented skin with a close association of dermal nerves 
with the basal melanocytes in a few of the patients. 
There was a direct contact between several of these 
intra-epidermal adrenergic nerves (Grillo 1966; 
Orfanos and Mahrle 1973) and functioning melanocytes 
in two of the patients. All these findings are 
similar to what have been previously observed in 
PUVA-treated skin. Minor pathological changes 
that were observed in two of the nerves were 
probably part of the general inflammatory reaction 
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in the skin which is similar to what has been seen 
in atopic dermatitis (Mihm et al 1976). 
The so-called "minor degenerative" changes 
previously observed by other workers can be attri- 
buted to the inflammatory changes as seen in 
vitiligo skin. 
A neurogenic theory has been suggested (Lerner 
1959; Chanco-Turner and Lerner 1965; Lerner 1971) 
to explain the pathogenesis of vitiligo. They 
postulated that there was an elevated level of 
norepinephrine or related catecholamines at the 
peripheral nerve terminal endings. According to 
this theory, the increased nerve-activity will 
enhance the cutaneous depigmentation. Surprisingly, 
there is an increased number of dermal and intra- 
epidermal nerves seen in PUVA irradiated skin 
(Kumakiri et al 1978; Kumakiri and Hashimoto 1978) 
and this associated with enhanced pigmentation. 
However, it has been noted in long term PUVA-treatment 
areas of hyperpigmentation and hypopigmentation of 
the skin develop (Gschnait et al 1980; Kanerva, 
Niemi and Lassus 1981). It seems unlikely this 
neurogenic hypothesis of the pathogenesis of vitiligo 
can be correct. 
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XII. COLLOID/AMYLOID BODIES 
A variety of names have been used for these 
bodies in the past, e. g. hyaline bodies, Civatte 
bodies, Sabouraud cells or filamentous bodies 
(Ebner and Gebhart 1977). These filamentous bodies, 
usually globular or ovoid in shape, about 7-2O4 in 
size are to be found in the upper papillary dermis, 
especially in relation to the dermo-epidermal 
junction. They can also be found within the basal 
layer of the epidermis. In haemotoxylin and eosin 
stained sections they appear eosinophilic and stain 
well with PAS and basic fuchsin. Direct immuno- 
fluorescence is usually positive especially with 
anti-IgA, anti-IgM, anti-IgG and less frequently 
with anti-C3, and antifibrin antibodies. The 
immunoglobulin could be 'washed out' overnight in 
O. 1M glycine at pH3 without changing the positive 
histochemical reactions of amyloid. Therefore, it 
was felt that the immunoglobulins were nonspecifically 
adsorbed by the amyloid (MacDonald, Fergin and Black 
1980). 
Electron microscopy reveals the filamentous 
nature of these bodies, which are composed of mainly 
of a dense network of 80-10OR filaments. Most of 
these bodies are composed of wavy filaments such as 
is seen in colloid bodies, but also in some of these, 
a network of straight filaments 70-10OR that are 
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characteristic of amyloid (Ebner and Gebhart 1975, 
1977). In the present study the diameter of these 
filaments in the colloid/amyloid bodies ranged 
from 70-1302 with a mean of 1OOä. This is similar 
to the cytofilaments of the melanocytes in patients 
with vitiligo. Not infrequently there is admixture 
of both types of filaments. Hence the use of the 
description colloid/amyloid bodies, though the 
majority of these cytoid bodies were more that of 
the colloid bodies in these patients with vitiligo. 
It is likely that both colloid and amyloid 
bodies in the skin have the same origin and a 
sequential change of epidermal keratinocytes to 
amyloid via filamentous degeneration has been 
observed in primary localised cutaneous amyloidosis 
(Kumakiri and Hashimoto 1979) and also in PUVA- 
treated human psoriatic patients skin (Hashimoto 
and Kumakiri 1979)., Similarly other workers have 
made this observation (Black and Wilson Jones 1971; 
Ebner and Gebhart 1975; MacDonald, Black and 
Ramnarain 1977). 
Degenerating epidermal cells contain bundles 
of filaments and have a fibrillar ultrastructure 
such as is seen in that colloid/amyloid bodies. 
Electron microscopic and histochemical studies 
(Anton-Lamprecht and Teligen 1972,1978; Ebner and 
Gebhart 1972, a, b) and more recently histochemical 
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staining for sulphhydryl (-SH) groups and disulphide 
(S-S) bonds (Danno and Horio 1981) support the view 
that amyloid is derived at least partially (a weak 
S-S fluorescence but not -SH was detected in dermal 
amyloid) from epidermal cells. While the colloid 
bodies are completely derived from keratinocytes 
(positive staining for both -SH groups and S-S bonds). 
From these studies it seems likely that there is 
little difference between colloid and amyloid bodies 
and that both can coexist in the same location. It 
is also possible that melanocytes form these cytoid 
bodies as a result of degenerating. Fine cyto- 
filaments 10OR in diameter are to be found within 
the melanocytes and these often have a wavy pattern 
and are arranged in bundles similar to those of 
colloid/amyloid bodies. 
Colloid/amyloid bodies are most frequently to 
be found in PUVA treated skin in both psoriasis 
(Hashimoto and Kumakiri 1979) and in mycosis fun- 
goides (Bleehen, Vella Briffa and Warin 1978). 
These bodies are also found in normal skin. The 
number of these colloid/amyloid bodies as detected 
by direct immunofluorescence and electron microscopy 
seemed to be increased in vitiligo when compared with 
that found in normal controls. This was a surprising 
finding in the present study. 
Colloid bodies have been described in a variety 
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of other pathological conditions. In lichen planus 
(Weedon 1974; Hashimoto 1976) in basal cell epithe- 
lioma (Kerr and Searle 1972) and in graft vs host 
reaction (De Dobbeleer, Ledoux-Corbusier and Achten 
1975). Also these bodies have been seen 3-n- regressing 
plane warts (Weedon and Roberston 1978). Immuno- 
fluorescence studies have demonstrated cytoid bodies 
in discoid lupus erythematous, fixed drug eruption, 
lichen planus and mycosis fungoides (Ueki 1969; 
Gogate et al 1980). 
Amyloid bodies have been observed in primary 
cutaneous amyloidosis (Hashimoto and Yoong Onn 1971; 
Black and Heather 1972; Black and Wilson Jones 1971; 
Black 1971). Secondary localised cutaneous amyloidosis 
has been described with basal cell epitheliomas 
(Sumegi, Goreczky and Roth 1954; Malak and Smith 
1962; Brownstein and Helwig 1970; Hashimoto and 
Brownstein 1973; Weedon and Shand 1979), Cylindroma 
(Freudenthal 1930; Heyl 1966), seborrhoeic keratosis 
(Malak and Smith 1962), actinic keratosis (Hashimoto 
and King 1973), Bowen's disease (Brownstein and Helwig 
1970), disseminated superficial actinic porokeratosis, 
(Piamphongsant and Sittapairoachana 1974), PUVA 
treated skin (Hashimoto and Kumakiri 1979) and in 
melanocytic naevi (MacDonald and Black 1980). 
As a regard the origin of amyloid deposits 
in the skin (Hashimoto, Gross and Lever 1965) suggested 
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that the amyloid fibrils in lichen amyloidosis 
were secreted by fibroblasts and then deposited in 
the papillary dermis. Since then several other 
investigators (Ebner 1968; Rodermund and Klingmüller 
1970; Pierard and Kint 1971; Hashimoto and Yoong 
Onn 1971) have stressed the role of dermal fibro- 
blast in the pathogenesis of lichen amyloidosis. 
In a light microscopic study of macular amyloidosis 
(Black and Wilson Jones 1971), it was st'ggested 
that damage to the lower epidermis might be the 
primary pathology and that degenerating epidermal 
cells could be converted into the deposits of 
amyloid. In a further enzyme histochemical study 
of lichen amyloidosis (Black 1971) it was considered 
that the epidermis was most likely to be involved 
in the pathogenesis of lichen amyloidosis. 
Both amyloid and colloid bodies have been 
observed in conditions where there is hyperpigmentation 
of the skin and an associated degeneration of the basal 
layer. In addition pigmentary incontinence is present 
in the upper dermis, such as in lichen planus and 
discoid lupus erythematosus (Ueki 1969), macular 
amyloidosis (Black and Wilson Jones 1971; Black and 
Heather 1972; Eng 1977), Riehl's melanosis (Nagaos 
and Iijima 1974), PUVA-treated skin (Hashimoto and 
Kumakiri 1979), also in fixed drug eruption. Black 
and Wilson Jones (1971) emphasized the morphological 
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similarities between colloid and amyloid bodies 
and in both conditions a reduction in the number 
of basal melanocytes was noted. The number of 
DOPA positive melanocytes have been shown to be 
markedly reduced in the epidermis overlying the 
amyloid deposits in lichen amyloidosis (Black 
1971), (even may be associated with leukoderma, 
Sharquie unpublished 1978) and that overly the 
colloid bodies in lichen planus (Black and Wilson 
Jones 1972). 
Melanocytes are probably also involved and 
destroyed by the disease process. Amyloid deposition 
has been identified within the tumour mass of melano- 
cytic naevi and it was thought that amyloid is likely 
to be derived from degenerating naevus cells 
(MacDonald and Black 1980). This is in agreement 
with this present study where the presence of these 
filamentous bodies was more related to the presence 
or absence of melanocytes. In addition in melano- 
cytes 1008 filaments are well developed, particularly 
in the inactive cell and these cytofilaments resemble 
these seen in the colloid/amyloid bodies. 
Not infrequently there is an admixture of wavy 
and straight filaments in the same filamentous body 
- those being colloid/amyloid bodies. Portions of 
dendrites of the melanocytes were seen in the 
papillary dermis and appeared to be very similar 
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to the adjacent colloid bodies. The absence of 
'effete' melanocytes high up in the epidermis 
points to the fact that the fate of these cells 
is that they drop off into the dermis and become 
apoptotic cells. These will be later changed into 
filamentous bodies. However, the change of these 
degenerating melanocytes into colloid/amyloid bodies 
occured inside the epidermis in the basal layer. 
This natural process of apoptosis is exaggerated 
in pathological conditions, especially when there 
is hyperpigmentation. Thus, in macular and lichen 
amyloidosis, PUVA-treated skin and also in vitiligo 
these colloid/amyloid bodies are more apparent than 
normal skin. 
The primary pathological process causing this 
secondary phenomenon of colloid/amyloid deposits 
differs according to the individual disease process. 
In a group of diseases a lymphocytic cell infiltrate 
is present as a form of immunological reaction 
causing damage to the basal layer of epidermis. This 
is seen in lichen planus, discoid lupus erythematosus 
graft versus host reaction (De Dobbeleer et al 1975) 
and regressing plane warts (Weedon and Roberston 
1978), causing deposition of colloid bodies. The 
colloid bodies were also observed in an in vitro 
cell mediated immune reaction (Don et al 1977). This 
immunological reaction might also explain the colloid/ 
amyloid formation in vitiligo, in particular, the 
presence of a lymphocytic cell infiltrate in 
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the epidermis. 
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XIII. OCCUPATIONAL VITILIGO 
A vitiligo-like'leukoderma that is often 
progressive is not infrequently seen in patients 
who have been in contact with a number of sub- 
stituted phenols that are known to have a melano- 
cytotoxic effect (Bleehen 1981). These compounds 
have a selective lethal effect on-functional 
melanocytes, both in vivo (Bleehen et al 1968; 
Riley 1969) and in vitro (Riley 1970; Bleehen 
1976; Mansur et al 1978). The mode of action in 
having a selective lethal effect on melanocytes 
is most probably that they are oxidised by the 
tyrosinase of the cells to give rise to free 
radical derivitives that are hicly toxic. 
Outbreaks of occupational vitiligo have 
occured due to contact with the monobenzyl ether 
of hydroquinone (Oliver et al 1940), P-tertiary 
butyl phenol (Kahn 1970; Malten et al 1971; Chuma- 
kov, Babanov and Smirnov 1962; James, Mayes and 
Stevenson 1977; Calnan and Cooke 1974), P-tertiary 
amyl phenol (Kahn 1970) and 4-tertiary butyl cate- 
chol (Gellin, Possick and Perone 1970). Often in 
these cases the depigmented areas fail to repigment 
and frequently metastatic areas of leukoderma 
develop a long time after the exposure to these 
phenolic compounds has ceased. Similarly, patients 
with various hypermelanotic conditions treated with 
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these compounds can develop confetti-like areas 
of depigmentation and often a progressive vitiligo- 
like leukoderma that may be more cosmetically 
disabling than original pigmentory disorder 
(Bleehen 1980). Patients with occupational vitiligo 
do not usually have an increased incidence of auto- 
immune disorders and autoantibodies (James et al 
1977). However, several cases have reported (Gold- 
man and Thiess 1976) in which organ specific auto- 
antibodies are present. 
Histopathological studies on biopsies from 
patients with occupational vitiligo have shown a 
picture similar to true (idiopathic) vitiligo (Kahn 
1970; Malten et al 1971; Bleehen 1981). The finding 
in this present study confirms those previous ones. 
In addition, there were marked inflammatory changes 
in both the dermis and epidermis, with mainly atypical 
lymphocytes and histiocytes infiltrating the epidermis 
both in the uninvolved and marginal areas. Langerhans 
cells seemed to be increased in number and some of 
these cells were seen in contact with lymphocytes. 
Filamentous bodies of colloid and amyloid nature were 
also seen in the papillary dermis of these patients. 
Immunofluorescence studies were also negative 
on the biopsies from these patients. All these 
findings do also suggest that a cell mediated reaction 
is involved in some of the cases of occupational 
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vitiligo. 
Histopathological studies on biopsies from 
experimentally (Bleehen et al 1968) and therapeutically 
(Bleehen 1976) induced depigmentation did not show 
any inflammatory changes. The inflammatory changes 
in this present study suggest that a primary immune 
reaction is involved rather than being secondary to 
melanocyte destruction. However, it could be 
argued that the inflammatory response was secondary 
though this does seem unlikely. 
It is also quite likely that the patients who 
readily develop occupational vitiligo are indeed 
'latent' cases of idiopathic vitiligo which is 
unmasked by the exposure to these chemicals (Richter 
1980; Bleehen 1981) 
- 176 - 
XIV. REPIGMENTATION IN VITILIGO 
Repigmentation of the skin in vitiligo can 
occur spontaneously or may be the result of therapy. 
It is most frequently perifollicular and also the 
pigmentation can occur around the margin of the 
lesions. The precise mechanism in which repopulation 
of the skin takes place is uncertain, but several 
possibilities have been suggested. 
It has been suggested that there is reactiva- 
tion of weakly dopa-positive residual melanocytes 
in the vitiliginous area of skin (Jarret and Szabo 
1956). Similarly inactive melänocytes in the areas 
of vitiligo become functional and produce pigment 
(El Mofty 1968). A number of studies suggest that 
the melanocytes involved are responsible for the 
repigmentation originate from the hair follicles, 
from melanocytes that may remain in the normal 
pigmented hair in their external hair root sheath 
(El Mofty 1968; Parrish et al 1976; Bleehen 1976; 
Ortonne, Sannwald and Thivolet 1978). This repig- 
mentation around hair follicles occurs either sponta- 
neously or as a result of treatment. Areas devoid 
of hair follicles such as the mucous membrane, palm 
and soles, if affected with vitiligo rarely repig- 
ment. Similarly, involvement of the hair in the 
affected areas 'leukotrichia' is a bad prognostic 
sign (Dutta and Mandall 1969) and rarely repigment. 
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In a study of hair follicles in PUVA-induced 
repigmentation of vitiligo (Urtonne et al 1979; 
Ortonne, Schmitt and Thivolet 1980) these workers 
found on split dopa preparations and on electron 
and scanning microscopy hypertrophic melanocytes 
in the hair follicles of the pigmented area. They 
suggested that melanocytes migrate from the external 
root sheath to the basal layer of the interfollicular 
epidermis to recolonise the areas of vitiligo. 
In the present study residual melanocytes 
were seen in the interfollicular areas of the epidermis 
in most of the biopsies from the involved areas of 
skin. Thus it seems likely that the interfollicular, 
as well as the follicular residual melanocytes, are 
involved when vitiligo repigments. No melanocytes 
were seen to be in mitosis in any of the biopsies 
that were examined in this study. However, the 
melanocytes that repopulate the areas of vitiligo 
when they repigment, almost certainly undergo 
mitosis and proliferate. 
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APPENDICES 
1. DIRECT IMMUNOFLUORESCENCE TECHNIQUE 
The biopsies are frozen as soon as possible 
following their excision. Each block is sectioned 
as soon as possible allowing one hour after mounting 
for temperature equilibrium in the cryostat. The 
total time being approximately 1-2 hours. Maximum 
number of specimens stained at one time is 4 (12 
slides). 
1. Cut cryostat sections 6-8i thickness, 2/slide, 
labelled. Storage slides are placed back to 
back and wrapped in foil (a layer of foil 
between each pair of slides) numbered and 
placed in the deep freeze. 
2. Label three slides in sequence with a glass 
marker as follows; leave the slides out to 
dry at room temperature for fifteen minutes. 
3. Remove diluted conjugates *** from the deep 
freeze to thaw out. 
4. Place the slides in a staining rack and immerse 
in a bath of 1 part veronal buffer*, 1 part 
distilled H20. Agitate slowly (at 2-3 using 
large magnet) on magnetic stirrer for fifteen 
minutes. 
5. Remove slide racks, drain slides and wipe 
around the marked sections so as to prevent 
excess dilution of the conjugates, but do not 
allow the sections to dry out. (put the lid 
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on the buffer bath). Using plastic pipettes 
put on sufficient diluted antiserum*** to 
cover the section (usually 1 drop) and leave 
in a moist box for thirty minutes, i. e. wipe 
the slides, place in the box which has been 
rinsed with water and drained. Use a separate 
pipette for each conjugate. Place lid on the 
moist box and leave undisturbed. Replace the 
conjugates in the deep freeze. Stain in 
sequence as in 2 above. 
6. Put the buffer on to stir vigorously a few 
minutes before putting the slides in. Drain 
the slides sideways so that the drop of con- 
jugate drains into the moist box, then put 
slides into the slide rack. Place the rack 
into the buffer with the magnetic stirrer at 
2. Leave for fifteen minutes. 
7. Remove the slide rack, drain the slides and 
carefully dry around the sections. Place 1 
drop of sodium barbitone/glycerol buffer** 
onto each section and place a clean coverslip- 
on top, ensuring no air bubbles are present by 
lowering the coverslip from the side. The stained 
slides are placed in the cardboard holders (in 
order as in 2 above), a label written out con- 
taining the number, name of patient and disease 
attached and kept in the deep freeze. 
- 181 - 
Veronal Buffer* 
20.6g sodium bicarbonate 
85g NaCl 
5L. H2O 
The powders are dissolved separately in 
measured amounts of distilled water, e. g. 500m1. 
each. Then added to the container and made up to 
5 litres. The pH is adjusted if necessary to 7.2 
using concentrated HC1. The above solution is 
diluted 1: 1 with distilled water for us. 
Mounting Medium** 
Sodium barbitone 0.1030g 
NaCl 0.85g 
H 20 
lOml. 
Glycerol 90m1. 
The powders are dissolved separately in 
measured amounts of distilled water, then made up 
to lOml. when put together. The glycerol is added, 
shaken and allowed to settle. 
Conjugates (antiserum)*** 
These were obtained as powder from the manu- 
facturer (Behringwerke). lmi. of distilled water is 
added to the ampule and elute 0.1m. of this solution 
into each of 10 bijou bottles, place these into the 
freezer. When needing to stain, remove one of the 
O. lml. bottles from the freezer and add 1.4m1. of 
normal saline. Mix well and use for the method***, 
One set of all the conjugates should be kept in 
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the above form***, replenishing when necessary from 
the O. lml. eluents. If received as a liquid (as 
in C4) elute O. lml. into the 10 bijou bottles and 
continue as before. 
Freezing Skin Biopsies for Direct Immunofluorescence 
Technique 
1. Biopsies are wrapped in gauze and immersed in 
normal saline for transport to the laboratory. 
The biopsy must be frozen immediately. The 
tissue is trimmed, taking care not to damage it. 
2. The tissue is frozen using Bright cryospray. 
A blob of OCT compound is placed on the frozen 
chuck and the frozen tissue is correctly aligned 
and embedded on the freezing medium using the 
tweezers and the cryospray. More medium is added 
if necessary so as to just cover the tissue. 
Water is used to seal the chuck to the block 
and the whole is wrapped in foil, numbered and 
stored in the cryostat until it is sectioned. 
After sectioning the block is removed and kept 
in numbered foil, either within the cryostat 
or in the deep freeze. 
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II. INDIRECT IMMUTIOFLUORESCENCE COMPLEMENT 
FIXATION TEST 
Procedures: 
1. Cut frozen human skin 6µ thick. 
2. Dry at room temperature for ten minutes. 
3. Wash in phosphate buffered saline (pH 7.2) 
for fifteen minutes. Phosphate buffered 
saline (PBS). 
PBS One litre 
NaCl 6.798 gm. 
Na2HP04 1.478 gm. 
(anhydrous) 
KH2PO4 0.43 gm. 
Add salts to portion of distilled water and 
mix on magnetic stirrer until dissolved, then 
make volume with distilled water. 
4. Cover the sections with patients and control 
sera (in different dilutions) in moist box 
at room temperature for 45 minutes. 
5. Wash sections with PBS for fifteen minutes 
and fan dry. 
6. Cover the sections with human complement (fresh 
human sera as source of complement) for 45 
minutes at 370C temperature in moist box. 
7. Change PBS, wash for fifteen minutes and fan 
dry. 
8. Incubate the sections with fluorescin conju- 
gated antihuman complement (C3) for 30 minutes 
in moist box at room temperature. 
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9. Wash for 30 minutes in PBS. Wipe around the 
sections. 
10. Mount the sections in sodium barbitone/glycerol 
buffer on ordinary slides. 
11. Examine with fluorescent microscope as early 
as possible otherwise the fluorescence fades. 
The antigens as human skin were taken from 
normal skin, involved vitiligo skin, pigmented 
naevus and blue naevus. 
For each vitiligo patient's serum that was 
studied, positive pemphigoid serum and that from a 
normal person were used as controls. All patients 
and control sera were diluted with PBS in dilutions 
of 1: 1,1: 2,1: 4 and 1: 8. The heating of sera of 
patients and controls at 56°C for 30 minutes made 
no difference. 
The human serum as source of complement was 
diluted with either complement diluent or PBS in1: 5. 
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III. HISTOCHEMISTRY STUDY (DOPA METHOD) 
L-Dopa - 1/1000 L-Dopa (0.25g. in 250 mis. 
water). This is made fresh each time and not 
stored for longer than one week in the refrigerator. 
The tissue is incubated in 7 ml. of 1/1000 L-Dopa 
to which is added 3 ml. of phosphate buffer. The 
pH of the solution being 7.2. The phosphate buffer 
is made up of 8 ml. 0.1M Na2HP04 and 2 ml. O. 1M 
NaH2PO4. 
T_____ _l_____ 
1. Incubate the shave biopsy in 2N NaBr at 37°C 
for one hour. 
2. Separate dermis from epidermis under the 
dissecting microscope using tweezers and a 
long needle. 
3. Partially fix in 5% cold formaldehyde saline 
for 5-10 minutes and then rinse thoroughly 
several times with distilled water. 
4. Incubate tissue in L-Dopa solution at 37°C for 
4-5 hours. If there is insufficent time that 
day, keep it in a refrigerator at 4 °C until 
next morning and thezincubate. 
5. Fix tissue in 10% formaldehyde saline at 37°C 
overnight. 
6. Dehydrate the tissues in 70%, 80% and 90ä ethanol 
for one hour in each and then in absolute 
alcohol for two hours. 
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7. Place in cedar wood oil to clear for at least 
24 hours. 
8. Put in xylene for two hours. 
9. Mount in depex on an ordinary slide, putting 
the dermal surface of the epidermis (curled 
side) up and cover with a glass coverslip with- 
out getting too many bubbles of air. For 24 
hours a small weight is applied on top of the 
coverslip until the mounting medium has set. 
The slide is then ready for examination. 
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IV. EPON EMBEDDED TISSUE FOR LIGHT MICROSCOPY 
(a) Processing of Tissue 
The tissue is kept in the glutaraldehyde for 
24 hours at 4°C. It is then stored in phosphate 
buffer until processed. 
1. Wash tissues in distilled water. Empty the 
buffer and wash with distilled water twice. 
Drain. 
2. Osmium tetroxide fixation (in a fume cupboard). 
Place 1 ml. of 2% Os04 into each pot (make sure 
all the tissues are in the liquid). Screw tops 
on and place in the fridge for 12-2 hours. 
3. Drain OsO 4 and wash with distilled water (as 
in No. 1). 
4. Drain water. Fill the pots with 70% alcohol. 
Drain. Add more 70% alcohol and leave for ten 
minutes. 
5. Drain 70% and add 90% alcohol for ten minutes. 
6. Drain 90% and add absolute alcohol for ten 
minutes. 
7. Drain absolute and add more-absolute alchol 
for ten minutes. 
8. Drain absolute and add absolute alcohol dried 
over Calcium Sulphate for ten minutes. 
9. Drain Calcium Sulphate alcohol. In a fume 
cupboard immerse tissues in epoxy propane 
(propylene oxide) for fifteen minutes with tops 
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on. Make up Epon* 
10. Drain epoxy propane and replace with fresh 
epoxy propane for a further fifteen minutes. 
11. Add epoxy propane to Epon* solution and mix 
well giving a 1: 1 solution. Epon** 
12. Drain epoxy propane from the tissues and add 
Epon**. Make sure the tissues are in the Epon. 
Leave for one hour with the tops off. 
13. Mix Epon*** forty minutes later. 
14. At the end of the one hour add epoxy propane 
to give 1: 3 mixture. Epon****. 
15. Drain the 1: 1 mixture well and add the 1: 3 
Epon. Leave overnight. 
16. Make up the day's Epon, i. e. four pots of epon 
minus DMP3O. Keep covered with a petri dish. 
17. Drain 1: 3 Epon and immerse tissues in full 
strength Ellon*****. Place the tissues in a 
fresh change of Epon***** at 10 a. m., 12 noon 
and 2.00 p. m. 
18. Embed tissues in Epon******. Place numbered 
labels in the flat embedder. Put the Epon on 
to mix. Remove the tissues from the epon and 
allow the excess Epon to drain from the tissues. 
After the Epon has mixed for 10-15 minutes 
place one drop of the prepared Epon into each 
mould at the tissue end using a2 ml. syringe. 
Place the drained tissue into the mould and line 
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up as follows. 
Tissue 113/31 
19. After 20 minutes of mixing the Epon, syringe 
it into the moulds to that it adequately covers 
the tissue and does not protrude over the sides 
of the mould. Place mould in 60°C oven over- 
night. 
20. Remove tissues at 9.00 a. m. the next day. 
(b) Epon Preparation 
Epon 812 ml. 
DDSA ml. 
MNA ml. 
DMP 3O ml. 
90 18 9 4.5 
70 14 7 3.5 
50 10 5 2.5 
4.2 0.84 0.42 0.21 
Above are quantities for full-strength Epon, 
depending on how many specimens are being processed. 
Example for 6 specimen pots 
1: 1 Epon 
Epon 812 13.5 ml. )) 
DDSA 10.5 ml. )) 
MNA 7.5 ml. )*) ** 
DMP30 0.63 ml. )) 
Epoxy propane (E. P. ) 32 ml. 
Use glass measuring cylinder for E. P. and syringes 
for resins, green needles for DMP3O. Prepare Epon. 
Mix (folding action) with glass rod. Place magnet 
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in, cover with petri dish lid, spin at 4-6 with 
no heat for twenty minutes. 
1: 3 Epon 
Epon 812 18 ml. )) 
DDSA 14 ml. )) 
MNA lO ml. ) *** ) 
DMP3O 0.84 ml. )) 
E. P. 14 ml. 
Prepare as above 
Epon for 3 full strength changes 
Epon 812 22.5 ml. ) 
DDSA 17.5 ml. ) ***** 
MNA 12.5 ml. ) 
DMP30 1.05 ml. ) 
Prepare as above. 
Epon 812 4.5 ml. 
DDSA 3.5 ml. ) ****** 
MNA 2.5 ml. ) 
DMP3O 0.21 ml. 
Prepare as above. 
**** 
(c) Staining Technique for Plastic Embedded Tissue 
'Huber' - Staining Method 
1. Cut lµ Epon sections. 
2. Place a small drop of H2O on a clean glass and 
with a wire loop, place 4-5 sections on the 
surface of the water. Usually two slides are 
prepared. 
3. Dry the sections on a hot place at 80°C for 
five minutes. 
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4. Ring the sections on the reverse side of the 
slide with a felt pen. 
5. Prepare an aqueous solution of 3% basic fuchsin 
and allow to mix well on a hot plate at 80°C 
for approximately thirty minutes before use. 
Filter the stain through a millipore filter into 
a bijou bottle and leave on the hot plate for 
as long as it is in use. This may be retained 
overnight in a 37 
°C incubator and used the 
following morning. However, the stain must be 
discarded after 24 hours and a fresh batch 
prepared. 
6. Stain sections for 0.5-1 minutes with basic 
fuchsin - cover the stain with a bottle top 
to prevent evaporation and precipitation. 
7. Destain the section for approximately 30 seconds 
with distilled water at 80°C. 
8. Air dry until cool. 
9. Stain with 2% alkaline methylene blue at pH 12.0. 
Alkaline Methylene Blue 
(a) Prepare a O. 1N NaOH solution, i. e lgNaOH: 250 ml. 
distilled H20. 
(b) Prepare a 2% aqueous solution of methylene blue. 
(c) Just prior to use, mix 5 units O. 1N NaOH +1 
unit of methylene blue. 
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10. Stain progressively at 15-30 second intervals 
until the desired effect is obtained. 
11. Dry at room temperature and mount in Lenzol. 
Seal the edges of the coverslip with glyceal. 
Preparation of glyceal = 50 ml. glyceal/50 ml. 
methanol. 
* slides may be stored in a dry, light tight box 
for. approximately one year after which time the 
sections will start to lose their true colour. 
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V. ELECTRON MICROSCOPIC STUDY 
(a) Processing Tissues for E. M. 
Processing can be carried out on either a 
Monday or a Wednesday. Pre-fix tissues in glutaral- 
dehyde 24 hours in fridge, then stored in P04 buffer 
until processed. 
1. Wash tissues with distilled water. Empty buffer 
out and fill the bottle with distilled water 
twice. Drain. 
2. Osmium tetroxide fixation (in fume cupboard). 
Place 1 ml. of 2% Os04 into each pot (making 
sure all tissues are in the liquid). Screw tops 
on, place in the fridge for 12-2 hours. 
3. Drain Os04. Wash with water as in 1. 
4. Block staining with Uranyl Acetate. (0.33g/llml. 
of 50% C2H50H dissolved using magnetic stirrer; 
covered with parafilm. Centrifuge. Keep at 
room temperature away from light). Place more 
than 5 ml. into each pot. Screw tops on and 
keep dark at room temperature for two hours. 
5. Drain Uranyl Acetate. Fill the pots with 70% 
alcohol, drain, add more 70% for 10 minutes. 
6. Drain 70%, then 95% for 10 minutes. 
7. Drain 95%, then absolute for 10 minutes. 
8. Drain absolute, then absolute for 10 minutes. 
9. Drain absolute, then absolute dried over Calcium 
Sulphate for 10 minutes. 
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10. Drain. CaSO4/alcohol. In fume cupboard immerse 
tissues in epoxy propane (propylene oxide) for 
15 minutes with tops on. Make up the araldite *. 
11. Drain epoxy propane. Immerse in more epoxy 
propane for 15 minutes. 
12. Add epoxy propane to araldite mixture, then drain 
epoxy propane and add ** araldite. Make sure 
all tissues are immersed. Tops off 24 hours. 
13. Drain araldite. Immerse in *** / accelerator 
araldite, tops on overnight. 
14. Make up the days araldite minus the DMP30 (keep 
covered with petri dishes). 
15. Make araldite and immerse tissues in full strength 
**** araldite (three changes). 
16. Embed tissues in ***** araldite. Place numbered 
labels in the flat embedder. Put araldite on to 
mix. Extract the tissues from the araldite so 
that they stick to side of the bottle and any 
araldite on them drains away. After 10-15 minutes 
of araldite mixing put one drop of the mixing 
araldite into each mould at the tissues end (with 
a2 ml. syringe). Place the drained tissues 
into the appropriate mould and line up as shown. 
After 20 minutes of mixing the araldite, syringe 
it into the moulds so that it covers the tissues 
adequately, but is flat when viewed from the side. 
17. Place mould in 600 oven for 48 hours. 
Ultrathin sections (60-70nm) are cut with glass 
knives on Reichert OMU3 ultramicrotome. 
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(b) Grid Staining with Lead Citrate 
Using a glass Petri dish and dental wax or 
coverslip and NaOH pellets. Place approximately 
15 pellets around a piece of dental wax in the 
petri dish. Put one drop of lead stain per grid 
to be stained onto the dental wax. Grids are floated, 
section down on the lead drops. The Petri dish is 
covered while staining. Stain each for four minutes. 
Remove grid and wash by immersing in a beaker of 
distilled water for thirty seconds. Dry on a filter 
paper. 
When staining more than one grid, the following 
formula must be used. One or two grids could be 
stained each time. 
Grid No. Grids into lead Grids out lead for wash 
10 min. 5 
22 .7 
349 
46 11 
58" 13 
6 10 15 
(c) Araldite Preparation 
CY212 50 40 30 20 10 mis. 
DDSA 50 40 30 20 10 mis. 
Di-Butyl phthalate 5 4 3 2 1 mis. 
DMP30 105 84 63 42 21 drops 
Drops from a syringe with a green needle. 
Above are the quantities for full strength araldite, 
depending on how many specimens are being processed. 
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Example for 6 specimen pots 
50/50 E. P. /araldite mixture 
CY212 20 ml. )) 
DDSA 20 ml. )) 
D. B. P. 2 ml. )*) ** 
DMP30 21 drops )) 
E. P. 42 ml. 
Use glass measuring cylinder for E. P. and syringes 
for resins, green needles for DMP3O. Prepare 
araldite. Mix (folding action) with glass rod. 
Place magnet in, cover with petri dish lid, heat 
at mark 15-20, spin at 4-6 for 20 minutes. 
Araldite for 2 DMP stage 
CY212 20 ml. 
DDSA 20 ml. ) *** 
D. B. P. 2 ml. 
DMP30 21 drops 
Prepare as above 
Araldite for 3 full strength changes 
CY212 20 ml. 
DDSA 20 ml. ) **** x3 D. B. P. 2 ml. 
DMP30 42 drops ) 
Araldite for embedding 
CY212 10 ml. 
DDSA 10 ml. ) ***** 
D. B. P. 1 ml. 
DMP30 21 drops 
Prepare as above 
VERY IMPORTANT - do not allow water near to any 
of the resins or tissue after starting dehydration. 
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(d) Solution Preparations 
Glutaraldehyde Fixative 
1. Prepare A+B buffer and store at +4°C (shelf 
life = several weeks). 
A buffer - NaH2PO42H2O = 1.56g/100 ml. 
B buffer - Na2HPO412H20 = 3.58g/100 ml. 
2. Prepare P04 buffer by mixing 77 ml. B+ 23 ml. 
A and store at +40C. 
3. Take 8.8 ml. PO4 buffer and 1.2 ml. glutaraldehyde 
to make 10 ml. buffered glutaraldehyde. Make up 
fresh each time. 
Lead Citrate Stain 
1. Lead Nitrate = 2.66g 100 ml. distilled water Sodium Citrate = 3.52g 
2. Dissolve separately with approximately 30 ml. 
water. 
3. Mix together in 100 ml. volumetric flask. The 
solution becomes white and cloudy. 
4. Shake well for 1 minute. 
5. Stand for 30 minutes with intermittent shaking. 
6. Prepare 1N NaOH solution, i. e. lg/25 ml. distilled 
water. 
7. Add 16 ml. of NaOH (freshly prepared) and mix 
well. The solution should be clear and PH 12.0. 
8. Centrifuge for 20 minutes at 2,000 r. p. m. and 
store at +4°C. Avoid contact with air. 
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Uranyl Acetate 
This substance is radioactive and all instruments 
should be decontaminated with concentrated decon 
for 24 hours. Plastic gloves should be worn. 
1. Prepare 0.33g Uranyl Acetate/11 ml. 50% alcohol. 
2. Mix well on a magnetic stirrer (covered). 
3. Centrifuge for 20 minutes at 2,000 r. p. m. 
4. Prepare fresh each time. 
Osmium Tetroxide (Os04) Fixative 
This substance is harmful and should always be 
handled in a fume cupboard. Plastic gloves should 
be worn. 
1. OsO4 is distributed in lg glass capsules. 
2. When preparing a 2% solution of Osmium - break 
open the capsule (using a wad of tissue), and 
quickly place the Osmium and the glass capsule 
into a brown stopped bottle. 
3. Add 50 ml. distilled water and shake well. 
4. Always return to the fridge immediately after 
use and store at this temperature. 
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